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Preface 
 
This thesis was conducted between October 2010 to December 2013 at the Group of Epidemiology 
and Risk Modeling, the National Food Institute, Technical University of Denmark. A part of the 
work in this thesis was performed during the three months stay at the National Institute for Public 
Health and the Environment (RIVM), The Netherlands. The project was funded by Technical 
University of Denmark through the FoodDTU programme.  
 
The thesis focuses on method development in risk-benefit assessment and burden of disease 
estimation of food.  
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Summary  
 
Due to the increasing interest of food authorities, producers and consumers in knowing the health 
outcomes of food consumption, risk-benefit assessment of food and burden of foodborne disease 
studies have become major topics for scientists in recent years. Health risk-benefit assessment of 
food and burden of foodborne disease studies are used to estimate the health outcomes related 
to food consumption. Both studies combine food consumption, epidemiological and population 
statistics data to predict the health outcomes of food consumption. While risk-benefit assessment 
of food integrates the health outcomes of the beneficial and hazardous components of food, the 
burden of foodborne disease study typically focuses on the health outcomes of the hazardous 
components of food.  
 
Progressively, the risk and benefit assessment of food is shifting from a separate qualitative 
assessment to an integrated quantitative risk-benefit assessment. During the last decade, methods 
for health risk-benefit assessment of food have been developed. Most of these methods focus on 
comparison of two or more scenarios and predict the relative health outcome of the scenarios.  
 
This thesis aims to further develop the existing methods for health risk-benefit assessment of 
food. The present thesis comprises of three studies. Given that microbial hazards were not well 
integrated in previous health risk-benefit assessment of food, the first study of this thesis 
illustrates how a microbiological hazard can be included in a typical risk-benefit assessment and 
how this may add to the existing risk-benefit assessment tools and methodologies (CHAPTER 6). 
Then, a method for health risk-benefit assessment of food is developed, using vitamin D as an 
example (MANUSCRIPT I). In addition, burden of disease estimates related to the various red meat 
cooking practices are performed (MANUSCRIPT II).  
 
In PAPER I, an integrated quantitative health risk-benefit assessment was conducted, using DALY 
(disability adjusted life years) as a common health metric. The health outcomes of Listeria 
monocytogenes and omega-3 fatty acids were estimated due to the consumption of CSS in 
Denmark using two consumption scenarios. The reduction of the risk of Coronary Heart Disease 
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(CHD) mortality and stroke, as well as enhanced cognitive (IQ) development of unborns following 
maternal intake, are identified as the main health benefits of omega-3 fatty acid from CSS. 
Contrary, risk of meningitis, septicemia and abortion are identified as health risk endpoints due to 
exposure to L. monocytogenes. Results show that the overall health benefits outweigh the risk, 
foremost contributed by the effect of decreased CHD mortality and improved IQ. The study 
demonstrated how microbial risks can be integrated in risk-benefit assessment, and shows that a 
sensitivity analysis has an added value, even if the benefits largely outweigh the risk in the initial 
analysis. This suggests that modulating the food processing parameter can have a significant 
impact in the reduction of the net health loss.  
 
In CHAPTER 7, a method for health risk-benefit assessment of food was developed, using vitamin D 
as an example. The method focuses on finding an optimum scenario that provides maximum net 
public health gain. The method is based on multiple scenario simulation. In addition to the 
reference scenario, several alternative scenarios are simulated to detect the scenario that 
provides maximum net health gains. As a common health metric, Disability Adjusted Life Years 
(DALY) has been used to project the net health effect by using the QALIBRA (Quality of Life for 
Benefit Risk Assessment) software. The example on vitamin D illustrates the applicability of the 
developed method. The method is illustrated only on nutrient, vitamin D. The method may include 
food processing parameter optimization (temperature – time of cooking, storage, handling 
condition and addition of preservatives) and scenario simulation as an integral part of the 
assessment to maximize the net health gain.  
 
In MANUSCRIPT II, the burden of disease estimates for the different red meat cooking practices 
was performed. The health impacts of barbecued, fried and roasted red meat were compared 
using DALY as a common health metric. The selected health effect linked to cooked red meat 
consumption includes colorectal, prostate, breast and pancreatic cancer. The result reveals that 
the healthy life year’s loss is considerable due to the consumption of barbecued red meat 
compared to the other cooking practices. This study indicates that the choice of cooking practice 
has an impact on the reduction of health loss. The method used to quantify the difference in 
disease burden consequential to different cooking practices can help to inform the consumer to 
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make a choice whether the benefit of a preferred cooking style is worth the associated health loss. 
This study is the first to show burden of disease estimate related to red meat cooking practices 
and the method applied in this study can be used as a basis for similar studies in the future.  
To conclude, this thesis contributes for further development of the existing risk-benefit 
assessment of food methodologies. Parts of the thesis also suggest that food processing 
parameter optimization and the choice of the cooking practice contribute for the improvement of 
public health linked to food consumption.  
 
In the future, additional case studies need to be performed to further apply the proposed method. 
For efficient integrated risk-benefit assessment, a database that encompasses data of nutrients, 
chemical contaminants, pathogens and their disease epidemiology needs to be constructed. 
Future risk-benefit assessment of food may incorporate emerging nutrigenomics, toxicogenomics 
and pathogenomics data, to take into account population genetic variation in response to intake 
and exposure to nutrients, chemical contaminants and pathogens. Additional studies are needed 
to investigate the impact of food cooking practices (in different food products) on the total burden 
of foodborne diseases. 
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Sammendrag 
 
Da fødevaremyndigheder, producenter og forbrugere har stigende interesse i at kende det 
sundhedsmæssige udfald af indtaget af fødevarer, er risk-benefit vurderinger og studier i 
fødevarerelateret sygdomsbyrde blevet et væsentligt emne for forskere i de senere år.  
Sundhedsmæssige risk-benefit vurderinger af fødevarer og studier i fødevarerelateret 
sygdomsbyrde bruges til at estimere det sundhedsmæssige udfald relateret til indtaget af 
fødevarer. Begge slags vurderinger/studier kombinerer fødevareindtag, epidemiologi og statistiske 
populationsdata til at forudsige det sundhedsmæssige udfald af indtaget af fødevarer. Risk-benefit 
vurderinger af fødevarer integrerer sundhedsmæssige udfald af både de gavnlige og de skadelige 
komponenter i fødevarer, hvorimod studier i fødevarerelaterede sygdomme typisk fokuserer på 
de sundhedsmæssige effekter af de skadelige komponenter i fødevarer. 
 
Vurdering af de gavnlige og skadelige effekter af fødevarer er gradvist skiftet fra at være separate 
kvalitative vurderinger til at være en integreret kvantitativ risk-benefit vurdering. Metoder til 
sundshedsmæssige risk-benefit vurderinger af fødevarer er blevet udviklet i løbet af det sidste årti. 
De fleste af disse metoder har fokuseret på at sammenligne to eller flere scenarier og forudsige 
det relative udfald af disse scenarier. 
 
Denne afhandlings formål er at videreudvikle de eksisterende metoder til sundhedsmæssig risk-
benefit vurdering af fødevarer. Afhandlingen består af tre studier. Da mikrobielle risici ikke er godt 
integreret i tidligere sundhedsmæssige risk-benefit vurderinger af fødevarer, illustrerer denne 
afhandlings første studie, hvordan mikrobielle risici kan inkluderes i en risk-benefit vurdering og 
hvordan dette kan forbedre de eksisterende risk-benefit værktøjer og metoder (KAPITEL 6). 
Dernæst er der udviklet en metode til sundhedsmæssig risk-benefit vurdering af fødevarer. 
Metoden er anvendt i et eksempel med D-vitamin (MANUSKRIPT I). Derudover er der gennemført 
sygdomsbyrde estimater relateret til forskellige tilberedningsmetoder af rødt kød (MANUSKRIPT 
II). 
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En integreret kvantitativ sundhedsmæssig risk-benefit vurdering, hvor DALY (disability adjusted life 
years) blev brugt som en fælles sundhedsenhed, blev udført i ARTIKEL 1. De sundhedsmæssige 
effekter af Listeria monocytogenes og omega-3-fedtsyrer blev estimeret på baggrund af indtaget 
af koldrøget laks i Danmark ved at bruge to indtags scenarier. Nedsat risiko for dødelighed af 
hjertekarsygdom (CHD) og slagtilfælde samt øget kognitiv (IQ) udvikling af ufødte afhængende af 
moderens indtag blev identificeret som de væsentligste gavnlige effekter af omega-3-fedtsyrer fra 
koldrøget laks. Risiko for meningitis, sepsis og abort/dødfødte blev identificeret som 
sundhedsmæssige risici, når man bliver udsat for L. monocytogenes. Resultaterne viser at 
overordnet er der samlet er en sundhedsmæssig fordel, især pga. effekten af nedsat CHD 
dødelighed og forbedret IQ. Dette studie viser, hvordan mikrobielle risici kan integreres i risk-
benefit vurderinger, og viser at sensitivitetsanalyser har en øget værdi, selvom de gavnlige effekter 
i høj grad overgår risikoen i de indledende analyser. Dette viser, at ændringerne i 
fødevareproduktionen (modulering af en fødevareproces parameter) kan have signifikant 
indflydelse på reduktionen af netto sundhedsmæssige tab. 
 
I Kapitel 7 er der udviklet en metode til at udføreen risk-benefit vurdering, hvor D-vitamin er brugt 
som eksempel. Metoden fokuserer på at finde det scenario, der giver flest sundhedsmæssige 
fordele for befolkningen, og er baseret på en simulation af mange scenarier. Udover 
referencescenariet er der simuleret flere alternative scenarier for at finde det scenarie, der giver 
den største sundhedsmæssige gevinst. Som en sundhedsmæssig fællesnævner benyttes ”Disability 
adjusted life years” (DALY), der udregnes vha. QALIBRA software (Quality of Life for Benefit Risk 
Assessment). Eksemplet med D-vitamin viser at den udviklede metode er anvendelig. Metoden er 
kun vist for et enkelt næringsstof, D-vitamin. I vurderingen kan der inddrages 
fødevareproduktionsparametre (temperatur, tilberedningstid, håndtering, opbevaring, og brug af 
tilsætningsstoffer) og simulation af scenarier som en integreret del af vurderingen for at optimere 
den sundhedsmæssige gevinst. Som eksempel og for at validere den foreslåede måde at vurdere 
risk-benefit på, har vi vurderet D-vitamin (Manuskript I). Eksemplet med D-vitamin viser at 
metoden er anvendelig.    
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I Manuskript II er sygdomsbyrden for forskellige måder at tilberede rødt kød på blevet vurderet. 
Den sundhedsmæssige betydning af grillet, pandestegt og ovnstegt rødt kød udtrykt som DALY er 
blevet sammenlignet. Kolorektal-, prostata-, og brystkræft samt kræft i bugspytkirtlen er de 
sundhedsmæssige effekter der er blevet kædet sammen med indtag af tilberedt rødt kød. 
Resultatet af sammenligningen viser at tabet af livsår er størst ved indtag af grillet rødt kød. 
Vurderingen viser at valget af tilberedelsesmetode har betydning for sundheden. Den anvendte 
måde at vurdere kvantificere sygdomsbyrde for forskellige tilberedelsesmetoder kan hjælpe 
forbrugerne til at træffe beslutningen, om fordelen ved en bestemt tilberedelsesmetode er 
risikoen værd. Dette forsøg er det første til at vise sygdomsbyrden relateret til indtag af tilberedt 
rødt kød, og demonstrerer at den anvendte metode kan bruges fremover.   
Det kan konkluderes at denne afhandling bidrager til den fortsatte udvikling af eksisterende 
værktøjer til risk-benefit vurderinger indenfor fødevareområdet. Afhandlingen viser også at 
optimering af fødevareproduktionsparametre og valget af tilberedelsesmetode bidrager til at øge 
folkesundheden. 
 
Der vil fremadrettet være behov for at udføre yderligere forsøg for at validere den foreslåede 
metode. I forhold til en integreret risk-benefit vurdering er det nødvendigt at lave en database der 
indeholder data om næringsstoffer, kemiske forureninger, patogener og deres 
sygdomsepidemiologi. Fremtidige helhedsvurderinger af fødevarer bør inddrage kommende 
nutrigenomics, toxicogenomics og pathogenomics data og medtage variationer i befolkningens 
genetik i forhold til indtag af, og eksponering til næringsstoffer, kemiske forureninger og 
patogener. Yderligere forsøg er nødvendige for at undersøge betydningen af tilberedelsesmetoder 
for forskellige fødevarer på den totale sygdomsbyrde. 
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1. Introduction 
 
A number of food products contain both beneficial and hazardous components.  The weighing of 
risks and benefits of food or food components has thereby become a main public health issue 
(Hoekstra et al., 2008). Risk-benefit assessments of food focus on interventions and policies in 
connection with food consumption and health outcomes (Hoekstra et al. 2012).  Food policy 
makers, scientists, nutritionists, dieticians, food industries as well as consumers are interested to 
know the health impact of food.  
 
The degree of the detrimental effect of a hazard on the health of the consumer is often 
established by risk assessment. Likewise, the extent of the beneficial effect of a food on the health 
of the consumer may be established by benefit assessment. In 1995, a risk assessment paradigm 
had been established (FAO/WHO, 1995). Until some time ago, the risk and benefit assessments of 
food have been separate processes with different methods. Due to the increasing interest of 
estimation of the overall health impact of food consumption, development of methods that 
integrate both the health benefits and risks of food in one go have gained interest. Gradually, it 
has been recognized that a similar paradigm as used for the risk assessment can be used for the 
benefit assessment and in addition for the integrated risk–benefit assessment approach (EFSA, 
2006a, EFSA, 2010).  
 
Usually, the health risk-benefit assessments of food have been performed qualitatively using a 
gauge such as tolerable upper intake level or acceptable daily intake or recommended daily intake 
level without integrating them in common health metrics (Sand et al., 2008). Thus, the result of 
the assessment about the risks and benefits of food are presented separately. Qualitative risk-
benefit assessment will not provide information about the healthy life years that could be gained 
or lost. Therefore, preferably the risk and benefit have to be combined to provide a signal about 
the overall health effect of a certain food or food components (Hart et al., 2010).   
 
During the last decade, scientists had worked to develop an approach that enables to perform a 
holistic quantitative risk-benefit assessment of foods (Hoekstra et al., 2008; Fransen et al., 2010; 
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Hoekstra et al., 2012; EFSA, 2010; Hart et al., 2013). Besides methodology development studies, 
several case studies have been conducted on risk-benefit assessment of different foods or food 
components (Gladyshev et al., 2008; Cohen et al., 2005; Guevel et al., 2008; Hoekstra et al., 2013b; 
Watzl et al., 2011; Schutte et al., 2012; Verhagen et al., 2012, Berjia et al., 2012).   
 
Recently, a progressively quantitative risk-benefit assessment approach that integrates the 
positive and negative health effects has been developed in an EU-funded project (Hoekstra et al., 
2012; Hart et al., 2013). However, these approaches and other similar quantitative case studies 
focus on comparison of two or more scenarios and state whether one scenario prevails over the 
other/s in terms of health effect (Cohen et al., 2005; Hoekstra et al., 2013b).  Ideally, it is 
imperative to make a statement about the best scenario that provides maximum health benefit to 
the public.  
 
To integrate the health effects of beneficial and hazardous components, DALY and QALY 
(disability/quality adjusted life years) is the best known health outcome measurement in the 
population. DALY is a measure of potential healthy life years lost due to premature death and poor 
health or disability (Murray and Lopez, 1996). QALY measure the total number of years of perfect 
heath in a population (Murray and Lopez, 1996). The detail of DALY and QALY is presented in 
chapter 5.1.  
 
DALY has mostly been used to estimate the burden of disease attributed to the environment, 
nutrition, foodborne pathogens and infectious diseases (Murray and Lopez, 1996; Murray et al., 
2013; Gkogka et al., 2011; Havelaar et al., 2012). It has also been applied in risk-benefit 
assessment of food (Hoekstra et al., 2008; Berjia et al., 2012; Hoekstra et al., 2013b). Nevertheless, 
the burden of disease study as well as risk-benefit assessment study related to the consequences 
of the different food preparation was not studied.  The common features of burden of disease 
study and health risk-benefit assessment of food study is that both studies deal with health 
outcomes interpreted using common health metric and are used to support decision makers in 
relation to public health issues.  
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1.1 Objectives of the thesis  
 
The overall objective of the PhD project was to further develop a risk-benefit assessment of foods 
or food components approach. 
   
The specific aims are:  
  
- To perform a case study in risk-benefit assessment of food. This case study deals with the 
benefit of omega-3 fatty acids and the risk of listeriosis due to the consumption of cold-
smoked salmon (PAPER I).  
- To develop a method for risk-benefit assessment of food which focus on finding optimum 
scenario that provides maximum net health gain (MANUSCRIPT I). 
- To perform a case study to develop a method that enable to estimate burden of disease 
related to different food cooking practices of the same food (MANUSCRIPT II). 
 
1.2 Outline of the thesis  
 
This PhD thesis is divided into 10 chapters. Chapter 1 (this chapter) provides general introduction 
about risk-benefit assessment and burden of disease. In addition, it contains the objectives of the 
PhD project and outline of the thesis.  Chapter 2 presents definitions in risk-benefit assessment of 
food and literature review related to food safety, food health hazards, food health benefits and 
risk-benefit assessment. Chapter 3 portrays the existing food health risk-benefit assessment 
methodologies and other risk-benefit assessment studies. In addition, it describes the similarities 
and differences of the existing food risk-benefit assessment methodology studies. Chapter 4 
depicts the application of health risk-benefit assessment of food and selected qualitative and 
quantitative risk-benefit assessment of fish studies. In addition, it presents an opinion about fish 
risk-benefit assessment studies. Chapter 5 discusses other issues related in risk-benefit 
assessment of food including common scale, data, uncertainty and sensitivity analysis, expertise 
needed and consumer perception in risk-benefit assessment food. Chapter 6 presents a case study 
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that deals risk-benefit assessment of cold-smoked salmon: microbial risk versus nutritional benefit 
(PAPER I). Chapter 7 presents a method to find the optimum scenario in risk-benefit assessment: 
an example on vitamin D (MANUSCRIPT I). Chapter 8 details a study on burden of disease estimate 
of the different red meat cooking practices in Denmark (MANUSCRIPT II). Chapter 9 discusses the 
results obtained from PAPER I and the MANUSCRIPTS produced during the PhD study. In addition, 
it discusses in broad context what need to be considered to find the optimum scenario that 
provides maximum net health gain in holistic risk-benefit assessment of food. Furthermore, it 
discusses the challenges in performing holistic integrated quantitative risk-benefit assessment of 
food. Chapter 10 summarizes the overall conclusion of the PhD study and future perspectives.    
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Chapter 2 
Definitions in risk-benefit assessment of food, 
burden of foodborne disease and concept of 
food safety hazard and benefit 
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2. Definitions in risk-benefit assessment of food, burden of foodborne disease and concept of 
food safety hazard and benefit  
This PhD thesis considers the health risk and benefit associated with the consumption of a 
particular food or food component. The health effects related to food consumption are a result of 
exposure to pathogens, chemical contaminants and intake of nutrients or combinations. 
Therefore, it is essential to have a general understanding of the different health hazards and 
beneficial components linked to food consumption. The definitions given hereunder include a 
general definition used in risk-benefit assessment of food, burden of disease and definitions 
specific to this PhD thesis.  
Hazard: The inherent property of a food that potentially causes detrimental health effects when 
an individual is exposed to it (IPCS, 2004). 
 
Risk: The probability of an adverse health effect in an individual in response to exposure to a 
hazard that may be present in a food or nutrient (IPCS, 2004). 
 
Benefit: The probability of a positive health effect and/or the probability of a reduction of an 
adverse health effect in a population when exposed to the food (EFSA, 2010; Hoekstra et al., 
2012). 
 
Risk-benefit assessment: The weighing of probability of an adverse health effect against the 
probability of benefit as a consequence of exposure, if both are known to be present (EFSA, 2010). 
 
Optimum health effect: The maximum health gain obtained by several scenario simulations, 
fortification, food processing parameter optimization or combinations, when relevant. The 
achievement of best scenario that provides optimum health effect gain may involve the reduction 
of the risk of the potential hazardous component of the food and maximizing the positive health 
effect of the beneficial component, when both hazardous and beneficial components are known 
to be present in a food.  
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Food processing parameter optimization: The process of identification of the parameters in food 
processing pathway (and in some cases after intake or exposure) that affect the concentration of 
the hazardous and beneficial components. Followed by incorporating those parameters in the 
model and quantify them in order to optimize the net health impact of food consumption. 
Examples of food processing parameters:  cooking time, temperature and storage conditions.  
 
Burden of foodborne disease: The health impact of food consumption in an individual or a 
population measured by common health metrics. It is often quantified in terms of QALY or DALY 
by combining food consumption, mortality, morbidity, recovery and population statistics data 
(Murray and Lopez, 1996; Hoekstra et al., 2012; Hart et al., 2013). 
 
DALY: An acronym for disability adjusted life year, is a measure of disease burden, expressed as 
the number of years lost due mortality, morbidity or recovery (Murray and Lopez, 1996; Hoekstra 
et al., 2012; Hart et al., 2013) 
 
Duration of the disease: is the period at which from the onset of the disease until recovery or 
death, it may also take into account recurrence period of the disease.   
 
Disability or severity weight: is a weight factor that reflects the severity of the disease on a scale 
from 0 (perfect health) to 1 (equivalent to death).  
 
Life expectancy: is the expected age at death (Hoekstra et al., 2012). 
 
 The following section elucidates the various hazardous and beneficial components linked to food 
consumption. 
 
2.1 Food safety health hazards  
 
Foodborne illness is a serious problem all over the world, causing a considerable morbidity, 
mortality and substantial economic losses. There are three known food safety hazards: biological, 
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chemical and physical hazards (Alli, 2004). With regard to health risk-benefit assessment of food 
and burden of foodborne disease, biological and chemical hazards are a major concern.  
 
2.1.1 Biological hazards 
 
The majority of the biological hazards linked to food are pathogenic bacteria and their toxins. 
Foodborne pathogenic bacteria are accountable for a great proportion of foodborne illness 
outbreak (IFT, 2004). Often, large shares of the reported cases are caused by Salmonella spp., 
Eschericha coli 0157:H7, Lysteria monocytogenes, Clostridium perfringens, Clostridium botulinum, 
Staphylococcus aureus, and Campylobacter jejeuni (IFT, 2004). Many severe and fatal incidents 
happen in infants, elderly and immunocompromised.  
 
In addition, certain viruses such as hepatitis A and E viruses, the Norwalk viruses and rotavirus can 
cause foodborne illness (Koopmans and Duizer, 2004). Moreover, several human parasites such as 
Cryptosporidium parvum, Giardia lambia and Ascaris lumbricoides (Dawson, 2005) and to a lesser 
extent fungi (such as moulds) can cause foodborne illness (Udagawa, 2005).  
 
2.1.2 Chemical Hazards 
 
The sources of the chemical contaminants in food are diverse. For example, food additives are a 
hazard when taken beyond the tolerable level. Food may contain naturally occurring chemical 
contaminants (oxalate in rhubarb, alkaloids in potatoes, toxins in mushrooms) (Watson, 2001).  
Agricultural residues such as pesticides, herbicides, fungicides, antibiotics and other veterinary 
drugs can also be food safety hazard (Schrenk, 2012). Industrial activity contaminants such as 
heavy metals (lead, mercury and arsenic), organochlorinated compounds such as polychlorinated 
biphenyls (PCBs) are a known chemical food safety hazards (Watson, 2001).   
 
Furthermore, some chemical contaminants can be formed during food processing especially 
during high temperature cooking of certain food products. Polyaromatic hydrocarbons, hetrocyclic 
amines, hetrocyclic amines and acrylamide are good examples of chemical contaminants formed 
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during high temperature processing of food (NTP, 1999; NTP, 2002; SCF, 2002; EFSA, 2008; 
WHO/IARC, 2010; EFSA, 2011).  
 
Other chemical food safety hazards related to the consumption of food includes food allergens 
that cause allergic reaction in some subpopulation (Schrenk, 2012) and mycotoxin formed due to 
fungal activities in food (Watson, 2001).    
 
2.1.3 Other food safety issue 
 
In addition to the biological and chemical hazards, some nutrients can be deleterious when the 
intake is too low (deficiency) or too high (excessive). This can be the case for folic acid, vitamin D, 
iodine, niacin, selenium, vitamin A and zinc (Vanderveen, 2006). Therefore, for nutrients that can 
induce adverse health effect at a lower or higher intake, determining the intake level that provides 
optimum health effect could be crucial.  
  
2.2 Concept of food safety risk analysis  
 
Food safety risk analysis is used to estimate the risks to human health due to the exposure to 
hazards during food consumption. Its primary aim is to estimate the probability of the occurrence 
of foodborne illness (FAO/WHO, 2005). In addition, it supports to find and apply appropriate 
measures to regulate the risks and to communicate with stakeholders about the possible risk 
mitigation (FAO/WHO, 2005). A risk analysis includes risk assessment, risk management and risk 
communication. In this PhD thesis more focus is given to risk-benefit assessment than to risk-
benefit management and communication.  
 
2.3 Food component health benefits 
  
Food contains various nutritional constituents that are indispensable for human health. The 
nutrients that contribute to the growth, development and well-being of human health are 
carbohydrates, fats, proteins, vitamins, minerals and water (Kohlstadt, 2009). The health benefits 
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of these components are diverse, for example supplying energy, built and repair body tissues, 
improve immune system, prevent or reduce several chronic and acute diseases (Kohlstadt, 2009).  
 
Several nutritional epidemiological studies reported the role of various nutrients in the prevention 
of several diseases, for instance omega-3 fatty acids prevent or reduce risk of cardiovascular 
diseases (Kris-Etherton et al., 2003), cobalamin in the prevention of megaloblastic anemia 
(Bolaman et al., 2003) or the role of vitamin D in the prevention of bone diseases (Bischoff-Ferrari 
et al., 2010).  
 
In addition to the nutrients, certain microbes could provide health benefits. For instance, 
probiotics may prevent necrotizing enterocolitis and mortality in preterm very low-birth-weight 
infants (Wang et al., 2012).  
 
On the other hand, some nutrients may be the source of both health benefits and risks. For 
instance, folic acid reduces the incidence of neural tube diseases (IOM 1998; Ray et al., 2002), and 
colorectal cancer (Kim et al., 2001; Sanjoaquin et al., 2004). On the contrary, folic acid may cause 
health problem such as masking vitamin B12-deficiency leading to progression of irreversible 
neurological symptoms (IOM, 1998; SCF, 2000).  
 
2.4 Risk-benefit assessment of food  
 
Food could contain both health benefits and risks. So, the weighing of the benefits against the 
risks becomes an interesting issue (Hoekstra et al., 2008). If the intake of a particular food or food 
component provides both health risk and benefit, it is essential to delineate an intake level within 
which the balance of risk and benefit is acceptable for risk management purposes (Hoekstra et al., 
2008).   
 
Due to the increasing interest of the integration of the health risk and benefit of food consumption 
among food chain stakeholders, significant progresses have been achieved in method 
development of health risk-benefit assessment of food during the last decade.  
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With regard to method development for human health risk-benefit assessment of food, EFSA has 
taken the initiative to organize a scientific colloquium on risk-benefit analysis of foods in July 2006 
to have an open scientific debate on the methods and approaches for risk-benefit analysis of 
foods. The outcome of the colloquium was that risk-benefit analysis and assessment should mirror 
the old paradigm of risk analysis and risk assessment. In addition, to facilitate the communication 
of the result of health risk-benefit assessment of food, a common scale particularly DALY and 
QALY, to combine the positive and negative health effect have been suggested (EFSA, 2006a).  
 
Later, it was proposed that guidance on risk-benefit assessment of food with respect to 
methodology, approaches, tools and potential limitations in the risk-benefit assessment should be 
documented. Since then, various EU-funded projects such as the Beneris, Qalibra, Brafo, 
Bepraribean and PlantLIBRA projects, have been launched to address health risk-benefit 
assessment of food and food ingredients.  
 
Among these projects, QALIBRA and BRAFO provide a quantitative integrated health risk-benefit 
assessment approach using common health metrics.  
 
The following chapter describes the existing methods in health risk-benefit assessment of food 
and other similar studies. In addition, the similarities and differences of the existing methods are 
elaborated in section 3.7.   
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Chapter 3 
The existing methods and other similar studies in 
risk-benefit assessment of food 
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3. The existing methods and other studies in risk-benefit assessment of food  
 
During the last decade, different approaches have been proposed to integrate the health risk and 
benefit of food or food component intake. Most of the risk-benefit approaches are established in 
EU-funded projects. These methods and other risk-benefit studies are presented hereunder.  
 
3.1 EFSA: Guidance on human health risk-benefit assessment of foods 
Probably, EFSA is the pioneer in conceptualizing the health risk-benefit assessment of food. EFSA 
suggests a progressively integrated health risk-benefit assessment of food by using the same risk 
assessment paradigm for benefit assessment (EFSA, 2010).  A stepwise approach is suggested for 
the risk-benefit assessment following a problem formulation. The aim of problem formulation is to 
elucidate what is included in the assessment (EFSA, 2010). 
 
The EFSA  guidance comprises of three steps:  i) initial assessment, addressing whether the health 
risks clearly outweigh the health benefits or vice versa, ii) refined assessment, aiming at providing 
semi-quantitative or quantitative estimates of risks and benefits at relevant exposure, by 
considering different populations and refining the dose-response; iii) comparison of risks and 
benefits using a composite metric such as DALYs or QALYs to express the outcome of the risk-
benefit assessment as a single net health impact value. At the initial assessment, the classical risk 
assessment paradigm is mirrored for benefit assessment. It includes: 1) hazard-positive health 
effect identification; 2) hazard-positive health effect characterization; 3) exposure assessment; 4) 
risk-benefit characterization. At each step of the process, the assessment could stop when it is 
clear that the risk outweighs the benefit or vice versa (EFSA, 2010).  
 
In EFSA guidance, various specific aspects of risk-benefit assessment issues including exposure 
scenarios, data, common health metrics and uncertainty analysis have been discussed. In addition, 
simple examples on fish and selenium have been performed to illustrate the method.  
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3.2 BRAFO tiered approach for benefit–risk assessment of foods 
BRAFO (Benefit–risk analysis for foods) is an EU project conducted from 2007 to 2010. The main 
aim of BRAFO was to develop a framework that allows for the comparison of human health risks 
and benefits in relation to foods and food compounds by using a common scale (when needed) 
(Hoekstra el al., 2012).  
 
The approach starts with pre-assessment and problem formulation, followed by a separate risk 
and benefit assessment as proposed by EFSA (2010). Like EFSA, it mirrors the classical risk 
assessment paradigm for benefit assessment. The approach consists of four tiers. In Tier 1, each 
risk and benefit is assessed independently. In Tier 2, risks and benefits are compared qualitatively 
without using common metric. In Tier 3, risks and benefits are combined quantitatively using a 
common metric, by a deterministic approach. In Tier 4, risks and benefits are integrated 
quantitatively in a common metric by a probabilistic approach. It should be noted that, at each tier 
the assessment could stop when it is clear that the benefit prevails over the risk or vice versa.  
 
In addition, a DALY and QALY model is developed in the BRAFO project, to integrate the health risk 
and benefit. The model considers three possible health outcomes after the onset of a disease: 
recovery from the disease, death as a result of the disease, or survive with the disease until the 
normal life expectancy (Hoekstra et al., 2012). This DALY model has been used throughout this 
PhD thesis to combine the health risk and benefit.  
 
Moreover, various issues related to risk-benefit assessment including DALY calculation for 
continuous and quantal health effects, dose-response for different health effects, data, 
presentation and interpretation of the outcome, and uncertainty have been described (Hoekstra 
et al., 2012).  
 
Furthermore, several case studies have been conducted to validate the BRAFO tiered approach, 
and in most of the case studies it has been observed that the assessment stopped at early stage 
before the health effects are integrated using common health metrics (Schütte et al., 2012; 
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Verhagen et al., 2012; Watzl et al., 2012).  The case studies demonstrate the applicability of the 
BRAFO tiered approach for health risk-benefit assessment of food.   
 
3.3 QALIBRA 
 
Qalibra (Quality of Life – Integrated Benefit and Risk Analysis) is also an EU project conducted from 
2006 to 2009. Qalibra aimed to provide a user-friendly tool for a deterministic and/or probabilistic 
(when needed) risk-benefit assessment of food (Hart et al., 2013). The software is developed for 
quantitative assessment of risks and benefits corresponding to tier 3 and 4 of the BRAFO tiered 
approach (Hoekstra el al., 2012). It quantifies uncertainties and variabilities at each stage of the 
process, if necessary.  
 
The case studies performed by using QALIBRA tool includes fish risk-benefit assessment (Hoekstra 
et al., 2013); a simple example on fish risk-benefit assessment to illustrate the output (Hart, et al., 
2013); benefit–risk assessment of plant sterols in margarine (Hoekstra et al., 2013a) and the 
vitamin D optimum scenario (chapter 7 of this thesis). The case studies illustrate how the QALIBRA 
tool can be used in a quantitative risk-benefit assessment.  
 
3.4 BENERIS: Benefit-risk assessment for food 
 
Beneris (Benefit-risk assessment for food) is an EU project conducted from 2006 to 2009. The 
general objective of BENERIS was to create a framework for handling complicated benefit-risk 
situations and apply it for analysis of the benefits and risks of certain foods using Bayesian belief 
networks (BBN) (Tuomisto, 2010).  
 
The main outcome of Beneris is the enhanced methodology (open assessment) for benefit-risk 
assessments in the web workspace Opasnet. The benefit-risk assessment method is described on 
the web workspace Opasnet (http://en.opasnet.org). A risk-benefit case study on fish was 
performed in order to illustrate the developed method and BBN in practice (Tuomisto, 2010).  
 
17 
 
3.5 BEPRARIBEAN: Best practices for risk-benefit analysis 
 
BEPRARIBEAN (best practices for risk-benefit analysis) is a state-of-the-art of benefit-risk analysis 
project conducted from 2009 to 2011. The BEPRARIBEAN project aims to advance benefit–risk 
analysis in the area of food and nutrition by learning from other fields. It describes the state of the 
art in benefit-risk analysis in medicine (Luteijn et al., 2012), food microbiology (Magnússon et al., 
2012), food and nutrition (Tijhuis et al., 2012), environmental health (Pohjola et al., 2012), 
economics and marketing–finance (Kalogeras et al., 2012) and consumer perception (Ueland et al., 
2012).  
 
3.6 PlantLIBRA: plant food supplements: levels of intake, benefit and risk assessment 
 
PlantLIBRA (plant food supplements: levels of intake, benefit and risk assessment is an ongoing EU 
project, aims to foster the safe use of food supplements containing plants or botanical products, 
by increasing science-based decision-making by regulators and food chain operators. PlantLIBRA is 
structured to develop, validate and disseminate data and methodologies for risk and benefit 
assessment and implement sustainable international cooperation 
(http://www.plantlibra.eu/web/node/44, 2013).  
 
3.7 Similarities and differences of the existing risk-benefit assessment methodologies 
 
The food risk-benefit assessment methodologies considered for comparison in this section 
includes EFSA guidance (EFSA, 2010), a tiered approach for risk-benefit assessment of foods, 
example on folic acid (Fransen et al., 2010; Hoekstra et al., 2008), the BRAFO tiered approach 
(Hoekstra et al., 2012), BENERIS (Tuomisto, 2010) and QALIBRA (Hart et al., 2013).  
 
The methodologies mentioned above are splitted into two categories depending on the 
resemblance of the study. Category 1) includes EFSA guidance, a tiered integrated approach for 
risk-benefit assessment of foods, example on folic acid and the BRAFO tiered approach. They 
provide risk-benefit assessment of food methodologies. Category 2) includes BENERIS and 
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QALIBRA, which are web-based tools that assist to perform quantitative risk-benefit assessment of 
food.  
 
Category 1): The commonality of these risk-benefit assessment methodologies is the application of 
the classical risk assessment paradigm for risk-benefit assessment of food. In category 1 the 
methodologies initially assess the risk and the benefit separately without integrating them in a 
common health metrics. Then, they follow a progressively integrated quantitative risk-benefit 
assessment, using a common scale.  When there is sufficient information to answer the risk-
benefit assessment question (whether the risk outweighs the benefit or vice versa), the 
assessment could stop at early steps. This implies that, the health impact of the beneficial and 
hazardous component of food may not be integrated using a common health metric, if the 
assessment stops at earliest steps. Furthermore, category 1 methodologies in most cases consider 
comparison of two or more scenarios.  
 
Category 2): Includes QALIBRA and BENERIS. QALIBRA helps to run quantitative risk-benefit 
assessment described in BRAFO tier 3 and 4 by either a deterministic or a probabilistic approach. 
QALIBRA considers both variability and uncertainty present in the assessment. In QALIBRA one can 
integrate the risk and benefit by using either QALY or DALY. QALIBRA quantifies and reports the 
health impact (DALY or QALY) explicitly for those who die from a disease, survive with a disease 
until the normal life expectancy and for those who recover from a disease.  Also, QALIBRA makes it 
possible to quantify quantal (effects that are modelled as either absent or present, e.g. cancer) or 
continuous (effects expressed as a change in a continuous variable, such as a change in body 
weight) health effects and produce either graphical or tabulated results (Hart et al., 2013). In 
addition to quantifying the DALY or QALY of each health effect, scenarios and the net DALY or 
QALY, QALIBRA automatically computes the incidences of the endpoints for each scenario. Even 
though in QALIBRA one can run a comparison of only two scenarios at a time, it is shown in 
MANUSCRIPT I that it is possible to run as many scenarios as possible by repeating the run for the 
different scenarios. This is especially useful if one aims to identify the scenario that provides 
maximum net health gain by several scenario simulations. Once the input data are ready, QALIBRA 
quantifies the health impact within short time as opposed to manual computation that usually 
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takes longer time. Moreover, QALIBRA makes it possible to handle large amount of data and share 
it with interested users. In QALIBRA tool, the user is guided through the assessment and it is made 
clear in advance which data is needed.  
 
Experiences show that QALIBRA may not be limited to only quantification of risk-benefit 
assessment of food, it would also probably be used to compute burden of disease including the 
sequelae’s from different attribution as long as the input data are readily sorted.  QALIBRA does 
not calculate the intake, dose-response and the parameters needed for DALY or QALY on its own. 
The values for each parameter should be calculated and saved on MS-Excel as a CSV (comma 
delimited) file and need to be uploaded in the software. Also, a single parameter value can also be 
used to run in QALIBRA without uploading matrix.  
 
BENERIS provides a tool to collect, organize and distribute information on issues relevant for 
benefit risk analyses of food and environmental issue. It allows for the integration of data from 
food consumption and nutrient intake studies with chemical contaminant to evaluate exposure to 
both contaminants and nutrients in food. BENERIS has developed and applied Bayesian belief 
networks (BBNs).  BENERIS does not apply QALY or DALY for the integration of health effect and 
provide no information about the net health impact of hazardous and beneficial components of 
food. In addition, it is limited to the assessment of nutrient and toxicants.  
 
In general, the method developed by Fransen et al. (2010); Hoekstra et al. (2008); Hoekstra et al. 
(2012); Hart et al. (2013) explicitly guide how to perform a progressive quantitative integrated 
risk-benefit assessment by using a common scale. These approaches do not contradict each other, 
but rather they are complementary (Hart et al., 2013). In this PhD thesis a part of BRAFO approach 
QALIBRA were used.  
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Chapter 4 
Application of risk-benefit assessment in food 
and selected case studies  
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4. Application of risk-benefit assessment in food and selected case studies  
 
In addition to the above risk-benefit methodologies and case studies, several risk-benefit 
assessment studies have been conducted especially on fish. This section presents the application 
of risk-benefit assessment in food and food components. Besides, selected qualitative and 
quantitative risk-benefit assessment case studies are discussed.  
 
Risk-benefit assessment can be applied to food or food components in different circumstances.  
EFSA, (2010) and Fransen et al. (2010) suggest different situations where risk-benefit assessment 
can be applied in food or food components. Risk-benefit assessment is needed when a single food 
constituent induces both positive and negative health effects, for example folic acid (Hoekstra et 
al., 2008). If a certain level of dietary exposure is associated with both risk and benefit in different 
subpopulations, risk-benefit assessment is needed to define the preferred intake level for the 
different subpopulations (Fransen et al., 2010). Also, if the positive and negative health effects are 
a result of the different components of a food product, risk-benefit needs to be performed, for 
example in the case of fish omega-3 fatty acid versus chemical contaminants or a pathogen (Cohen 
et al., 2005; Hoekstra et al., 2013b; Berjia et al., 2012). In addition, risk-benefit assessment can be 
applied to determine the optimum scenario that provides maximum health gain (MANUSCRIPT I). 
 
Moreover, risk-benefit assessment can be applied when a substantial modification of dietary 
consumption patterns occur; for instance in case of food substitution (Verhagen et al., 2012). Risk-
benefit assessment is essential when chemicals are used to reduce microbial contamination 
(Havelaar et al., 2000). Risk-benefit assessment can be applied when enhanced bioavailability of 
nutrient by improving processing is associated with an increased survival of foodborne pathogens 
(EFSA, 2010). When a new food product is developed (that contains both beneficial and hazardous 
components), risk-benefit assessment can be applied to define the intake level to maximize the 
benefit and minimize the potential associated risk (EFSA, 2010).  
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4.1 Selected qualitative risk-benefit assessment of fish consumption studies 
 
Risk-benefit assessment of food, especially of fish, has gained interest in the recent years in 
Europe and USA. The risk-benefit assessment of fish studies in the Nordic countries are mostly 
evaluated in qualitative terms, which do not consider integration using common health metrics.  
The summary of risk-benefit assessment studies related to fish consumption in Denmark, Sweden, 
Norway, Finland, UK and Belgium is presented below.  
 
4.1.1 Fish risk-benefit assessment in Denmark 
 
In the Danish fish risk-benefit assessment, several nutritional benefits (such as vitamin A, D, 
selenium and iodine) and hazardous chemical contaminants (such as methyl mercury, cadmium, 
lead, arsenic and PCB) were reviewed. Nevertheless, the benefit of omega-3 fatty acids and risk of 
methyl mercury were highlighted (Fødevaredirektoratet, 2003).  
  
The Danish assessment recommends the intake of fish should be 200-300 g/week, with special 
consideration for certain fish species and subpopulations. As certain fish species contain high level 
of methylmercury, it was suggested that pregnant and breast-feeding women and should avoid 
the consumption of fish that contain high level methylmercury (Fødevaredirektoratet, 2003). For 
the elderly, the beneficial cardiovascular effects of omega-3 fatty acids outweigh risks associated 
with exposure to contaminants (Fødevaredirektoratet, 2003). 
 
4.1.2 Fish risk-benefit assessment in Finland 
 
In the Finnish fish risk-benefit assessment, the benefit of omega-3 fatty acids and the risk of 
chemical contaminants such as dioxins and dioxin-like PCBs and mercury have been studied. Fish 
should be consumed at least 200g/week and consumption should be varied between different fish 
species in order to minimize the intake of any individual contaminant. (Livsmedelssäkerhetsverket, 
2006). In addition, due to the contaminant levels, children, young people and persons at fertile 
age should only eat large Baltic herring, salmon, or pike (Livsmedelssäkerhetsverket, 2006).  
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4.1.3 Fish risk-benefit assessment in Norway 
 
The Norwegian assessment stressed the positive health effect of omega-3 fatty acids and the 
negative health effect of dioxins and dioxin-like PCBs and mercury.  Norwegians are generally 
recommended to eat more fish, varied between lean and fatty fish. A higher consumption is 
mainly advised due to beneficial cardiovascular effects in the older population and also beneficial 
effects on pregnancy and foetus development. From a toxicological point of view, it is reported 
that there is no danger associated with a high consumption (4 meals/week or more) if 
consumption is varied and fatty fish does not exceed 2 meals/week.  (VKM, 2006).  
 
4.1.4 Fish risk-benefit assessment in Sweden 
 
The Swedish risk-benefit assessment of fish consumption focuses the risk of dioxin and dioxin-like 
PCBs, and methyl mercury and the benefit of omega-3 fatty acids and vitamin D.  The Swedish 
assessment recommends an increased fish consumption. The Swedish assessment concludes that 
an increased fish consumption in line with the general dietary advice of 2–3 meals a week (250–
375 g/week), with consumption of different fish, is supported (Livsmedelsverket, 2007).  
Nevertheless, intake of certain fish (e.g. fish from Baltic sea) that contain high contaminant levels 
could lead to intake that surpasses the tolerable intake limits; this primarily concern children and 
women of child bearing age (dioxins/PCBs), and pregnant women (methyl mercury) 
(Livsmedelsverket, 2007).  
 
In general, in all the Nordic assessments the chemical contaminant risks are assessed in terms of 
the likelihood to exceed tolerable intake limits. All assessments take in account the positive health 
effect of omega-3 fatty acid on the cardiovascular system to be the most important and probable 
beneficial effects on foetus development are also pointed out (Sand et al., 2008). 
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4.1.5 Fish risk-benefit assessment in United Kingdom 
 
In the UK assessment, it was concluded that British consumers should eat more fish and 
recommends at least two portions per week, of which one should consist of fatty fish. This is 
because the positive effects on reducing the risk of cardiovascular disease and foetal development 
due to intake of omega-3 fatty acids (SACN/COT, 2004).  
 
4.1.6 Fish risk-benefit assessment in Belgium 
 
In the Belgian fish risk-benefit assessment, the benefits of omega-3 fatty acids, vitamin D, and 
iodine were stressed. A broad range of chemical contaminants such as dioxin, mercury were 
considered. It was concluded that a regular consumption of oily fish together with intake of EPA 
and DHA enriched margarine is advised to increase omega-3 fatty acids intake without exceeding 
the tolerable intake of contaminants (Sioen, 2007).  
 
In general, the consumption of fish seems the benefit outweighs the risk. However, pregnant 
women and children need to minimize the consumption of fish species that contain high 
concentration of chemical contaminants.   
 
4.2 Selected quantitative risk-benefit assessment of fish consumption studies  
 
In this section the quantitative risk-benefit assessment study performed using common health 
metrics is presented.  It includes the fish risk-benefit assessment study in The Netherlands, France 
and USA.  
 
4.2.1 Fish risk-benefit assessment in The Netherlands 
 
The Netherlands fish risk-benefit assessment study is a quantitative study that integrates the 
health effects using a common health metric, DALY.  The nutritional benefit and the risk of 
chemical contaminants were compared. The model was implemented in the QALIBRA tool. It was 
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concluded that the overall benefits of eating 200 g of fish per week, instead of the current 
consumption amounts, outweigh the risks. Eating 500 g of fish per week is even more beneficial, 
but the associate risks would also increase (Hoekstra et al., 2013b). 
 
4.2.2 Fish risk-benefit assessment in USA 
 
In USA, a risk-benefit analysis of fish consumption is performed that focusses on omega-3 fatty 
acids and mercury, using QALY to integrate the health effects. The result of the assessment shows 
that, replacement of fish with high mercury level with fish containing less mercury in childbearing 
age women provide considerable developmental benefits with few negative impacts. But, if 
women reduce fish consumption, countervailing risks substantively reduce net benefits. If adults 
reduce their fish consumption, the net public health impact is negative (Cohen et al., 2005).  
 
4.2.3 Fish risk-benefit assessment in France 
  
France conducted a fish risk-benefit assessment using a similar QALY model as in the USA study 
(Cohen et al., 2005). The benefit of omega-3 fatty acids and the risk of mercury were considered. 
Results show that increasing fish consumption may have a beneficial impact on health. The 
increase in fish consumption in pregnant women may have a negative impact due to mercury 
(Guevel et al., 2008).  
 
In general, integrated quantitative risk-benefit assessment of food seems a more structured and 
transparent approach which explicitly shows what is included, missed and assumed in the 
assessment. This helps the decision maker to understand the logic, interpretation and limitation 
the assessment at each step of the process. In addition, it enables to compare the healthy life 
year’s loss and gain due to the hazardous and beneficial components of food, which cannot be 
determined using qualitative assessment.  
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4.3 Opinion about fish risk-benefit assessment studies 
 
Since fish is somehow a unique food that contains several harmful and beneficial components in 
one packet, several risk-benefit assessment case studies have been performed on fish. In addition 
to the above selected case studies on fish, several studies have also been conducted at national 
and international level (Ponce et al., 2000; IOM, 2007; FAO/WHO, 2010).  
 
Many of fish risk-benefit analysis conclude that the benefit of fish consumption in the general 
population greatly outweighs the risk. However, special attention should be given to sensitive 
populations such as pregnant women, infants and neonates.   
 
All the fish risk-benefit assessment studies focus on comparison of nutritional benefits and risks of 
chemical contaminants. Ideally, an integrated risk-benefit assessment that considers the major 
nutritional benefits, the risk of pathogens and chemical contaminants would be sought to better 
estimate the overall health impact. As a result, an optimum risk-benefit management practice can 
be reached to support decision making. Currently, there are very limited studies that integrate the 
risk of microbial pathogens in risk-benefit assessment (Havelaar et al., 2000; Berjia et al., 2012). 
But, to the author’s knowledge there is currently no study that holistically integrates the risk of 
pathogens and chemical contaminants with the benefit of nutrients. The quantitative risk-benefit 
assessment study on cold-smoked salmon integrates the risk of Listeria monocyogenes and the 
benefit of omega-3 fatty acid (Berjia et al., 2012).  
 
Although a majority of research has shown that the benefit of fish consumption greatly outweighs 
the risks, it is important to keep in mind that this field of science is just at the incipient levels of 
determining how to precisely assess the everyday choices we make in our diet and how these 
ultimately affect our lives (Rosalee et al., 2012). However, integrated risk-benefit assessment of 
food clarifies the overall health impact of food and food component consumption. It helps to set 
the best food or food component consumption recommendation by balancing the risk and the 
benefit. It supports to identify potential health risk mitigation and benefit improvement strategies 
linked to food consumption, so optimum health gain can be attained. It provides a broader 
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overview of public health statistics related to food consumption as it combines incidence, 
mortality, severity and duration of health effect, unlike the classical risk assessment, which often 
measures only incidence.    
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Chapter 5 
Other issues in risk-benefit assessment of food 
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5. Other issues in risk benefit assessment of food 
 
Risk-benefit assessment of food is a complex multi-disciplinary study.  The following section 
discusses other topics related to risk-benefit assessment of food including data needed, 
uncertainty analysis, experts needed and consumer perception in risk-benefit assessment food. 
 
5.1 DALY and QALY in integrated risk-benefit assessment 
 
In performing integrated quantitative risk-benefit assessment, one of the challenges is the 
comparison of positive and negative health effects associated with nutritional, chemical and 
microbiological components of food using common scale. 
 
Negative health impact due to the exposure to the hazardous components of food is measured in 
terms of healthy life year’s loss. The positive health impact due to the intake of the beneficial 
components of food is measured in terms of the extra healthy life year’s gain or reduction of the 
negative health impact. For both the positive and negative health impact different dimensions of 
health (incidence, severity, morbidity, mortality and duration of the disease) together with 
consumption data are used to measure the health gain and loss (EFSA, 2010; Hoekstra et al., 
2012).  
 
In order to integrate the negative and positive health impacts of food consumption to predict the 
net health effect, a common health metric is used (EFSA, 2010; Hoekstra et al., 2012; Sand et al., 
2008). In risk-benefit assessment of food and/or burden of foodborne disease estimation, a 
common health metric is a measurement expressing the health effect of the hazardous and/or 
beneficial components in the same unit.  
 
Disability or quality adjusted life years (DALYs or QALYs) are the best known common health 
metrics used to combine the different dimensions of health outcomes.  One DALY can be 
considered as loss of one healthy life year (Murray and Lopez, 1996). QALY measure the total 
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number of years of perfect health in a population. A year in perfect health is considered equal to 
1.0 QALY (Murray and Lopez, 1996).  
 
In this PhD thesis, several other studies on risk-benefit assessments of food as well as burden of 
disease studies, DALY is the most frequently used common health metric. Murray and Lopez 
(1996) first used DALY in a global burden of diseases estimate to measure the population health 
outcome using the information on mortality and morbidity in the population.  According to Murray 
and Lopez (1996), DALY is calculated as the sum of YLL (years of life lost due to death) and YLD 
(years lived with disability) in the population. This DALY model predicts only the health outcomes 
of the hazardous components in terms of health life year’s loss at population level. It considers the 
health loss due to mortality and morbidity. It is suitable to be used in burden of disease estimation 
studies but not for risk-benefit assessment studies. This DALY model is extended later by Hoekstra 
et al. (2012) who consider recovery from the disease when quantifying the morbidity. In the 
Murray and Lopez (1996) model, the duration of the disease after its onset is only considered for 
those who live with the disease but not for those who eventually die from it. In Hoekstra el al. 
(2012) model, the duration is considered for those who die due to a disease, lives with disease and 
recover from disease.  This extended model can be used to estimate the health loss and gain due 
to the hazardous and beneficial components of food at individual level. In Hoekstra et al. (2012) 
model, the probability of onset of disease (Peff) has to be estimated depending on the intake of 
compounds for individuals. The relation between intake or exposure and Peff is the dose-response 
relation that is an essential part of the analyses in this thesis. The Murray and Lopez (1996) model 
does not consider the Peff. Hence, Murray and Lopez (1996) model cannot be applied to estimate 
the health loss based on intake of food or food components following the risk-benefit assessment 
paradigm. The risk-benefit assessment paradigm is the steps that are mirrored from the classical 
risk assessment approach (EFSA, 2010; Hoekstra et al., 2012). It includes: 1) hazard-positive health 
effect identification; 2) hazard-positive health effect characterization; 3) exposure assessment; 4) 
risk-benefit characterization. This paradigm used to estimate intake or exposure based disease 
probability.  
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The DALY model according to Hoekstra et al. (2012) describes the disability adjusted life years lost 
for a specific endpoint (a disease) for an individual of age CA: 
 
DALYCA = Peff  * [Prec * YLDrec * w + Pdie * (YLDdie * w + LECA - CA - YLDdie) + (1 - Pdie - Prec) * (LECA - CA) * 
w] 
Where:  
DALYCA             disability adjusted life years for an individual of age CA 
Peff                   probability of onset of the disease per year  
Prec                  probability of recovery from the disease 
Pdie                  probability that the disease causes death  
YLDrec   mean duration of disease for those who recover (in years) 
YLDdie              mean duration of disease for those who die (in years) 
CA    current age of individual in year at disease onset  
LE                     life expectancy at the onset of the disease 
w                     disability weight for disease 
 
This equation refers to the DALY loss for three possible health outcomes of a disease. The DALY 
loss for an individual who recovers from the disease can be calculated as:  
DALY = YLDrec * w 
The DALY loss for an individual who does not recover, but survives with the disease until their 
normal life expectancy can be calculated as:  
 
DALY = (LE – CA) * w 
 
The DALY loss for an individual who dies from the disease can be calculated as: 
 
YLDdie * w + LE – CA - YLDdie 
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In addition, the Hoekstra et al. (2012) model can be used to quantify the healthy life years gained 
or lost at population level when exploring the difference in health impact of changing from a 
reference intake scenario to an alternative scenario. 
 
ΔDALY = ΣDALYalt – ΣDALYref 
 
Where, ΔDALY is change in DALY; ΣDALYalt, summation of DALYs caused by every endpoint of all 
individuals in the population at the alternative scenario and ΣDALYref, summation DALYs caused by 
every endpoint of all individuals in the population at the reference scenario.  
 
The DALY model according to Murray and Lopez (1996) describes the disability adjusted life years 
lost at population level:  
 
DALY = YLL + YLD 
YLL = Nd * e 
YLD = Ni * d * w 
 
Where, Nd is number of deaths at each age, e indicates life expectancy for each age, Ni is number 
of cases, d is duration of the disease (years) and w is the disability weight of the diseases.  
 
In general the DALY model proposed by Murray and Lopez, (1996) is applicable to burden of 
disease estimate of food and environmental related hazardous compounds as well as infectious 
diseases. On the other hand, the DALY model proposed by Hoekstra et al. (2012) is applicable to 
risk-benefit assessment of food with different scenarios. However, experience shows that it is also 
applicable for burden of disease estimate study.  
 
The DALY model proposed by Hoekstra et al. (2012) is used in this PhD thesis (PAPER I, 
MANUSCRIPT I and II).   
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5.2 Data needed in risk-benefit assessment of food 
 
The quality of the output of the assessment is dependent on the quality of input data used during 
the assessment. Experiences show that, the complete dataset required to perform comprehensive 
quantitative risk-benefit assessment is not readily available. For performing a comprehensive 
quantitative risk-benefit assessment of food, various data are needed such as toxicological, 
nutritional, microbial, epidemiological and population statistics data.  
 
At the beginning of risk-benefit assessment, data related to food safety (pathogens, their toxins 
and chemical contaminants) and nutritional composition of the food are necessary in order to 
identify the hazardous and beneficial components. In addition, epidemiological data with respect 
to the identified hazardous and beneficial components are required to identify the associated 
health impacts. The strength of the association between the intake of the hazardous or beneficial 
components and consequences for human health is important (WHO, 2003). Data obtained in 
intervention studies in human is strong and convincing, whereas, data from animal studies are 
relatively weaker, which need extrapolation to human situation (EFSA, 2010).  
 
After the identification of the components and the associated health effects, food consumption 
data is required to estimate the intake of beneficial and hazardous components of food. The food 
consumption data are often available in national consumption survey studies and food 
composition data can be obtained from the national food composition database. If the hazard is a 
pathogen, the required data includes concentration and prevalence of pathogen in the food and 
pathogen characteristics related food processing pathway. This is because pathogens in the food 
can grow, survive and/or inactivated during food processing, handling and storage. If the hazard is 
chemical contaminant, often concentration data is needed, likewise for nutrients. This is the major 
difference between microbial exposure assessment and nutrient and chemical contaminant intake 
assessment. Ideally, nutrients and chemical contaminants intake assessment should also consider 
the effect of food processing, handling and storage on the concentration. This is because certain 
nutrients and chemical contaminants can be washed out during washing and eliminated or 
reduced in concentration during high temperature cooking. Nevertheless, there seem to be 
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relatively less experience in modeling the intake of nutrients and chemical contaminants following 
food processing pathway, handling and storage compared to pathogens. Besides, data needed for 
modeling exposure to most foodborne pathogens in relation to growth, survival and inactivation is 
relatively available. But, the current available data to model the intake of nutrients and chemical 
contaminants may be inadequate to perform comprehensive quantitative intake assessment by 
taking food processing pathway, handling and storage into account.  
 
In order to estimate the probability of disease occurrence or prevention due to the exposure to 
pathogens or intake of contaminants and nutrients, epidemiological data of the health effects are 
essential. For pathogens, the data required at this level include specific dose-response parameters 
of the pathogen, which is can be obtained from outbreak data or human volunteer studies. With 
regard to pathogens, estimate of incidence can be found based on risk assessment or clinical 
epidemiological data. For the estimation of number of cases, population statistics data is 
necessary at this level.  
 
In epidemiological studies, the probability of chemical contaminants and nutrients to cause or 
prevent diseases are usually presented relative to certain reference intake level, often zero intake 
or placebo, and expressed as relative risk, odds ratio or hazard ratio. For DALY calculations, these 
have to be converted to absolute probability of effect (Peff), by using incidence data for each 
health effect.   
 
In order to estimate the health loss and gain due to the hazardous and beneficial components and 
to estimate the net health impact, further epidemiological data is crucial. In addition to the 
absolute probability of each disease, mortality, severity, duration of each disease, population 
statistics (number of population per age and sex for each disease) as well as life expectancy data 
are required. Furthermore, the duration of the disease is varied depending on whether the disease 
leads to recovery, death or survival with the disease until the normal life expectancy. Often, these 
data are not readily available and usually parameter values are estimated based on some 
assumption. The duration of the disease for those who survive with the disease until their life 
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expectancy is normally the difference between life expectancy and current age at the onset of the 
disease (Hoekstra et al., 2012).  
 
Data on the severity weight of some common diseases can be found in WHO (2008) burden of 
disease estimate study.  But, the severity weight is not available for all diseases; in this case 
assumptions have to be used. When the severity weight of a disease is not available in literature, 
the severity weight of another disease with similar symptoms, duration and complications from 
WHO (2008) severity weight list may be used in consultation with a relevant expert. Severity 
weight is derived from epidemiological data based on relative health state valuation of a disease 
(Murray et al., 2002).  
 
Furthermore, data on different probabilities related to a disease are required; these probabilities 
include probability of death due to a disease, probability of recovery from the disease and 
probability of survival with the disease. Probabilities of death and survival are usually obtained 
from national public health statistics or other national epidemiological data. On the contrary, 
probability of recovery from a disease is often unavailable. Basically, probability of survival is not 
directly required to estimate DALY. However, it helps to estimate the probability of recovery 
because all these probabilities sum to one.  
 
In general this section discussed what sorts of data are required to perform a quantitative risk-
benefit assessment and how these data can be obtained. In risk assessment, estimation of the 
intake based probability of disease and number of cases are usually the end of the assessment. 
But, in a comprehensive integrated quantitative assessment of risks and benefits, further steps 
and data are required.  Due to the variability of source of data, expert judgment is essential in 
interpreting the results of a particular study intended to be used in risk-benefit assessment of 
food.  
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5.3. Uncertainty and sensitivity analysis in risk-benefit assessment of food 
 
Uncertainty is a state of having limited or no information to delineate the existing state and 
predict future outcome (Cacuci et al., 2005). Usually, when there is limited data or no knowledge 
of one or more inputs in risk-benefit assessment of food, assumptions or expert opinion are used 
to fill the data gaps. An uncertainty analysis can be used to describe the set of possible outcomes 
of the input assumptions in the model (Cacuci et al., 2005). In risk-benefit assessment of food, 
uncertainty analysis supports decision-making through the quantification of uncertainties in the 
relevant variables in the model. It determines how likely certain outcomes are when some 
variables in the model are not exactly known and it helps to identify the most important data gaps 
and guide future data collections (Cacuci et al., 2005).  
 
Uncertainties are inevitable in risk-benefit assessment of food because of the lack of data. They 
can be treated qualitatively or quantitatively (EFSA, 2006b). For the qualitative treatment of 
uncertainty EFSA (2006b) suggests to use scores (like, ++/--) to represent a subjective assessment 
of the direction and magnitude of the potential influence of each source of uncertainty on the 
assessment.  The quantitative treatment of uncertainty considers deterministic or probabilistic 
approach. Several sources of uncertainty that frequently affect risk–benefit assessment are listed 
by Hoekstra et al. (2012). Example of uncertainty that may present in risk-benefit assessment of 
food include uncertainty in intake data, identification of health effect and population, choice of 
dose-response models and estimation of mortality rate (Hoekstra et al., 2012). QALIBRA presents a 
general model for food risk–benefit assessment that quantifies variability and uncertainty in a 
deterministic or a probabilistic way (Hart et al., 2013).  
 
Sensitivity analysis describes how the variation in the output of a model can be apportioned to 
different sources of variation in the input (Cacuci et al., 2005). The main purpose of sensitivity 
analysis is to identify and focus on data and assumptions that have most influence on the final 
outcome.  
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In risk-benefit assessment of food, sensitivity analysis helps:  
 
- To identify critical assumptions that most influence the model output.  
- To improve the interpretation of the outcome of the assessment.   
- To optimize resource allocation  
- To support food authorities in making decision related to food consumption. 
 
Even though there are challenges in conducting comprehensive quantitative risk-benefit 
assessments due to a lack of truly representative data, the use of sensitivity analysis may provide a 
great advantage in providing essential information for decision making in relation to food 
consumption.  
 
5.4 Consumer perception in health risk and benefit of food 
 
A final outcome of health risk-benefit assessment of food, used to support food policy decision 
makers, may be to intervene by a food consumption recommendation in order to improve public 
health. This implies communication of the risk benefit analysis result to consumers. With respect 
to food choice and consumption, consumers are usually uncertain about the positive and negative 
health outcomes of the food they consume. Ideally, consumers want to know the risk and the 
benefit linked to the food consumption. Still, the consumer perception of the health risks and 
benefits associated with food consumption is highly variable.  Risk and benefit of food is key 
determinants of food choice and food consumption recommendation setting. Therefore, 
understanding the consumer perceptions of the risk and benefit connected to food consumption is 
essential in determining food choice and consumption recommendation setting. The consumer 
perception about the risk and benefit of food is described in general by Ueland et al. (2012) and 
specific to fish by Willems et al. (2006).  
 
Food risk and benefit perception is the subjective judgment of consumers about the negative and 
positive health impact of food consumption. Perceived risks due to the consumption of food are 
associated to morbidity, mortality and severity of consequence which is feared by the consumer 
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(Ueland et al., 2012). Benefit perceptions are often associated with food’s ability to exert positive 
consequences. This includes sensory properties (good taste, texture and color), convenience, 
healthiness aspects and value for money or benefit related to food production in an ethically and 
environmentally friendly way (van Kleef et al., 2005).  
 
Consumers’ benefit perception of foods is more emotionally triggered compared to risk perception 
(Fischer and Frewer, 2009).  The taste, color, texture and other emotional aspects of food benefit 
is often the result of own experience with the products (Cardello, 2003; Fischer and Frewer, 2009). 
Investigation on consumer choice of products with health benefits, such as lower energy content, 
show that consumers invariably choose the version with the taste benefit and not the health 
benefit (Tepper and Trail, 1998; Urala and Lähteenmäki, 2006; Verbeke, 2006). However, 
consumers with special health interest may find health benefits of higher importance than taste 
benefits (Zandstra et al., 2001). Nevertheless, in a real consumption situation, consumers may not 
coincide with their perceptions of the product (Kalogeras et al., 2012). Real product experience 
has been found to increase consumer acceptance of products that consumers otherwise have 
negative perceptions about (Cardello, 2003). The food benefits other than emotional aspect of 
benefits depend highly on the consumer interest (Ueland et al., 2012). 
 
In general, benefit-risk evaluations of consumers incline towards acceptance of all that is 
traditional and well-known (benefits), and rejection or suspicion towards anything that is novel 
and highly processed (risks) irrespective of real risk resent in the food (Ueland et al., 2012). So far, 
this type of perception based evaluations or benefits and risks are not included in formal risk-
benefit assessments of foods, as treated in this thesis.  
 
5.5 Expertise needed in risk-benefit assessment of food 
Risk-benefit assessment of food is still under development and there is currently no internationally 
accepted standard methodology available for use. A reason for that may be the complex and 
demanding nature of the task and the requirement of experts from different disciplines to 
collaborate intensively.  However, new methods for risk assessments are gradually being 
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developed (Hoekstra et al., 2008; Fransen et al., 2010; Hoekstra et al., 2012; Hart et al., 2013; 
MANUSCRIPT I).  
 
In order to develop an integrated quantitative risk-benefit assessment of food, it is crucial to 
determine what data are required, as explained in section 5.2. This section describes the experts 
involved in quantitative risk-benefit assessment of food.   
 
Basically, at the beginning of a practical quantitative risk-benefit assessment of food, it is required 
to have experts from food safety (microbial and toxicological), nutrition and epidemiology. This is 
because, the first steps in risk-benefit assessment of food is to identify the food or food 
components, safety and benefit concern. Progressively, experts in exposure assessments of 
pathogens, chemical contaminants and nutritional components supported by a mathematician are 
required to estimate the intake of the beneficial and hazardous component of food. Successively, 
statistician is needed to combine all quantitative data and to estimate the health outcome. 
Eventually, for presentation of the results and discussion, all stakeholders need to sit together to 
better interpret the results, explain the different disciplines’ point of view and to send the 
message to the public. If all relevant stakeholders are involved in the assessment, the choice of 
risk-benefit management measure may be optimal from a public health perspective.  
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Chapter 6 
PAPER 1. Risk-benefit assessment of cold-
smoked salmon: microbial risk versus nutritional 
benefit 
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ABSTRACT
The objective of the study is to perform an integrated analysis of microbiological risks and
nutritional benefits in a fish product, Cold Smoked Salmon (CSS).
Literature study identified the major health risks and benefits in connection with CSS
consumption. The reduction of the risk of Coronary Heart Disease (CHD) mortality and
stroke, as well as enhanced cognitive (IQ) development of unborns following maternal
intake, are identified as the main health benefits of omega-3 fatty acid from CSS. Contrary,
risk of meningitis, septicemia and abortion/stillborn are identified as a major health risk
endpoints due to exposure to the pathogen L. monocytogenes.
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Two consumption scenarios were considered: a reference scenario (23g/day and 20g/day
for man and woman respectively) and an alternative scenario (40g/day for both sexes). In
order to evaluate and compare the risks and benefits, the Disability Adjusted Life Years
(DALY) method has been used as a common metric.
Results show that the overall health benefits outweigh the risk, foremost contributed by the
effect of decreased CHD mortality and IQ increase. A sensitivity analysis indicated that
this result was robust for the analyzed parameters, except the storage time: the adverse
effect of consumption of CSS prevails over the beneficial effect if the storage time of CSS
is increased from two weeks to five weeks or more, due to an increased risk of listeriosis.
This study demonstrates how microbial risks can be integrated in risk-benefit assessment,
and shows that a sensitivity analysis has an added value, even if the benefits largely
outweigh the risk in the initial analysis.
Keywords: Cold-smoked salmon; Listeria monocytogenes; omega-3 fatty acids; DALY.
1. INTRODUCTION
Risk-benefit assessment is the weighing of the probability of an adverse health effect against
the probability of a beneficial effect as a result of exposure/intake of food (EFSA, 2010).
Examples and a guidance of how to perform risk-benefit assessment of foods have recently
been provided (Hoekstra et al., 2010; EFSA, 2010). Nonetheless, risk-benefit methods need
further development. There is currently no internationally agreed method to perform human
health risk-benefit assessment of food and so far only a few risk-benefit assessments
studies included microbiological hazards (Havelaar et al., 2000; Magnússon et al., 2012).
Typical aspects of microbiological risk assessment, like the inclusion of the impact of storage
and processing on the weighing of the risk and benefit, are therefore rarely included in
published risk-benefit assessments.
In this paper we present a risk-benefit assessment on a fish product. Several studies have
assessed the risk of toxic contaminants and benefits of nutrients following the consumption
of  fish (Gladyshev et al., 2008; Cohen et al., 2005b; Guevel et al., 2008; FAO/WHO, 2011;
Hoekstra et al., 2012) and found that in general the public health benefits are larger than the
risks. However, microbial risks have not been integrated into these risk-benefit assessments.
The present study aims to illustrate how a microbiological hazard can be included in a typical
risk-benefit assessment and how this may add to the existing risk-benefit assessment tools
and methodologies. Furthermore, we included a sensitivity analysis to evaluate the impact of
some of the model parameters on the assessment.
2. RISK-BENEFIT ASSESSMENT OF COLD-SMOKED SALMON: MODEL
2.1 Scope
The risk of the bacterial pathogen (L. monocytogenes) is evaluated against the benefits of
the intake of omega-3 fatty acids in a risk-benefit assessment of CSS consumed in
Denmark. Salmon is an oily fish containing considerable amount of omega-3 fatty acids, it is
a popular ready-to-eat food in most part of the world and it is consumed in many European
countries (WHO/FAO, 2004).
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The assessment compares a reference scenario with an alternative scenario, as in
(Hoekstra et al., 2010). In this comparison it is assumed that CSS is added to the normal diet
in an isocaloric way and substitution by other food items with potential health effects is
neglected. Best estimates are applied for the various model parameters. Disability Adjusted
Life Years (DALYs) are used as an integrated health measure to compare risks and benefits
(Hoekstra et al., 2010).
All statistical and mathematical modelling is implemented in Microsoft Office, version 2007
except for the dose-response modelling of CHD mortality and stroke (Appendix) which was
performed on statistical software R, version 2.10.1.
2.2 Hazard Identification, Selected Health Effects and Affected Subpopulation
Cold-smoked fish products may be contaminated with L. monocytogenes, the agent that
causes foodborne listeriosis. Vacuum-packed cold-smoked fish has a long shelf-life and can
support the growth of L. monocytogenes (WHO/FAO, 2004). The contribution of salmon for
the cases of listeriosis has been reported (Pouillot et al., 2007; Lindqvist and Westoo, 2000;
WHO/FAO, 2004). Recently an increasing incidence of invasive listeriosis, primarily
septicemia and meningitis have been reported in several European countries (Allerberger
and Wagner, 2010; Jensen et al., 2010). Listeriosis during pregnancy is also a serious threat
to the unborn child, which can lead to abortion/ stillborn (Smith, et al., 2009). Hence,
meningitis, septicemia and abortion/stillborn are selected as the endpoints following
exposure to L. monocytogenes.
Elderly, immunocompromized and pregnant women and/or their unborn fetuses are the most
susceptible groups for listeriosis (WHO/FAO, 2004; Allerberger and Wagner, 2010).
Therefore, both sexes aged ≥ 60 are selected for septicemia and meningitis. The population
of interest for abortion/stillborn, are potentially pregnant women aged 20-45.
2.3 Benefit Identification, Selected Health Effects and Affected Subpopulation
The nutrients in fish that have plausible and significant health benefits for human are omega-
3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA)
(Mozaffarian, 2006). Intake of fish may protect against CHD mortality and stroke
(Mozaffarian, 2006). In addition, an association is found between the maternal intake of DHA
and a beneficial effect in cognitive development of their unborn child, measured as an
increase in IQ (Cohen et al., 2005a). Zeilmaker et al. (2012) investigated both the adverse
(MeHg) and beneficial (DHA) effect of fish intake on IQ and found a very small IQ gain for
salmon intake. Therefore, reduction of CHD mortality and total stroke, and improved
cognitive development are selected endpoints in this paper.
Most of the studies mentioned in the Appendix (Table 8 and 9), which are incorporated in the
dose-response modeling of CHD mortality and total stroke, included adults of both sexes
older than 35 years. Hence, both sexes aged ≥ 35 are selected for both endpoints as a
target population. For the benefit of maternal intake of DHA on the child’s IQ, it is assumed
that women aged 20-45 give birth with different probabilities depending on age (Table 3).
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2.4 Intake and Exposure Assessment
The current mean fish intake is 20 and 23 g of fish/day for women and men respectively
(Pedersen et al., 2010). In the reference scenario it is assumed that every individual
consumes the current mean fish consumption as CSS i.e. 20 and 23 g for women and men.
For the alternative scenario it is assumed that every person consumes 40 g CSS/day. The
intake of CSS is assumed the same for all age groups in each scenario.
Omega-3 fatty acid intake is computed from the official Danish Food Composition Database
in combination with the consumption scenarios (Denmark Technical University, 2011).
For L.monocytogenes, an exponential growth model is applied to assess the distribution of
concentrations at consumption as a function of initial concentration, storage time, growth
rate and lag-time (Table 1, eq. 7). The 10-based logarithm of initial concentrations (N0) of
L.monocytogenes {0.5: 1.5: 2.5: 3.5} and their prevalences {0.28: 0.05: 0.01: 0} are taken
from Jørgensen and Huss (1998). For the exposure assessment, these results are combined
with the consumption scenarios.
2.5 Integration of the Health Effects
To combine the health outcomes of the risk and the benefit we have chosen the DALY
model of (Hoekstra et al., 2010). For an individual of age CA, the amount of DALY per
person per year is:
DALYa,s=Peff,a,s[(Prec*YLDrec*w+Pdie(YLDdie*w+LEa,s-CA-YLDdie)+(1-Pdie-Prec)*(LEa,s-CA)*w]
Where:
DALYa,s disability adjusted life years at age, a and sex, s
Peff,a,s probability of onset of the disease at age, a and sex, s, per year
Prec probability of recovery from the disease
Pdie probability the disease causes death
YLDrec duration of disease for those who recover
YLDdie duration of disease for those who die
CA current age of individual in year of disease onset (years)
LEa,s normal life expectancy for an individual of age CA1
w disability weight for disease.
2.6 Dose-Response Relationship
After a literature survey, eleven and eight studies are incorporated for the dose-response
modeling of CHD mortality and total stroke respectively (Appendix, Tables 8 and 9). The
results from studies that are included in the dose-response relation of CHD mortality and
total stroke have been implemented by a relation where the relative risk (RR) of the health
outcomes is a function of fish intake. Different functions are analyzed in order to select the
best model based on the best fit statistics (Appendix 1).
1 LE is interpreted here as expected age at death not as the also  commonly used expected
remaining years of life
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Table 1. Model equations applied and point estimates of the parameters
Model equation Parameter values Description (unit)
1. IDHA = Fintake * DHA Fintake, scenarios
DHA = 1.16g/100g
IDHA, intake of DHA (g/d); Fintake, fish intake
(g/d); DHA content of CSS (g DHA per g
CSS) (DTU, 2011).
2. ΔIQ = d*IDHA
(Cohen et al. 2005a)
d = 1.3, uncertainty
interval (0.8-1.8)
ΔIQ, change in intelligent quotient; d,
coefficient.
3. Peff(IQ) = Probability of a
woman giving a birth,
Peff(IQ), vary
depending on age of
a women giving a
birth
Peff(IQ), probability of onset of IQ  effect which
is equivalent to probability of a woman giving
a birth (Table 3).
4. ln(RR) = a + b* ln(Fintake) RR, a=0.17, b=0.137
for CHD mortality
and a=0.113,
b=0.094 for stroke
RR, relative risk of CHD mortality and total
stroke; a and b are estimated in the meta-
analysis in appendix1.
5. Peff,ep,r (a,s) = Inc(a,s)/N(a,s) Variable with age a,
sex s and endpoint
ep
Peff,ep,r(a,s) probability of onset of endpoints
ep, (CHD mortality and total stroke) at
reference intake r, in 5 year age class a, for
sex s; Inc(a,s), current incidence of endpoint
ep in (a,s); N(a,s), number of population in
(a,s). Note: It is assumed that the probability
of effect is the current incidence rate for
reference intake for both endpoints.
6. Peff,ep,a(a,s) =RR(s)a Peff, ep,r
(a,s) /RR(s)r
Varies with
scenarios, ages and
sexes
Peff,ep,a(a,s), probability of onset of endpoint at
alternative intake at age and sex; RR(s)a,
relative risk of alternative scenario at sex, s;
RR(s)r, relative risk of reference scenario at
sex, s.
7. logNt = logN0 + μ(t – λ) N0, (see section 2.4),
t=14; μ=0.113;
λ=0.167 (WHO/FAO,
2004)
Nt, concentration of Listeria after storage
(CFU/g); N0, initial concentration (CFU/g); μ,
growth rate (log CFU/d); t, storage time
(day); λ, lag-time (day). At storage
temperature of 5ºC
8. Dlisteria = Fintake * Nt Dlisteria, dose of listeria (CFU/d).
9. Pinf = 1-e-rDlisteria r= 5.85 * 10-12 Pinf, probability of infection and illness of
Listeria; r, dose-response parameter specific
to Listeria for susceptible population
(WHO/FAO, 2004).
10. Peff(mengi) = Kmengi * Pinf K = 0.24 Peff(mengi), probability of onset of meningitis;
Kmengi, proportion of meningitis cases among
those infected with Listeria.
11. Peff(septi) = Ksepti * Pinf Ksepti = 0.74 Peff(septi), probability of onset of septicemia; K
septi, proportion of septicemia cases among
those infected with Listeria.
12. Peff(abo/stl) = K(abo/stl) * Pc *
Pinf
K(abo/stl) = 0.266; Pc,
variable with age
Peff(abo/stl), probability of onset of
abortion/stillborn; Kabo/stl, proportion of
abortion/stillborn among pregnant women
infected with Listeria. Pc, probability of giving
birth
European Journal of Food Research & Review, 2(2): 49-68, 2012
54
In addition, the models are validated using residual analysis and QQ-plot (Ekstrøm and
Sørensen, 2011). Based on this, the log-linear model has been selected to estimate the RR
based on the intake scenarios. Then, the estimated RR are converted into absolute risk by
combining the RR’s and the current incidence rates of CHD mortality and total stroke, which
are obtained from Denmark Statistics (2011). To characterize the benefit of maternal DHA
intake to the cognitive development (IQ) of their offspring, the relation described in Table 1,
eq. 1 is applied.
The exponential dose-response model for L. monocytogenes is used to characterize and
estimate the probability of infection (Table 1, eq. 9).
The DALY calculation has been performed for each sex, age and scenario. From these, the
total DALYs are calculated for the Danish population by summation; population’s data are
shown in Table 2 and obtained from Denmark Statistics (2011). Parameter estimates for
DALY computation are also presented in Table 5 and explained in sections 2.7 and 2.8.
Table 2. Number of population by age and gender (Denmark Statistics, 2011)
Sex
Man Woman Total
Age ≥ 60 582589 642706 1225295
18-49 1155573 1155573
≥ 35 1556888 1631905 3188793
5569661
2.7 Estimation of DALY Parameters for Listeriosis
The probability of developing septicemia (Peff(septi)) and meningitis (Peff (mengi)) depends on the
infection probability, Pinf, which depends on fish intake. In the reference scenario Pinf is
8.9*10-6 for women (20g CSS) and 1*10-05 for men (23 g CSS. In the alternative scenario (40
g CSS) it is 1.78*10-05. In this study it is assumed that the percentage of septicemia and
meningitis (Ksepti, Kmengi) is 74% and 24% respectively (Gerner-Smidt et al., 2005). Studies
reported that the percentage of abortion/stillborn (Kabo/still) is about 15-25% (Mylonakis et al.,
2002) and 33.3% (Smith et al., 2009). Consequently, we take the mean (26.6%) of the two
reported percentages to estimate the abortion/stillborn percentage.
Pdie is assumed to equal published case fatality rates, 20.8% and 25.4% of the patients died
of septicemia and meningitis respectively within a month of diagnosis in a 10-years follow up
study period (Gerner-Smidt et al., 2005). For septicemia it is assumed that people who do
not die will recover, so Prec = 1- Pdie. For meningitis the sequela is taken into account, so Prec
= 1- Pdie -0.14 (Aouaj et al., 2002).
YLDdie is computed for meningitis and septicemia from (Gerner-Smidt, et al., 2005). YLDrec
and w for both meningitis and septicemia are obtained from (Kemmeren et al., 2006).
Abortion/stillborn implies that the life of a newborn is lost. Therefore, YLDdie, YLDrec, CA and
Prec are 0 and Pdie is 1.Obviously abortion/stillborn can only happen with pregnant women
therefore the probability of a pregnancy, Pc is included and Peff(abo/stl) is estimated using eq.
12 on Table 1. It is assumed that women give birth with different probabilities depending on
age. The probabilities of pregnancy at age below 20 and above 45 are assumed zero.
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Table 3. The annual probability that a woman gives birth depending on age (Denmark
Statistics, 2011)
Age mother Pc, Probability
of giving birth
20 - 25 year 0.039
25 - 30 year 0.1139
30 - 35 year 0.127
35 - 40 year 0.057
40 - 45 year 0.01
2.8 Estimation of DALY Parameters for CHD Mortality, Stroke and IQ
The case fatality rate of total stroke is assumed to be the same as for ischemic stroke, so
Pdie=0.26 (Andersen et al., 2009). Prec and YLDrec are set to zero, assuming no one can
recover from stroke. We also assumed that the YLDdie is associated with highest mortality
period which is within 30 days, this leads to an estimate of approximately 0.082 (Ingall, 2004;
Andersen et al., 2009). The disability weight of stroke varies depending on the stages of
stroke. WHO estimated that for the first-ever stroke cases and long-term stroke survivors, w
is 0.92 and 0.266 respectively (WHO, 2008). In our case, we take the rounded mean of the
two values (w=0.6). Peff depends on RR, age and sex (eq. 4 in Table 1). RR for stroke for 20,
23 and 40 g fish/day is 0.84, 0.83 and 0.79.
For fatal CHD, because no one recovers from fatal CHD, Prec and YLDrec are set to 0. By
definition Pdie of fatal CHD is 1. Peff depends on RR and age and sex (eq. 4 in Table 1). RR
for fatal CHD for 20, 23 and 40 g fish/day is 0.79, 0.77 and 0.71 respectively.
For IQ, Peff(IQ) is assumed to be the probability that a woman delivers a baby (Pc, Table 3).
The probability of having a particular IQ (from the definition of IQ, normal distributed, mean
100, standard deviation 15) resulting from the change in IQ obtained from Table 1 eq. 2
linked with the disability weight of a particular IQ (Table 4) results in a weighted average w
depending on IQ change as in (Hoekstra et al., 2012). For the IQ effect, the parameters
YLDdie, YLDrec, Pdie, Prec and CA are 0.
Table 4. Disability weights of IQ levels (Stouthard et al., 1997)
IQ W
>85 0
70-84 0.09
50-69 0.29
35-49 0.43
20-34 0.82
0 <20 0.76
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Table 5. Parameter values for the DALY calculations as estimated from
epidemiological data
Health effects Estimated parameters
Prec YLDrec Pdie YLDdie W
Meningitis 0.625 0.5 0.254 0.08 0.32
Septicemia 0.792 0.02 0.208 0.08 0.93
Abortion/stillborn 0.0 - 1 - -
CHD mortality 0.0 - 1 - -
Total stroke 0.0 - 0.26 0.082 0.6
IQ 0.0 - 0.0 - X *
X* is dependent on IQ (Table 4) which depends on the maternal intake of DHA (Table 1 eq 2).
The net DALY is calculated using:
ΔDALY = ∑DALYalt - ∑DALYref
Where, ΔDALY is change in DALY; ∑DALYalt, summation over all persons in the population
of DALY’s for the alternative scenario; ∑DALYref, summation over all persons in the
population of DALY’s for the reference scenario.
DALY represents health loss; therefore, if the estimation of ΔDALY results in a positive value
then the change in consumption has an adverse health effect. If the ΔDALY is negative, then
the change in consumption has a beneficial effect (Hoekstra et al., 2010).
2.9 Sensitivity Analysis
A sensitivity analysis is performed to explore the impact of modifying some of the model
parameter estimates on the risk-benefit assessment. Targeted parameters are the d-value
for the effect of DHA intake on IQ change (Table 1, eq. 2), the parameters a and b defining
RR of CHD and total stroke (Table 1, eq. 4), the storage time t (Table 1, eq. 7) and the lag-
time of L. monocytogenes, λ (Table 1, eq. 7). These parameters relate to different endpoint
and are known to be variable and/or uncertain. Moreover, for the estimation of RR of CHD
mortality and total stroke one more function (exponential function, ln(RR)= b* Fintake is
analysed to see the difference in DALY estimate of the two endpoints compared to the DALY
estimate obtained from function, ln(RR)= a + b*ln( Fintake).
For example, the storage time of CSS was wide in range in various studies (Hansen et al.,
1998; Leroi et al., 2001; WHO/FAO, 2004). L.monocytogenes relative lag time in foods is in
the range of 0–40h, with a peak value near 2.5. Lag-times in laboratory broths had a similar
range, but the peak value was nearer to 4.5h (Ross, 1999). In this study 4h is selected as a
baseline lag-time value and converted to day unit (Table 1, eq. 7) and for the sensitivity
analysis 2.5h and 4.5h is used from the peak value of foods and laboratory broths.
Furthermore, the uncertainty interval of the d-value in Table 1, eq, 2 and the 95% CI of the
selected (bold) function in the appendix on Table 10 for the parameter a and b of RR of both
CHD mortality and stroke are analyzed for sensitivity. The sensitivity analysis is done by
varying one variable at the time (OAT) while keeping the others constant at their baseline
value. More sophisticated sensitivity methods are possible (Saltelli et al., 2000), but in this
relatively simple model the OAT approach is sufficient to identify the greatest sources of
uncertainty and their approximate influence on the end result.
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3. RISK-BENEFIT ASSESSMENT OF COLD-SMOKED SALMON: RESULTS
3.1 Baseline
The assessment shows that increasing the consumption of CSS has an overall health gain
with respect to the selected endpoints, as the beneficial effects of fatty acids clearly
outweigh the adverse health effect of Listeria (Table 7).
The extra cases of the hazardous endpoint and the prevented cases of the beneficial
endpoint due to the change in consumption are presented in Table 6 below.
Table 6. The number of extra/prevented cases when change in consumption per year
Endpoints Reference Alternative Extra/prevented
cases
Septicemia 8.66 16.2 7.54
Meningitis 2.83 5.25 2.42
Abortion/stillborn 1.5 3 1.5
CHD mortality 5435 4953 -482
Stroke 3787 3580 -207
The number shows the number of cases per year at the different scenario. The last column
shows that the additional cases (positive value) due to listeriosis and the prevented number
of cases (negative value) due to omega-3 fatty acid when change in consumption.
When comparing the hazardous endpoints, for listeriosis there are more life years lost due to
septicemia and meningitis in women compared to men. This is due to a larger increase in
intake of CSS for women compared to men. The amount of healthy life years lost is largest
for septicemia, followed by abortion/stillborn and meningitis.
Table 7. The baseline DALY’s for each sex and scenario
Men Women
Ref Alt ΔDALY Ref Alt ΔDALY Sum of
DALY
Septicemia 13 23 9.7 14.6 29 14.5 24.
Meningitis 6 10.6 4.5 6.74 13.5 6.8 11
Abortion/Stillborn* 11 23 12 12
CHD mortality 32093 29592 -2501 23402 21032 -2370 -4871
Stroke 11874.7 11302 -572 15192.5 14284 -908 -1480.5
IQ* -3139 -6181 -3042 -3042
Net DALY -9343
Ref, reference scenario; Alt, alternative scenario
*Because abortion/stillborn and IQ endpoints are result of maternal consumption on their fetus, the
DALY is only reported for women.
On the other hand, there is a large gain in healthy life years for both sexes due to reduction
of CHD mortality and stroke. Likewise, a large benefit is obtained due to the IQ effect.
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Women achieve more benefit than men by the prevention of stroke and men attain more
benefit from the prevention of CHD mortality than women.
As a result, the net public health effect of the change of consumption of CSS leads to a gain
of 9343 healthy life years in the population of approximately 5570000.
3.2 Sensitivity Analysis
The sensitivity analysis shows quantitative and qualitative changes in ΔDALY depending on
theparameters. As illustrated in Fig. 1, increasing the storage period  leads to higher risks of
listeriosis and has no effect on fatal CHD, stroke and IQ change in newborns. The net DALY
shows that the adverse effect of consumption of CSS prevails over the beneficial effect from
five weeks of storage time on. It leads to a loss of 1677 and 58391 healthy life years in the
population at five and six weeks storage period respectively.
2 weeks, 4 weeks, 5 weeks, 6weeks
Fig. 1. Sensitivity analysis for the effect of storage time.
The sensitivity analysis for the RR for CHD mortality and total stroke, lag-time of listeria and
the d-value uncertainty interval shows no change in the overall balance of the risk-benefit.
The result of all the parameters analysed for sensitivity is presented in Fig. 2 below,
including the net DALY when using the exponential RR model of CHD mortality and total
stroke as an alternative model. The figure includes the net DALY for the baseline scenario
given in Table 7, which is represented by “baseline”. The various parameters and their
values that are used to estimate the baseline net DALY are presented in Table 1.
In Fig. 2 it appears that there is no difference between the resulst of the lag-time sensitivity
analysis and the baseline result. The other parameters (RR and d) show a beneficial effect
of net DALY which is similar to baseline result qualitatively. However, there can be seen a
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shift of beneficial to hazardous effect at which the bar extends to the positive direction at
storage time of 5 weeks and further.
Fig. 2. Result of sensitivity analysis for all selected parameters
When using the exponential function (ln(RR)=  b* Fintake) the predicted DALY decrease to -
5580 and -1964 for CHD mortality and total stroke respectively compared to the DALY
estimate obtained by ln(RR)= a + b*ln( Fintake) (Table 7).
4. DISCUSSION
4.1 The CSS Study
In this study with CSS, major health benefit is obtained from the prevention of CHD mortality
and the IQ increment of newborns. This is in accordance with other studies on fish
consumption and/or omega-3 fatty acid intake (Cohen et al., 2005b; Guevel et al., 2008;
Hoekstra et al. 2012). In Hoekstra et al. (2012) the health benefit was higher for stroke than
IQ effect, in this study the health benefit is higher for IQ than stroke. This may be related to
the difference in dose-response model used for stroke and because salmon is an oily fish
that have a significant effect on IQ. As a part of sensitivity analysis the dose-response model
used by Hoekstra et al., (2012) for stroke is applied to see the difference and the outcome
indicate that the benefit would step up but still the health benefit is higher for IQ gain than for
stroke.
Our paper is the first that shows that these health benefits also outweigh the risk of
listeriosis, unless the storage time is too long (>4 weeks) and leads to the exposure to high
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concentrations of the pathogen. Note though that if abortion was valued less severe than in
our analysis storage time can be longer before risks outweigh benefits.
As common in microbiological risk assessment, different parameters (storage time, lag-time,
growth rate, etc) that affect the concentration of the pathogen have been considered in the
exposure assessment of L. monocytogenes. However, in the intake assessment of omega-3
fatty acid, the different parameters that affect its concentration have not been considered in
the same way. For instance, processing and storage of CSS, and the biovailability of the
compound could affect its  concentration before it reaches to target organ. In a comparative
approach of the microbial risk and the nutritional benefit, the exposure assessment for
nutrients and chemical contaminants should consider all the factors that affect the
concentration until the compound in question reaches the target organ to exert an action.
The dose-response models that are applied for CHD mortality and stroke used aggregate
data and different models have been used and validated to optimize the output.
Nevertheless, the conversion of the estimated RRs to absolute risk is associated with
uncertainty (Table 1, eq. 5 and 6). On the other hand, a few aggregate data have been used
to model the dose-response relationship of the hazardous endpoints. In addition, in this
study the intake assessment uses a point estimate of CSS and DHA intake for all age
groups but take into account the differences between sexes. These all together might have
an impact on the final outcome.
The result is expressed in DALY (morbidity, mortality and recovery) and it appears that, the
septicemia to meningitis DALY ratio is approximately 2:1 (Table 7). Compared to men, the
DALY changes are higher for women for both septicemia and meningitis cases this could be
linked to the increase in intake of CSS on women than men. Looking back the history of
invasive listeriosis in Denmark, in most cases men have higher incidence of invasive
listeriosis than women (Gerner-Smidt et al. 2005). Septicemia has been the highest
morbidity compared to meningitis. On the other hand, the mortality rate is higher for
meningitis than septicemia (Gerner-Smidt et al. 2005). However, mostly in comparative
studies on overall invasive listeriosis (septicemia vs meningitis), the ratio of septicemia to
meningitis is 5:1 (Jensen et al., 2010); 3:1 (Gerner-Smidt et al. 2005).
In this study four parameters have been tested for sensitivity. The most sensitive parameter
was the storage time. The shift of a net public health benefit to a net public health risk is
observed when CSS is consumed at five weeks of storage and further (Fig. 2). The shift is
mainly because of the increased concentration of L.monocytogenes that entails increased
incidence of listeriosis. According to our model prediction, maximum benefit with minimum
risk can be attained from the consumption of CSS within two weeks of production. The risks
increase with storage time whereas benefits remain unchanged. Further study may
encompass stochastic analysis of all the uncertain parameters presented in the study.
The study was not meant to thoroughly address all beneficial and hazardous components;
neither includes the all related endpoints in connection to CSS consumption. Instead, focus
was on the integration of microbial hazards and nutritional benefits. Although there could be
more endpoints due to the intake/exposure of the selected risk and benefit, this paper
assess health outcomes with strong evidences that enable quantitative evaluation. In
addition, we evaluated only endpoints that we expected to have relatively high public health
impact. For example, febrile gastroenteritis is usually caused by L. monocytogenes
(WHO/FAO, 2004); but reported quantitative data with respect to this endpoint are
insufficient to do a risk-benefit assessment and moreover, febrile gastroenteritis has less
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public health impact than septicemia and meningitis. Thus, febrile gastroenteritis is not
considered in this assessment. Other health effects related to fish/omega-3 fatty acid intake,
for instance neuropsychiatric disorders (Young and Conquer, 2005) are not considered for
the same reason. If our study would have included chemical hazards as well (dioxin-like
compounds and mercury) and would have included all the endpoints, the net DALY would
change quantitatively, and the balance between risk and benefit might change as well.
4.2 Implications for Future Risk-Benefit Assessment Methodology
If a pathogen is selected as a hazard, it is essential that the specific associated endpoints
are considered instead of considering the generic clinical syndrome. Nevertheless, most
Quantitative Microbial Risk Assessments (QMRA) report the generic clinical syndrome cases
only. For example, if the assessment includes listeria then the endpoint is cases of listeriosis
(Pouillot et al., 2007; Lindqvist and Westoo, 2000; WHO/FAO, 2004). However, these types
of data are insufficient if one intends to integrate pathogens in risk-benefit assessment
because of the exclusion of the mortality, morbidity, recovery and/or sequela of the specific
diseases. In this risk-benefit assessment, the specific major clinical syndromes of foodborne
listriosis (meningitis, septicemia and abortion/stillborne) are included, instead of the generic
endpoint “cases of listeriosis”. On the other hand, this could also be a problem in dose-
response modeling as most studies on the pathogenesis of pathogens have dose-response
parameters only for general cases like listeriosis, salmonelosis, campylobacteriosis. In this
case, different epidemiological data could be used to extrapolate the percentage of the
specific endpoints as in section 2.7.
In addition, the integration of the health effects of microbial hazard into risk-benefit
assessment may need further refining in the distinction of pathogenesis from the pathogens
itself and the microbial toxins especially with regard to exposure assessment and dose-
response modeling. Depending on the pathogens/toxins, the exposure assessment and the
dose-response relationship require additional investigation like for example the stomach and
small intestine dynamics as explained by (Pielaat et al., 2005) for Bacillus cereus.
Moreover, in this study the DALY is used as a common health metric to integrate microbial
hazard in risk-benefit assessment.  Here a thorough quantitative assessment has been done
to the end, as opposed to the EFSA, 2010; Hoekstra, et al., 2010) where the assessment
stops when the benefit outweighs the risk or vice versa. Had we followed the tiers of BRAFO
tiered approach (Hoekstra et al., 2010) in this study, we might have stopped at the earlier
stage. For example, in our assessment the baseline result showed that, the benefit clearly
outreaches the risk (Table 7); as of Hoekstra, et al., (2010), we could have stopped at this
point. However, further quantitative analysis gives a different result in connection with the
change in storage time of CSS (Fig. 1), which, in our view, is an important result. This shows
that the integration of microbial risk and/or benefit into risk-benefit assessment may require a
more elaborate quantitative assessment to reach to best estimation of public health impact.
Furthermore, in general some disease may have some major secondary disease (sequela)
that result from the primary clinical syndrome. For instance, if someone gets liseriosis
meningitis then there is some probability that person would get neurological sequela (Aouaj
et al., 2002).  The DALY model applied in this study does not consider this kind of endpoints.
However it can be extended to do so easily.
Consequently, the current risk-benefit assessment framework/models need more refinement
in regard to the aforementioned points.
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5. CONCLUSION
This paper evaluated and integrated the major risk and benefits in connection with the
change in CSS consumption. Our risk-benefit assessment predicted that the overall health
impact of change in consumption of CSS from reference to alternative intake provide more
health benefits for the Danish population.
The model predictions depend on the assumptions taken during the analysis and the
sensitivity analysis reveals that the most sensitive parameter was the storage time.  If CSS is
consumed after two weeks of storage, the benefit remains the same but the risk increases
significantly with storage time.
This study provides an insight for future improvement of the methodologies with regard to
exposure assessment of the different component, dose-response relationship and common
health metric and general framework for risk-benefit assessment.
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APPENDIX
1. The Relative Risks of CHD Mortality and Total Stroke
Tables 8 and 9 present the results of studies on the relation between fish intake and the
relative risks of CHD mortality and stroke. These results are used for dose response
modeling. The most appropriate model is selected after analysis from the five functions
mentioned below, based on best fit statistics using statistical computing R-programme.
 RR = a + b * Fintake
 RR = a + b * ln(Fintake)
 ln(RR) = a + b * Fintake
 ln(RR) = b * Fintake
 ln(RR) = a + b * ln(Fintake)
Where, RR is relative risk; a and b are parameters and Fintake, is fish intake per day (Dose).
Table 8. The studies incorporated in the dose-response modeling of CHD mortality:
fish intake (g/d) and relative risk (RR)
Reference Dose
(g/d)
RR (95% CI) Reference Dose
(g/d)
RR (95%CI)
Kromhout et al.,
1985
0 1 Mozaffarian et
al., 2003
0 1
7.5 0.63 7 0.78 (0.47, 1.28)
22.5 0.56 14 0.77 (0.45, 132)
37.5 0.36 29 0.53 (0.30, 0.96)
75 0.39 71 0.47 (0.27, 0.82)
Ascherio et al.,
1995
0 1 Mann et al.,
1997
0 1
7 0.74 (0.38, 1.45) 7 1.21(0.62, 2.38)
18 0.86 (0.5, 1.47) 29 1.23 (0.7, 2.17)
37 0.71 (0.41, 1.21) Oomen et al.,
2000, The
Netherlands
0 1
69 0.54 (0.29, 1.00 10 1 (0.59, 1.68)
119 0.77 (0.41, 1.44) 35 1.1 (0.68, 1.79)
Daviglus et al.,
1997
0 1 Oomen et al.,
2000, Finland
10 1
9 0.88 (0.63, 1.22) 30 0.97 (0.68, 1.38)
26 0.84 (0.61, 1.17) 70 1.25 (0.89, 1.76)
67.5 0.62 (0.4, 0.94) Jarvinen et al.
2006
4 1
Albert et al.,
1998
0 1 12·0 0.91 (0.55, 135)
7.5 1.18 (0.59, 2.26) 19.8 0.77 (0.48, 1.23)
21 0.82 (0.45, 1.51) 32 0.68 (0.42, 1.12)
50 0.91(0.5, 1.66) 70·0 0.59 (0.36, 0.99)
86 0.81(0.41, 1.61) Hu et al., 2002 0 1
Oomen et al.,
2000, Italy
0 1 7 0.8 (0.56, 1.15)
10 0.94 (0.55,1.59) 14 0.65 (0.46, 0.91)
30 0.93 (0.53, 1.63) 43 0.72 (0.48, 1.09)
70 0.67 (0.33, 1.39) 86 0.55 (0.33, 0.91)
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Table 9. The studies incorporated in the dose-response modeling of total stroke: Fish
intake (g/d) and relative risk (RR)
Reference Dose
(g/d)
RR (95% CI) Reference Dose
(g/d)
RR (95% CI)
He et al., 2002 0 1 Mozaffarian et al.,
2005)
0 1
7 0.73 (0.48-1.10) 7 0.88 (0.66–1.17)
14 0.74 (0.52-1.04 36 0.74 (0.56–0.98)
43 0.67 (0.46-0.96 86 0.77 (0.56–1.07)
86 0.83 (0.53-1.29) Orencia et al.,
1996
0 1
Iso et al., 2001 0 1 9 0.98 (0.61, 1.59)
7 0.93 (0.65-1.34) 26 0.94 (0.59, 1.52)
14 0.78 (0.55-1.12) 50 1.26 (0.74, 2.16)
43 0.73 (0.47-1.14 Larsson et al.,
2011
0 1
86 0.48 (0.21-1.06) 17 0.87 (0.75, 1.01)
Gillum et al.,
1996
0 1 25 0.92 (0.82, 1.09)
7 0.78 (0.54, 1.12) 36 0.88 (0.76, 1.02)
14 0.77 (0.53, 1.13) 64 0.84 (0.71, 0.98)
60 0.55 (0.32, 0.93) Wang et al., 2011 7 1
Gillum, et al.,
1996
0 1 29 0.7 (0.5, 0.98)
7 1.27 (0.83, 1.96) 80 0.82 (0.61, 1.11)
14 1.23 (0.79, 1.91)
60 0.85 (0.49, 1.46)
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Table 10. The model outputs for the relative risk of CHD mortality and stroke
Models CHD Stroke
RR= a + b* Fintake RR= 0.9-0.0028* Fintake
CI 95%: (0.79, 1.01) and (-0.005, -
0.0004)
p-value: (<0.001) and  (0.023)
RR= 0.935-0.0024*
Fintake
CI 95%: (0.82, 1.05) and
(-0.005, 0.0001)
p-value: (<0.001) and
(0.0593)
RR= a + b*ln(Fintake) RR= 1..11-0.0964*ln(Fintake)
CI 95%: (0.86, 1.36) and (-0.172, -
0.021)
p-value: (<0.001) and (0.014)
RR= 1.09-
0.075*ln(Fintake)
CI 95%: (0.83, 1.34) and
(-0.15, 0.003)
p-value: (<0.001) and
(0.059)
ln(RR)= a + b* Fintake ln(RR)= -0.13-0.004* Fintake
CI 95%: (-0.271, 0.02) and (-0.007, -
0.0008)
p-value: (0.081) and (0.016)
ln(RR)= -0.08-0.003
(Fintake)
CI 95%: (-0.21, 0.05)
and (-0.006, 0.0002)
p-value: (0.235, 0.038)
ln(RR)= b* Fintake ln(RR)= -0.006* Fintake
CI 95%: (-0.008, -0.0041)
p-value: <0.001
ln(RR): -0.0045* Fintake
CI 95%: (-0.006, -0.003)
p-value: <0.001
ln(RR)= a + b*ln (Fintake) ln(RR)= 0.17-0.137*ln (Fintake)
CI 95%: (-0.16, 0.5) and (-0.24, -
0.04)
p-value:(0.3) and (0.008)
ln(RR)= 0.113-0.094*ln
(Fintake)
CI 95%: (-0.184, 0.41)
and (-0.184, -0.004)
p-value: (0.44) and
(0.04)
The last model is used to estimate the relative risk for each scenario and endpoints.
_________________________________________________________________________
© 2012 Berjia et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
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ABSTRACT  
Background: In risk-benefit assessment of food and nutrients, several studies so far have 
focused on comparison of two scenarios to weigh the health effect against each other. One 
obvious next step is finding the optimum scenario that provides maximum net health gains.  
Aim: This paper aims to show a method for finding the optimum scenario that provides 
maximum net health gains.  
Method: A multiple scenario simulation. The method is presented using vitamin D intake in 
Denmark as an example. In addition to the reference scenario, several alternative scenarios are 
simulated to detect the scenario that provides maximum net health gains. As a common health 
metric, Disability Adjusted Life Years (DALY) has been used to project the net health effect by 
using the QALIBRA (Quality of Life for Benefit Risk Assessment) software. 
Results: The method used in the vitamin D example shows that it is feasible to find an optimum 
scenario that provides maximum net health gain in health risk-benefit assessment of dietary 
exposure as expressed by serum vitamin D level. With regard to the vitamin D assessment, a 
considerable health gain is observed due to the reduction of risk of other cause mortality, fall 
and hip fractures when changing from the reference to the optimum scenario.  
Conclusion: The method allowed us to find the optimum serum level in the vitamin D example. 
Additional case studies are needed to further validate the applicability of the approach to other 
nutrients or foods, especially with regards to the uncertainty that is usually attending the data.  
Keywords: Optimum scenario; vitamin D; risk-benefit assessment; DALY; QALIBRA 
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1. INTRODUCTION 
Risk-benefit assessments of food and nutrients focus on interventions and policies in 
connection with food consumption and health outcomes [1]. Until recently, the risk and benefit 
assessments of food have been separate processes with different methods. Due to the 
increasing interest of estimation of the net health impact of food consumption, development of 
methods that integrate both the health benefits and risks of food (ingredient) in one go have 
gained interest.  
Currently, there are some methods and approaches on how to perform risk-benefit assessment 
of food [2, 3, 4, 5, 6, 7]. These methods focus on comparison of two or more scenarios and 
determine which one of the scenarios prevails over the other from the perspective of public 
health. When applying these methods, the assessment may stop at an early stage, i.e. before 
the health effects are integrated in a common health metric. Several case studies have been 
performed; low calorie sweeteners [8], farmed salmon, soy protein [9], benzo[a]pyrene and 
heat treatment of milk [10]  to validate the applicability of the BRAFO tiered approach [5].  
 
Whereas those studies typically compared two scenarios, one obvious next step is to 
investigate more than two scenarios and find the optimum scenario to improve public health. 
This approach was suggested by [11, 12]. This paper aims to show how this can be done by 
comparing the net health gains of different scenarios, expressed in a common health metric 
(DALY, disability adjusted life years). The method is presented in a case study on vitamin D 
intake in Denmark. So far, the health risk and benefit associated with vitamin D have not been 
integrated using common health metric. Our objective is to illustrate how an optimum scenario 
can be found. Therefore, several simplifying assumptions are made and the result is a crude 
estimate of the optimal vit D serum level needed to be achieved for the maximum net health 
gain in Danish population.   
The method focusses on estimating each health effect expressed in DALYs in the reference 
scenario, followed by the estimation of the health effect of alternative scenarios with changing 
serum 25(OH)D concentration. The DALY difference between the alternative scenarios and 
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reference scenario expresses the net health gain. It is computed with the QALIBRA (Quality of 
Life for Benefit Risk Assessment) tool [4]. Subsequently, the scenario that results in the 
maximum net health gain is considered the optimum scenario.  
2. VITAMIN D 
Vitamin D plays an important role in reducing the risk of several diseases [13]. However, the 
current dietary intake in the population is lower than the recommended intake [14, 15]. Due to 
the high latitudes, indoor activities and low vitamin D intake, the serum 25(OH)D level is 
relatively low in most populations in Northern Europe [16]. Hence, it has been suggested to 
increase the recommended intake [15, 17, 18]. Recently, the Nordic Nutrition 
Recommendations (NNR) increased the recommended dietary intake from 7.5 to 10 ug/day 
[15]. 
Studies suggest that higher 25(OH)D serum levels are associated with beneficial effects, i.e. for 
reducing the risk of several diseases [13, 19, 20, 21, 22, 23]. On the other hand, some studies 
report that vitamin D may lead to an adverse effects at both higher and lower levels [24] and 
when taken excessively [25]. This implies that there will be an intermediate optimal serum 
25(OH)D level and finding this level would be imperative to attain the maximum health 
benefits.  
Several studies suggest various optimal serum 25(OH)D levels, needed to reduce the risk of 
some diseases. Based on the existing data, the suggested optimal serum level needed to reduce 
the risk of osteoporosis, cardiovascular diseases and colorectal cancer is 75-110 nmol/l [20]. For 
fracture 75 nmol/l [26] and to lower the risk of mortality 50-60 nmol/l [24] have been 
suggested.  
In this paper, we aimed to establish the optimum serum 25(OH)D level for the Danish 
population and therefore several alternative scenarios are simulated from which an optimum 
serum level can be identified using DALY. 
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2.1 Health effect identification 
To identify the endpoints that are associated with vitamin D, we reviewed national and 
international authoritative reports such as WHO/IARC [27], EFSA [17] and IOM [18] which are 
up-to-date scientific opinions based on a collection of nutritional and observational studies.   
 
According to WCRF/AIRC and WHO/FAO [28, 29] criteria for the strength of evidences, the most 
convincing evidence is substantiated by multiple randomized controlled intervention trials of 
sufficient size, duration and quality in a population representative for the target population 
showing consistent effects. So far, there is strong scientific evidence for the effect of vitamin D 
on bone related diseases [18, 19, 21, 22, 30], while the evidence for other endpoints such as 
cardiovascular diseases and diabetes is conflicting [17, 18, 27].  
  
In this paper, we have considered endpoints that have convincing evidence. These are: hip 
fracture, other nonvertebral fracture and fall. In addition, we have included an endpoint where 
the evidence is relatively weak, but the reported quantitative data on the dose-response 
relationship are particularly suitable for the purpose of our study (total mortality). As the 
endpoint “total mortality” includes mortality from the other endpoints considered in this 
assessment, we use the term “other cause mortality” to distinguish this effect from “total 
mortality”. 
 
2.2 Description of dose-response and selection of population  
 
Various studies on the association between vitamin D and health effects describe the vitamin D 
dose differently in the dose-response relation. Usually, the dose is represented as 25(OH)D 
level in nmol/l serum [24] or ng/ml serum [31] and sometimes the dose is represented as intake 
in IU or μg per day [22]. The serum level of vitamin D gives information about the recent 
exposure to vitamin D [32] and since we wanted to establish the optimal serum 25(OH)D level, 
we related the dose to serum level in nmol/l throughout this study. The relation between 
intake and serum level (nmol/l) is presented in section 2.5. 
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For fall and fractures, the selected populations are elderly of both sexes because the 
Randomized Control Trial (RCT) studies included in the dose-response considers elderly of 
general population [19, 21, 22]. The sub-populations associated to the selected endpoints and 
the types of study are given in table 1.  
 
Table 1. The selected endpoints and population of interest related to vitamin D intake 
 
Endpoints Type of study and 
population characteristics 
References 
Fractures (hip and other 
nonvertebral) 
Meta-analysis of RCT*, ≥65 
years old, both sexes. 
[22] 
Fall Meta-analysis of RCT*, ≥65 
years old, both sexes 
[19] 
Other cause mortality Cohort study, survey, ≥30 
years old, both sexes 
[24, 33, 34] 
  *RCT: Randomized controlled trial 
 
For other cause mortality, various studies conducted the relation between vitamin D and 
mortality in different subpopulation [24, 33, 34]. In our study, the target population is both 
sexes of age ≥30 years old for this endpoint.  
 
 2.3 Intake of vitamin D and serum 25(OH)D level  
 
In Denmark, fish is the primary dietary source of vitamin D [14], followed by eggs, milk and 
meat products. The relative contribution of the various foods for the daily dietary intake of 
vitamin D in Denmark is shown in table 2 [14].  
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Table 2. Food type contributing to the daily vitamin D intake of the Danish population 
 
Food type % of contribution 
Fish 43 
Meat 29.5 
Milk and cheese 13 
Eggs 9.5 
Butter and margarine 5 
 
The average dietary vitamin D intake is obtained from [14]: 3.8 μg/d for men and 3.1 μg/d for 
women. These values are transformed to serum levels in nmol/l as explained in section 2.5. As 
alternative scenarios, we have simulated a series of serum 25(OH)D level: 35, 50, 65, 72, 80, 90, 
100, 120 and 166 nmol/l for both sexes and ages. These values were chosen in a process of trial 
and error, using interpolation to find the optimum. 
 
2.4 Health impact estimation  
To estimate the net health effect, the QALIBRA (Quality of Life for Benefit Risk Assessment) 
software is used [4]. This software run the simulation based on the following DALY equation for 
each disease [5]. For the net effect, DALYs are summed over every disease.  
 
DALYa,s = Peff(a,s) * [Prec * YLDrec * w + Pdie * (YLDdie * w + LEa,s - CA - YLDdie) + (1 - Pdie - Prec) * (LEa,s 
- CA) * w]………(1) 
Where:  
DALYa,s            disability adjusted life years at age group a and sex s 
Peff(a,s)              probability of onset of the disease at age and sex, per year 
Prec                  probability of recovery from the disease 
Pdie                   probability that the disease causes death  
YLDrec    mean duration of disease for those who recover  
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YLDdie              mean duration of disease for those who die  
CA    current age of individual in year of disease onset (years) 
LEa,s                 normal life expectancy (i.e. expected age at death) at age a and for sex s  
w                     disability weight for disease.  
 
Since we are interested in the health effect of the difference of the scenarios, estimating the 
change in DALY between scenarios is imperative [5].    
 
The ΔDALY between scenarios is calculated using: 
 
ΔDALY = ΣDALYalt – ΣDALYref.................. (2) 
 
Where, ΔDALY is change in DALY; ΣDALYalt, summation of DALYs caused by every endpoint of all 
individuals in the population at the alternative scenario and ΣDALYref, summation DALYs caused 
by every endpoint of all individuals in the population at the reference scenario. 
 
The DALY is summed for the ages and sexes considered for each endpoint, with Na,s the 
populations size for age and sex in Denmark. 
 
ΣDALY = Σendpoints, Σa,s Na,s * DALYa,s……….(3) 
 
DALYs represent health loss; therefore, if the estimation of ΔDALY results in a positive value 
then the change in consumption has an adverse health effect (health loss). If the ΔDALY is 
negative, then the change in consumption has a beneficial effect [4, 5].     
  
2.5 Conversion of vitamin D intake in 25(OH)D serum level and dose-response 
 
Vitamin D intake has to be related to 25(OH)D serum concentration because our aim is to find 
an optimum serum level. It also allows a comparison of all endpoints, because some studies 
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report an association between serum level and disease instead of intake and disease. For the 
conversion of intake to serum concentration, we used two studies by Cashman et al. [36, 37], 
that relate the dietary vitamin D intake (μg/d) with serum level (nmol/l) in two age groups. We 
have chosen the 50 percentile data points from both studies as point estimates of the vitamin D 
intake level that is needed to achieve the serum level in the study subjects. So, for fall, hip and 
other nonvertebral fracture the 50 percentile data points for both sexes as reported by 
Cashman et al. [36] are used, because the target populations for these endpoints are elderly of 
both sexes. Since the target population for other cause mortality is ≥30 years old of both sexes, 
the intake in μg/d is related to serum level in nmol/l using the 50 percentile data points of both 
studies of Cashman et al. [36, 37].  For all conversion from dietary intake in μg/d to serum (S) 
level in nmol/l serum, the following linear model (eqn. 4) is used.  
 
(S, nmol/l) = a * (vitamin D intake, μg/d) + b……… (4) 
 
The fitted values for a and b are a=2.08 and b=35.2 when both sexes data points are used, i.e. 
for hip fracture, other nonvertebral fracture and fall [36]; a=1.95 and b=35 when both sexes 
data points from [36, 37] studies are used, i.e. for other cause mortality.  
 
For different endpoints, this approach may assign different reference scenario intakes in terms 
of serum levels to men and women. These reference scenario serum levels are derived from 
different average intakes for men and women (see section 2.3) and eqn. 4. They are 43 nmol/l 
(fractures and fall) and 42 nmol/l (other cause mortality) for men and 42 nmol/l (fractures and 
fall); 41 nmol/l (other cause mortality) for women. As a side effect of our approach, this may 
result in small differences in the assumed reference level as a function of the same intake for 
different endpoints.  
 
Using this method, intakes are converted to serum concentrations expressed as nmol/l. 
Subsequently, to determine the relative risk (RR) based on our intake scenarios, the serum 
level-RR relations are derived from studies that describe vitamin D intake in IU/d for most of 
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the selected endpoints (table 3). When the doses are given in a range, we have used the mean 
value. The intake values in the dose-response for fall were reported in ranges and qualitatively 
as less or greater than 60nmol/l [19]. When given in range, the mean value was used and when 
given qualitatively, we assumed 55 nmol/l and 87 nmol/l. To relate IU/d to μg/d, we used the 
standard conversion formula [35]: 1 IU = 0.025 μg.   
 
Table 3. Data (intake, serum level and mean Relative Risks) of each endpoint, used to derive 
the dose response relations.  
The values printed in italics in the table are calculated using equation 4.  
Endpoints IU/d μg/d nmol/l 
 
 
Mean RR 
 
 
95% CI References 
Hip fracture 400* - - 1.15 0.88,1.5 [21,22] 
 500 12.5 61 0.91 0.78, 1.05 
600 15 66 0.82 0.69, 0.97 
750 18.75 74 0.74 0.61, 0.88 
Other 
nonvertebra
l fracture 
400* - - 1.03  0.86,1.24 
500 12.5 61 0.86 0.77, 0.96 
600 15 66 0.8 0.72, 0.89 
750 18.75 74 0.77 0.68, 0.87 
Fall   55 1.35 0.98, 1.84 [19] 
850 21.25 80 0.81 
 
0.71, 0.92 
  87 0.77 0.65, 0.9 
Other cause 
mortality 
  10 2.13 2.02, 2.24 [24] 
  50 1.0 - 
  140 1.42 1.31,1.53 
*Vitamin D dose of ≤400 IU/d is not sufficient for the prevention of fractures [21, 22]. Therefore, data points of ≤400 IU/d were not used for 
fractures. 
72 
 
In the studies used for fall, hip and other nonvertebral fracture [19,21,22] the relative risks 
were determined compared to placebo, so presumably RR= 1 at an intake of 0 IU/d (serum level 
≈ 35 nmol/l). This is not included in our analysis because it is not explicitly stated in the papers, 
and it is indicated that in general vitamin D doses ≤400 IU/d are not sufficient for the 
prevention of fractures [21, 22]. Also, the fit of the dose response model to the data would not 
benefit from including values corresponding to this RR=1 in the analysis. 
The dose response relations expressing RR as a function of serum level are modeled using a log-
linear function for each endpoint separately, except for other cause mortality.  
 
ln(RR) = (S, nmol/l) *c + d…………..(5) 
 
The fitted values (c and d) are given in table 4.  
 
The parameters c, d and the estimated RR for the reference scenario using eqn. 5, are shown in 
table 3. Equation 5 is applied to calculate the RR for the alternative scenarios. 
 
Table 4. The fitted values and estimated RR’s for the reference scenario serum levels per 
endpoint and sex. 
    
Endpoint Fitted values  RR-men  RR-women 
 c d   
Hip fracture -0.016 0.85 1.19 1.22  
Other nonvertebral 
fracture 
-0.009 0.44 1.04 1.06 
Fall -0.018 1.3 1.67 1.73 
*Total mortality   1.26 1.25 
*Calculated by a hazard ratio (HR) using eqn. 10. 
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Figure 1 illustrates the serum level (nmol/l)-RR data points that are used to estimate the fitted 
values shown in table 4, and the fitted dose-response models. The fitted models have RR=1 at 
different serum levels values above the zero intake and reference intake scenarios, which 
means that RRs cannot be compared between endpoints. 
 
 
 
Figure 1. The serum level-RR data points (Table 3) and the fitted lines describing the relation 
between serum level and relative risk (eqn 5).  
 
The serum level-RR relations for hip fracture, other nonvertebral fracture and fall show the 
same trend (decreasing risk with increasing serum level). For other cause mortality, the serum 
level-RR relation shows increasing risk at low and high serum level.  
 
The estimated RR has to be converted to absolute risk for the reference scenario Peff(Sref). To 
this end we have assumed that the current incidence Inc is related to the current intake. Thus,  
 
∫ P𝑒𝑓𝑓(𝑆)p(S)dS = Inc/N∞0 ………….. (6) 
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However, by assuming that everyone’s serum level is the average of the population, we 
simplified the above equation to: 
Peff(a,s)(Sref) = Inca,s / Na,s………..(7) 
 
Where Inca,s is the incidence of the diseases in the relevant sex and age group, which is 
obtained from epidemiological studies as described in section 2.6. The variation in incidence 
per age group and (when relevant) sex is considered for hip fracture and fall. Due to lack of 
data, only sex variation is considered for other nonvertebral fracture.  
 
To estimate the absolute risk at an alternative scenario Peff(Salt), we use the fact that by 
definition the ratio of absolute risk to relative risk at the reference scenario is similar to the 
ratio of absolute risk to relative risk at an alternative scenario [38].  
 
Peff(Sref) / RR(Sref) = Peff(Salt) / RR(Salt) ........(8) 
 
Then, by rewriting eqn. 8, Peff(Salt) becomes: 
 
Peff(Salt)= RR(Salt) * Peff(Sref) / RR(Sref) .........(9) 
 
The hazard ratio HR. of total mortality is described by a quadratic function of serum 
concentration, the reported serum 25(OH)D level S and respective HR data points from [24] are 
analyzed and the fitted values are given in eqn. 10. In the study, the HR was determined based 
on a median of three years total mortality [24]. In our study, the estimated HR for the reference 
as well as alternative serum levels is for one year.  
 
HR = 0.0003 * S2 - 0.0434 * S + 2.54……… (10) 
 
The hazard ratio HR is interpreted as the relative risk RR, and calculated for the reference and 
alternative scenarios.  
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To estimate the probability of effect for mortality at the reference scenario (Peff,M(Sref)), the 
mortality rate is used. This mortality rate is calculated for the different age groups and sexes 
separately, data is obtained from [39].  
 
Peff,M(a,s)(Sref) = Mortalitya,s / Na,s………(11) 
 
To estimate Peff,M(Ialt)  we use the same definition as eqn. 8. Thus,   
  
Peff,M(Salt) = HR(Salt) * Peff,M(Sref)HR / HR(Sref)...........(12) 
 
The above equation gives us total mortality. However, total mortality also includes the 
mortality from the other endpoints included in our study (fall, hip fracture and other 
nonvertebral fracture). Hence, taking into account the other endpoints from total mortality, the 
probability effect for other cause mortality (Peff(other cause mortality))  becomes: 
 
𝑃𝑒𝑓𝑓(𝑜𝑡ℎ𝑒𝑟 𝑐𝑎𝑢𝑠𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦) 𝑎,𝑠(𝑆) = 𝑃𝑒𝑓𝑓,𝑀(𝑎,𝑠)(𝑆) − ∑ 𝑃𝑒𝑓𝑓(𝑗)𝑎,𝑠(𝑆) ∗ 𝑃𝑑𝑖𝑒(𝑗)𝑎,𝑠(𝑆)𝑗  …….(13) 
 
Where Pdie(i) and Peff(i) are the probability of death due to disease j  and the probability of onset 
of disease j,.  
 2.6 Parameters for DALY calculation  
 
To estimate the input parameters in QALIBRA, a similar approach as in [38] is used. Mainly 
Danish national epidemiological data are used and to some extent, international and analogous 
country epidemiological data were used in case of scarcity of Danish data. Furthermore, in case 
of data unavailability, assumptions have been made, as explained below. The model population 
is 1000 individuals with age and sex representative of the Danish population [39].  
 
Peff(a,s), is estimated for all endpoints as explained in section 2.5. The incidences, Inc are 
obtained from different studies; for hip fracture [40], nonvertebral fracture [41] and fall [42]. 
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Peff, for other cause mortality is described in eqn. 13, mortality rate is obtained from Denmark 
Statistics [39].  
 
When an individual develops a disease, either the individual recovers from the disease (Prec), 
dies due to the disease (Pdie) or survives with the disease (Psur) until the normal life expectancy 
[4, 5]. Pdie, is estimated for hip fracture [43], nonvertebral fracture [44] and fall [45]. Pdie, for 
other cause mortality by definition is 1.  
 
Psur, is estimated for hip fracture from [46], nonvertebral fracture [44], fall [47] and for other 
cause mortality is set to 0.  
 
Prec, is calculated for all endpoints using  
 
Prec = 1 - (Psur + Pdie)………….. (14) 
 
YLDdie, for hip fracture is assumed to be 2 years, the highest mortality period since onset of hip 
fracture [43] and YLDrec is assumed as the follow up period, 5 years [48]. For the other bone 
related diseases, it is assumed that YLDrec and YLDdie are equal to the values used for hip 
fracture. For other cause mortality, by definition both parameters are set to 0.  
 
Severity weight w, is obtained from the WHO burden of disease estimation [49]. The summary 
input parameters are presented in table 5.  
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Table 5. The summary of input parameters for DALY calculation 
 
Endpoints Estimated parameters 
 *Psur Prec YLDrec Pdie YLDdie w 
Hip fracture 0.57 0.135 5 0.295 2 0.372 
Nonvertebral fracture 0.65 0.23 5 0.122 2 0.18 
Fall 0.11 0.78 5 0.11 2 0.2 
Other cause mortality 0 0 0 1 0 1 
* The Psur is not a typical input parameter required to estimate DALYs in QALIBRA, but it is used 
to estimate Prec. 
 
3. RESULTS   
 
Table 6 contains the DALYs simulated with the QALIBRA tool for each endpoint. Our aim was to 
determine the optimum scenario that provides maximum net health gains in comparison with 
the reference scenario. The results presented in Table 5 are the differences in DALYs between 
the alternative scenarios and the reference scenario, for each endpoint. That can be 
interpreted as the health, expressed in DALYs, one can gain if the serum concentration changes 
from the reference to the alternative.  
  
It appears that for hip fracture, nonvertebral fracture and fall, the healthy life years increase 
with increasing serum 25(OH)D level. Among these endpoints, a considerable gain of DALYs is 
observed primarily from fall prevention when the serum level increases. For other nonvertebral 
fracture only a slight benefit is observed with increasing serum 25(OH)D level.  
 
Apparently, a substantial gain in healthy life years is achieved with increasing serum 25(OH)D 
level up to 72 nmol/l from the reduction of the risk of other cause mortality, reaching a 
maximum benefit of -69 DALY/1000 individuals. However, the benefit gradually decreases when 
the achieved serum 25(OH)D level at >80 nmol/l. Combined with the other endpoints, the 
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health benefits gained by the reduction of the risk of other cause mortality is dominant up to 
the serum level of 72 nmol/l.  
 
Table 6. The estimated median DALYs/1000 individuals for each endpoint. 
Scenarios 
(nmol/l) 
Hip 
Fracture 
Other 
nonvertebral 
Fracture 
Fall Other 
cause 
mortality 
Net 
Ref. Vs. 35 12 0.85 9.7 3.9 26.5 
Ref. Vs. 50 -2.6 -1.0 -9.5 -47 -60 
Ref. Vs. 65 -7 -2.8 -23 -65 -98 
Ref. Vs. 72 -8.6 -3.4 -28 -69 -108 
Ref. Vs. 80 -9.6 -4.2 -32 -60 -106 
Ref. Vs. 90 -12.4 -5.2 -37 -40 -94 
Ref. Vs. 100 -13.7 -6.0 -41 -0.3 -61 
Ref. Vs. 120 -16.4 -7.3 -46.4 113 43 
Ref. Vs. 166 -20 -10 -53 516 433 
The DALY of the optimum scenario is printed in Bold in table 6. 
Even though the net healthy life year’s is gradually reducing after 72 nmol/l, there seems to be 
a benefit compared with the reference serum concentration up to the 100 nmol/l. At a level of 
120, the net benefit shifted to net risk, 43 DALY/1000. Since the DALY was not calculated for the 
serum level between 100-120 nmol/l, the precise turning point from net benefit to net risk 
cannot be defined in our assessment. However, it is in the range of serum level of 100-120 
nmol/l.  
Figure 2 shows the results presented in table 5 in a graph. The maximum net health gains is 
achieved when serum 25(OH)D level reaches the optimum serum level of 72nmol/l (rectangular 
green mark on the red line). Note however, that many uncertainties have not been 
incorporated and that the curves showing the DALYs versus serum level is rather flat.  
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It is noted that the shape of the curve for the total DALY (red line) in Figure 1 is highly 
influenced by the DALY of “other cause mortality” (blue line). As it turns out the optimum for 
just other cause mortality is also the optimum for the combined effect. That is no real surprise, 
mortality is the most severe health effect (w=1) and affects a wide range of subpopulation 
groups compared to the other endpoints. Compared with mortality, fall and fractures are 
relatively small health effects.    
 
 
─ net DALY;    ─  other cause mortality;    ─ fall;      ─ hip fracture;    ─ other nonvertebral fracture        
 
Figure 2. The DALY of each health effect and total DALY.  
 
Table 6 shows the incidences at the reference and the optimum serum levels computed with 
the QALIBRA tool.  The percent of reduction of incidences of fall and hip fracture is relatively 
higher; accounting for 50% and 36% respectively, when changing from the reference to the 
optimum scenario.  
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Table 7. The incidence/1000 person per year at reference optimum scenario and % change of 
incidences between the scenarios 
 
Scenarios 
(nmol/l) 
Hip 
Fracture 
Other nonvertebral 
Fracture 
Fall Other cause 
mortality 
*Reference 8.7 5.4 36 54 
Optimum 5.6 4 18 40 
% of Change  36 26 50 26 
*The serum level for the reference scenario varies between 41- 43 nmol/l (see section 2.3).  
Figure 3 shows a scatter plot of the variation in DALYs gained/lost when changing from the 
reference scenario to the optimum scenario, produced by the QALIBRA tool. Each dot in the 
graph shows the DALY change for an individual characterized by age (left side plot) and by sex 
(right side plot). 
 
The left plot shows the variability of DALYs gain/lost with age. The increase in healthy life years 
gain is observed with increasing age, because elderly people benefit primarily from the 
prevention of fractures, falls and other cause mortality when the serum 25(OH)D concentration 
changes from the reference to the optimum scenario. Adults of age 30-64 gain less DALYs 
compared to the elderly since this age group benefits only from the reduction of other cause 
mortality as for this age class the other endpoint are not included in the analysis. Also in the 
young age groups the probability of (other cause) mortality is very low and therefore a 
reduction in mortality risk has a small effect. 
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 Figure 3. Scatter plot of the DALY change per age and per sex (0 in the x-axis represent 
women, 1 in the x-axis represent men) at optimum scenario. 
  
The second scatter plot (right plot) shows the variation of DALY in sex, it is noted that age 
contributes more to the total variation in DALY than sex, because the variation of mortality rate 
(for other cause mortality) and incidence rate are larger per age class than per sex.  
 
4. DISCUSSION AND CONCLUSION  
 
The case study of vitamin D illustrates a method for finding the optimum scenario that provides 
maximum net health gains. To show how to find the optimum scenario, the net health impact 
of the different endpoints for several scenarios were calculated with the QALIBRA software 
(www.qalibra.eu). The QALIBRA software explicitly uses two scenarios (reference and 
alternative scenario) and shows the DALY difference of those scenarios. Since our aim was to 
determine the scenario that provides maximum health gains in comparison with the reference 
scenario, several alternative scenarios have been simulated in QALIBRA. Then, the difference of 
the DALY between the alternative and reference scenario that gives the maximum net health 
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gain is considered the optimum scenario. In the vitamin D example, nine alternative scenarios 
were compared to the reference scenario to determine the scenario that provides maximum 
net health gains.  
 
The study is the first to show a comprehensive quantitative assessment of vitamin D on 
aggregate health effects by expressing them in common health metrics (DALY). In addition to 
the well-known effect of vitamin D on bone, other effects are reported to be associated with 
vitamin D. However, so far only strong scientific evidence for a preventive effect of vitamin D on 
fall and fractures exists [19, 21, 22]. In this assessment, we have considered these endpoints 
that have strong scientific evidences and another endpoint (total mortality) with less convincing 
scientific evidences, in order to analyze their contribution to the net health effects. The 
preferred way to combine convincing and less convincing effects is to incorporate uncertainty. 
Although the QALIBRA tool allows for the introduction of uncertainty by making a probabilistic 
assessment, this was not done here. The focus of this paper was to show a method to find the 
optimum scenario (serum level). For this reason other simplifications have been introduced as 
well.  
 
The most important finding of this study is showing that it is possible to determine the scenario 
that provides the optimum public health effect from the cumulative effect of all the endpoints 
considered. Because the function that describes the relation between serum concentration and 
net health gain is rather smooth a simple series of increasing serum concentrations readily 
shows the optimum If the net health effect appears to change quickly with increasing serum 
levels, then the bisection method or even more sophisticated mathematical methods can be 
used. Consequently, according to our assessment the simulated scenario that provides the 
maximum benefit is when serum 25(OH)D level reaches 72 nmol/l. Because the net health 
effect hardly changes between 65 and 80 nmol/l the optimum would be somewhere between 
65 and 80 nmol/l. The result is approximately in accordance with other study [50], although 
these studies predicted the optimal level for specific endpoints. The result is also in line with 
another study conducted for multiple diseases [51].  Ideally, men and women would have 
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different optimal serum levels because of the small difference in response to intake of vitamin 
D and/or serum level. However, in this assessment the intake and the dose-response difference 
in men and women are not substantially different (see section 2.3 and 2.5).   
 
It is essential to point out the limitations of the assessment to better interpret the quantitative 
result. For the reference serum level, we have derived the serum level that results from the 
mean Danish intake stratified by sex. For the conversion of intake in µg/d to nmol/l, we have 
used only two studies [36, 37] and ignored the variation between individuals by using the 50 
percentile intake-serum relationship only. Note that serum levels do not only depend on intake 
but that UV exposure contributes a large part of the serum level. However, when we used 
another study [50] to relate the intake in µg/d to serum 25(OH)D level in nmol/l the results are 
fairly similar. Also, we have included an endpoint (total mortality) that has relatively weak 
scientific evidences but dominates the outcome. Moreover, very few data points were available 
to estimate the relation between the RRs and serum concentration, and extrapolation beyond 
the range of the available data (see Figure 1) was needed to analyze all the different 
scenarios. The choice of the log-linear model (eqn 5.) and the decision not to include low 
intake relative risk values when fitting the model have an impact on the quantitative result. 
Furthermore, YLDdie and YLDrec are assumed to have a fixed value but these values may depend 
on age, sex and/or vitamin D serum level. Because of all these assumptions and uncertainties, 
the quantitative result obtained in this assessment should be interpreted with care. When more 
data will become available in the future, the same methodology can be applied to obtain more 
precise estimates of the health impact of different intake scenarios.  
 
The change of serum 25(OH)D level from the reference scenario (see section 2.5) to the 
optimum scenario (72 nmol/l) provides a gain of -108 DALY/1000 Danish individuals. For this -
108 DALY net health gain, other cause mortality contributes for more than 64%. The target 
population for other cause mortality includes a larger fraction of the population compared to 
the other endpoints. Combined with the maximum severity of the effect (death), this explains 
why the DALY gain by this endpoint alone accounts for approximately 64% of the net gain. Fall 
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contributes about 26% for the net gain. The DALY gain from hip and other nonvertebral fracture 
seem relatively trivial. On the other hand, when the serum level reaches to120 nmol/l and up, 
the healthy life years loss (due to other cause mortality) prevail over the healthy life years gain 
due to hip fracture, nonvertebral fracture and fall.  
 
The net DALY in figure 2 is highly influenced by the DALY of the other cause mortality. Studies 
show a U- or reverse J- shape for the association of vitamin D with mortality [24, 33]. This 
implies that there is an increasing risk of mortality at high and low serum level. The dose-
response study we used in our assessment for the other cause mortality obtained a reverse J-
shape association [24]. Both low (10 nmol/l) and high (140 nmol/l) level lead to an increasing 
risk of mortality and 50-60 nmol/l serum level give the lowest risk of mortality [24]. The fitted 
DALY curve for this endpoint (equation 10) shows a maximum DALY gain at 72 nmol/l.  
 
Concerning the variation in sex and age, the variation of the DALY in Figure 2 is mostly due to 
the variation in the incidences and mortality rate variation per age class. For most of the 
selected endpoints, the difference in incidences and mortality rate (other cause mortality) is 
larger between age classes than between sexes, (see Figure 2, right plot).  
 
In this study we have used vit D to show a method to find the best scenario, which achieves the 
maximum net health gain. A similar approach can be used for other foods or food components 
and biomarkers. As part of determining the best scenario, food processing parameter 
optimization (e.g. time-temperature, storage time) may also be integrated into the risk-benefit 
assessment to optimize the health [6].  
  
The vitamin D concentration is the result of food and supplement intake but is also the result of 
UV-exposure. UV exposure is linked with skin cancer risk. That risk is not directly included in our 
assessment. A more complete assessment would separate the intake and UV-exposure effects. 
Furthermore, the development of methods to include aspects of a disease such as disease 
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recurrence, complete and partial disease remission is needed. Future research may also focus 
on method development for output validation in relation to the QALIBRA tool.   
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Abstract 
 
The burden of disease estimate has been performed for diseases attributable to nutritional 
deficiency, foodborne pathogens, the environment, infection and other factors. However, the 
burden of disease estimate attributable to different food processing practices has not been 
investigated before. The aim of this study is to compare the burden of disease estimate 
attributed to red meat consumption processed using different cooking practices.  
 
The red meat cooking practices were categorized into three: A) barbecuing/grilling; B) 
frying/broiling and C) roasting/baking. The associated endpoints, affected population, intake 
and dose-response data are obtained by literature survey. The selected endpoints are four 
types of cancer: colorectal, prostate, breast and pancreatic. The burden of disease per cooking 
practice, endpoint, sex and age is estimated in the Danish population, using disability adjusted 
life years (DALY) as a common health metric.  
 
The results reveal that the consumption of barbecued red meat is associated with the highest 
disease burden, followed by fried red meat and roasted red meat. 
  
The method used to quantify the difference in disease burden of different cooking practices can 
help to inform the consumer to make a choice on whether the benefit of a preferred cooking 
style is worth the associated health loss. 
 
Keywords: Cooking practice; red meat; cancer; DALY 
 
* Corresponding author. Tel.: +4551801526 
Email address: firew.lemma@yahoo.com (Firew Lemma), maana@food.dtu.dk (Maarten 
Nauta), morp@food.dtu.dk (Morten Poulsen).  
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1. Introduction  
 
Food processing adds values to products; processed food products display specific flavor, taste, 
color or texture, which can be seen as a benefit from a food quality perspective (Heinz and 
Hautzinger, 2007). In addition, processing, especially cooking at high temperature, may 
inactivate pathogens in the food (WHO/FAO, 2004) but may also cause formation of hazardous 
chemical compounds (Badry, 2010). Thus, cooking at high temperature can be both beneficial 
and detrimental for health, which may leave the consumer with a dilemma when cooking. 
 
Meat and meat products are ubiquitous and consumed cooked worldwide. Meat is cooked in 
various ways, and the cooking practices often used are braising, stewing, broiling/frying, 
grilling/barbecuing and roasting/baking. When meat is cooked at high temperatures, several 
hazardous chemical contaminants such as polyaromatic hydrocarbons (PHAs) and hetrocyclic 
amines (HCAs) may be formed (Jägerstad & Skog, 2005; Aaslyng et al., 2013). The concentration 
of these contaminants varies with meat type, temperature and time of cooking, and method of 
cooking (Knutsen et al., 2007; Badry, 2010; Aaslyng et al., 2013).  Some of these chemical 
contaminants are known to be carcinogenic and may cause substantial health losses (EFSA, 
2008; SCF, 2002). To inform consumers on the potential health impact of cooking red meat, it is 
relevant to quantify these health losses.  
 
Burden of diseases is a quantitative measure of population health outcome using the 
information on mortality and morbidity (Murray and Lopez, 1996) and in addition recovery in 
the population (Hoekstra et al., 2012). Knowledge of burden of disease estimates may help to 
prioritize the major causes of health loss and to evaluate the potential impact of taking action 
to improve health.  Burden of disease estimate has been performed for diseases attributed to 
nutritional deficiency, foodborne pathogens, environment, infections and other factors (Murray 
et al., 1996, Murray et al., 2013; Gkogka et al., 2011; Havelaar et al., 2012). However, to our 
knowledge, the burden of disease estimate attributed to meat cooking practices has not been 
studied before.  
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The aim of this study is to compare the burden of disease estimates (expressed in disability 
adjusted life years, DALY) attributed to different cooking practices used to process red meat. 
The available data from epidemiological studies where cancer risks (consequential to exposure 
to PHAs and HCAs) are associated with cooking practices are applied, together with Danish 
consumption data. A method is developed that allows the estimation of the burden of disease 
for different cooking practices for different sexes and different age classes, based on these 
data. The outcome of this study will enable us to inform consumers on the difference between 
the expected health impacts of different cooking practices and may allow individuals to weigh 
that against the perceived quality associated to these cooking practices. 
 
2. Material and methods  
 
For the purpose of this study, we have considered three categories of red meat preparation by 
the consumer: A) barbecuing (BBQ)/grilling (direct heat contact); B) frying/broiling (pan); C) 
roasting/baking (dry heat, oven).  
 
The health hazards, endpoints and affected populations related to the consumption of cooked 
red meat are obtained from the literature. In order to estimate the probability of onset of each 
disease that can arise from the different cooking practices, the relative risks (RR) associated to 
intake of red meat per cooking practice were identified from literature, stratified and modeled 
using a linear or a log-linear function. Model validation is performed to select the best fit, using 
residual analysis and QQ-plot (Ekstrøm and Sørensen, 2011). Next, the RR based on the Danish 
red meat intake distribution is estimated. Then, the probability of onset of the disease per 
cooking practice is estimated as a function of the incidence of disease, the frequency of the 
application of the cooking practices, the probability of intake and the RR for different age 
classes and sexes.   
 
The burden of disease of each cooking practice per selected endpoints is estimated using the 
DALY model developed in Hoekstra et al. (2012). For the sake of relative comparison, the 
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burden of disease for no intake of cooked red meat is also estimated. The analysis is performed 
in R-statistical software, version 2.15.2 and MS Excel 2010. A detailed description of the 
method is presented in the following sections.  
 
2.1. Major health hazards associated with cooked meat consumption 
 
When meat is heat treated, deleterious compounds including various mutagens and 
carcinogens may be formed. The two widely known group of hazardous chemical compounds 
formed during meat cooking are HCAs and PAHs (Jägerstad and Skog, 2005; Badry 2010; 
Aaslyng et al., 2013). The formation of these toxicants is primarily linked to the cooking 
temperature-time relationship and the final concentration in the meat varies with different 
cooking practices (Badry, 2010).   
 
Even though both HCAs and PAHs are associated with serious health risks, there are only few 
reports concerning the intake of these components (Aaslyng et al., 2013). The lack of data 
about the intake of these compounds makes it difficult to make a direct link of these 
compounds with the cancer risks. However, several epidemiological studies correlate red meat 
intake cooked in different ways with cancer risks. Hence, in this study we use the 
epidemiological studies to estimate the burden of disease of eating red meat cooked in various 
ways. 
 
2.2 Health effect related to cooked red meat consumption 
 
Colorectal cancer is the cancer type most often associated with meat consumption (Probst-
Hensch et al., 1997; Sinha et al., 1999; Sinha et al., 2001; Ishibe et al., 2002; Sinha et al., 2005; 
Wu et al., 2006; Butler et al., 2003; Gunter et al., 2005; Cross et al., 2007) followed by breast 
cancer (Zheng et al., 1998; Steck et al., 2007), prostate cancer (Cross et al., 2005; Koutros et al., 
2008; John et al., 2011) and pancreatic cancer (Anderson et al., 2002; Li et al., 2007; 
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Stolzenberg-Solomon et al., 2007).  In this study we have therefore selected these endpoints. 
The population is based on studies referred to in table 1.   
 
Table 1 
Selected endpoints and population  
Selected endpoints Population  Reference 
Colorectal cancer Both sexes, age 50-71 years  Cross et al., 2007 
Prostate cancer Men, age 40-79 years  John et al., 2011 
Pancreatic cancer Both sexes, age 50-71 years Stolzenberg-Solomon et al., 2007 
Breast cancer Women, age > 49 years Steck et al., 2007 
 
2.3. Intake of red meat  
 
To assess the burden of diseases of the different meat cooking practices we have to know the 
intake of meat. For that purpose we have adopted the red meat consumption distributions by 
age classes and sexes from Pedersen et al. (2010) and presented in table 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
Table 2 
The red meat intake (g/day) distribution in Denmark by age classes and sexes (Pedersen et al. 
2010) 
Percentile  1 5 10 25 50 75 90 95 99 
Sex Age          
Men 35-44 38 55 69 100 139 188 261 292 364 
 45-54 24 57 67 96 134 177 223 256 282 
 55-64 28 60 70 91 124 164 223 259 348 
 65-75 16 41 58 81 112 145 178 193 239 
Women 35-44 13 27 39 59 83 111 136 158 198 
 45-54 7 25 36 53 79 106 140 156 197 
 55-64 6 24 37 54 76 103 125 144 183 
 65-75 11 18 29 48 70 92 123 147 243 
*p(i) (%)   2 6 4 26 24 26 4 6 2 
*The probability of intake p(i) gives the fraction of the population that is assumed to have the 
indicated intake i in each age/sex class. It is assumed to be an interval around the percentiles 
reported by Pedersen et al. (2010), where the reported percentile is the median value of each 
interval. This p(i) is required for the model calculations (section 2.4). 
  
The age classes for intake (table 2) were adapted to fit with the selected populations for the 
endpoints (table 1).  When the age class in the intake distribution is 35-44, 45-54, 55-64 and 65-
75 years, the age in the selected population (for instance, age 40-79 years, prostate cancer) is 
then accordingly catagorized as 40-44, 45-54, 55-64 and 65-79 respectively. Furthermore, since 
the last age class in table 2 is 65-75, we have assumed that persons older than 75 years have 
the same intake distribution as persons aged 65-75 year.  
 
 
 
 
98 
 
2.4. Estimating the probability of onset of the diseases 
 
To estimate the probability of onset of the diseases, we did  a literature search that particularly 
focussed on red meat intake by cooking practice in relation with the endpoints we have 
considered. The relative risk data for different intake levels, endpoints and cooking practices 
are presented in table 3.   
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Table 3  
Intake-Relative risk (mean, 95%CI) data points per cooking practice and endpoint used in the dose-response modeling  
Cooking 
category  
      
Colorectal cancer  Prostate cancer  Breast cancer  Pancreatic cancer  
Intake 
(g/d) 
Relative Risk Ref Intake 
(g/d) 
Relative Risk Ref Intake 
(g/d) 
Relative Risk Ref Intake 
(g/d) 
Relative Risk Ref 
Barbecuing/ 0 1 a 0 1 c 0 1 f 0 1 g 
grilling   3 0.9 (0.6, 1.2) a 3 1 (0.8,1.2) c 12 1.2 (1.0,1.5) f 2 1.4(0.7–2.7) g 
 8 0.9 (0.7, 1.3) a 9 1 (0.8,1.4) c 27 1.2 (1.0,1.4) f 7 1.2(0.7–1.9) g 
 17 1 (0.7,1.3)  a 17 1.1 (0.8,1.5) c 49 1.6 (1.3,1.9) f 35 2.2 (1.4–3.4) g 
    *0 1 d       
 30 0.9 (0.6, 1.3) b *0 1.36(0.86,2.16) d       
 0 1 b 60 1.26(0.76,2.07) d       
 3 1.58 (0.67-3.71) b 120 1.63(0.99,2.68) d       
 45 1.89 (1.04,3.45)  b 0 1 e       
    44 1.5(1.03,2.19) e       
    98 1.69(1.19,2.38) e       
    188 1.61 (1.13,2.28) e       
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Frying/  0 1 b 0 1  0 1 f 0 1 g 
broiling 1 0.55 (0.15-2.03) b 3 0.9 (0.7,1.1)  12 1.0 (0.9,1.3) f 2 1.1(0.6,2) g 
 3 0.53 (0.24-1.17) b 7 0.9 (0.6,1.2)  27 1.5 (1.3,1.8) f 8 1.9(1.1,3.3) g 
 10 0.69 (0.33-1.47) b 13 1  (0.7,1.4))  49 1.3 (1.1,1.6) f 17 1.6(0.9,2.8) g 
 40 0.72 (0.34-1.55)  b 0 1 c 0 1 f 95 1.4 (0.7,2.6) g 
 0 1 b 3 1.2 (1, 1.5) c 12 1.1 (0.9,1.4) f 0 1 g 
 18 0.22 (0.07-0.67)  b 7 1.2(0.9,1.6) c 27 1.2 (1.0,1.4) f 8 0.9(0.5,1.4) g 
    13 1.2 (1, 1.8) c 49 1.3 (1.0,1.4) f 10 0.7(0.4,1.1) g 
 0 1 a 0 1 d    90 0.7(0.4,1.2) g 
 2 1.1 (0.8, 1.6) a 0 1.38(0.88,2.16) d       
 7 1.2 (0.8, 1.7) a 60 1.42(0.84,2.39) d       
 13 1.1 (0.7-1.6)  a 120 1.41(0.83,2.37) d       
 20 1.3 (0.9-1.9)  a 0 1 d       
 0 1 a 0 1.32 (0.83,2.09) d       
 2 1.1 (0.8,1.6) a 60 1.52 (0.93,2.49) d       
 9 1.3 (0.9-1.9) a 120 1.42 (0.86,2.43) d       
 18 1.5 (1-2.2) a          
 35 2 (1.4,3)  a          
Roasting/  0 1 a 0 1 c 0 1  f 0 1 h 
baking 1.5 1.4 (0.9,2.1) a 1.5 0.7 (0.5,1.1) c 12 1.3 (0.9,1.7) f 1 1.1(0.78, 1.55) h 
 4 1 (0.6,1.5) a 3.5 0.8 (0.4,1.4) c 27 1.0 (0.8,1.2) f 2 1.16(0.88, 1.53) h 
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Ref: References. a:  Butler et al. (2003); b: Gunter et al. (2005); c: Joshi et al. (2012); d: John et al. (2011); e: Punnen  et al. (2011); f: 
Fu et al. (2011); g: Anderson et al. (2002); h: Stolzenberg-Solomon et al. (2007). 
*The same reference can provide several relative risks for the same intake because the relative risks are estimated for both no 
intake of red meat (RR = 1) and no intake of barbecued/grilled red meat (RR = 1.36) (John et al., 2011). 
 6 0.6 (0.3,1) a 6 0.9 (0.5,1.6) c 49 1.1 (0.9,1.3) f 0 1 h 
    0 1 d       
 12 1.1 (0.7, 1.7)  a 0 1.4 (0.9,2.18) d    2 0.91 (0.63, 1.34) h 
    60 1.38 (0.66,2.9) d    6 0.81 (0.54, 1.2) h 
    120 1.55 (0.6,2.58) d       
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The dose-response modeling requires point estimates of mean intake in g/day for the intake 
categories as applied in the different studies. Generally, these mean intakes are not provided in 
the selected studies. Therefore, different assumptions have been made when the intakes were not 
sufficiently quantified to be used for the dose-response modelling in this assessment:  
 
1. For the intakes that are given in interval, for example Butler et al. (2003), we have taken the 
mean.  
2. For the intakes that are described in qualitative terms such as low, medium and high intake 
(Punnen  et al., 2011), we have assumed the 10 percentile, median and 90 percentile of Danish 
meat consumption (Pedersen et al., 2010; table 2).  
3. For the intake given as below median and above median (John et al., 2011), we have assumed 
60 and 120 g/day respectively, which is roughly below and above median of Danish red meat 
intake (Pedersen et al., 2010).  
4. For the intakes that are given by quartiles (Fu et al., 2011); Q1, Q2, Q3, Q4, we have assumed no 
intake, 25%, median and 75% of the Danish intake respectively. The no intake is assumed for Q1 
because the relative risk for Q1 is 1.   
 
All the data used for the dose-response modeling are presented in table 3.  
  
Since the prevalence of the selected endpoints at population level in Denmark is less than 10%, we 
have assumed that the odds ratio (OR) and the hazard ratio (HR) in the Anderson et al. (2012) 
study are similar to the relative risk (RR) (Cummings, 2009; McNutt et al., 2003). 
  
To estimate the RR based on the intake scenarios, we have analyzed the data using linear, log-
linear and exponential model to find the best fit. Model validation is performed using residual 
analysis and QQ-plot (Ekstrøm and Sørensen, 2011). The selected model for each endpoint per 
cooking practice and the parameter estimates are given in table 4.  
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Table 4 
Models used to estimate the relative risk based on intake (i) for all endpoints and cooking 
practices (cp) for the age classes and sexes indicated in table 2.  
 Colorectal cancer  
 
Prostate cancer  Pancreatic cancer Breast cancer  
BBQ/ 
grilling 
RR = 0.012 (i) + 0.99 RR=0.004*(i)+1.1 RR= 0.043*(i)+1.08 Ln(RR)= 0.009*(i)+0.015 
Frying/ 
broiling  
Ln(RR)= 0.004*(i)-0.12 Ln(RR)= 0.003*(i)+0.09 Ln(RR)= 
-0.001*(i)+0.1 
Ln(RR)= 0.006*(i)+0.0182 
Roasting/ 
baking 
Ln(RR)=  
-0.012*(i)+0.04 
RR= 0.005*(i) +0.97 Ln(RR)=  
-0.04*(i)+0.06 
RR= -0.0002*(i)+1.1 
 
The RR per cooking practice (cp) at intake i, RR(i, cp) can be estimated using the equations in table 
4 for the different endpoints. As the equations are based on different studies, the RR(i,cp) values 
have different reference points where RR(i,cp) = 1. To allow a comparison of the RR values, they 
are rewritten to a relative risk RR0, so that by definition RR0(0,cp) = 1: 
 
RR0(i, cp) = RR(i, cp)/RR(0, cp)                                                                                               (1) 
 
Where RR(0,cp) is relative risk for no intake which is obtained from the equations in table 3, 
setting i=0. 
Disease is associated with absolute risk; therefore, the RR0 (i, cp) has to be converted to absolute 
risk (Peff(a,s)(i,cp)) for each endpoint (Hoekstra et al., 2013). The incidence rate of a disease due to 
eating cooked red meat per endpoint is a function of intake, probability of cooking practice, and 
probability of getting a disease.  
 
Inc(a,s)ep = ∑ i  p(a,s) (i) * (∑cp q(a,s) (cp)) * ( Peff(a,s)ep(i,cp))                                                              (2) 
 
where Inc(a,s)ep is the incidence rate in age group a, for sex s for endpoint ep; pa,s(i) is the 
probability of intake i in age class a, for sex s; qa,s (cp), is the probability of cooking practice, cp , in 
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age class a, for sex s; Peff(a,s)ep(i,cp) is the probability of getting the disease with intake i and 
cooking practice cp, in age class a, for sex s.  
 
However, q(a,s) (cp) is unknown for the different age and sex, so it is assumed to be the same for all 
age and sex classes and the incidence rate at age a for  sex s becomes: 
 
Inc(a,s)ep = ∑ i  p(a,s) (i) * ( ∑  cp q(cp))*( Peff(a,s)ep(i, cp))                                                                   (3) 
 
As for Peff(a,s)ep(i, cp) we know that 
 
Peff(a,s)ep(i, cp) = Peff(a,s)ep(0,cp)* RR0(i, cp)/ RR0(0,cp)                                                               (4) 
 
For an individual who does not consume cooked red meat, RR0 (0, cp) = 1 for each cooking practice 
and Peff(a,s)ep(0,cp) = Peff(a,s)ep (0) must be the same for all, because the individual does not use any 
of the cooking practices. Hence,  
 
Peff(a,s)ep(i, cp) = Peff(a,s)ep (0)* RR0(i, cp))                                                                                     (5) 
 
And therefore, 
 
Inc(a,s)ep = ∑ i  p(a,s) (i) * ( ∑cpq (cp) *Peff (a,s)ep(0)* RR0 (i, cp))                                                      (6) 
 
              = Peff(a,s)ep(0) * ∑ i  p(a,s) (i) * ( ∑cpq (cp)* RR0 (i, cp))                                                      (7) 
 
So we can calculate, 
 
Peff(a,s)ep(0)  = Inc(a,s)ep / (∑ i  p(a,s) (i) * ( ∑cp q (cp)* RR0 (i, cp)))                                                    (8) 
 
pa,s(i) is obtained from the percentile distributions of red meat intake (Pedersen et al., 2010) and 
given in table 2 as % in class. q(cp) is the probability of cooking practice cp. They have to sum up to 
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1 and were assumed to be 0.25, 0.5 and 0.25 for barbecuing, frying and roasting respectively. The 
assumption behind these cooking probabilities is that consumers usually fry meat more frequently 
than that they roast or barbecue it. The incidence rates for all endpoints are obtained from 
(Sundhedsstyrelsen, 2004). 
 
Thus, we have estimated the probability of onset of the disease per age and sex for each 
distribution of intake as presented in table 2. Then, the mean Peff(a,s)ep(i, cp) of the distributions is 
used to estimate DALY.  This has been done for each endpoint per cooking practice. 
 
Peff(a,s)ep(cp) =  Peff (a,s)ep(0)*∑ i p(a,s) (i)* RR0 ep (i, cp)                                                                    (9) 
 
This Peff(a,s)(cp) is the mean probability of disease per person associated with the endpoint ep per 
year, given the distribution of intakes in Denmark (table 2), for a person of sex s in age class a, 
given the person is always using cooking practice cp when consuming meat.  
 
2.5  Parameter estimation for DALY calculation 
  
Disability adjusted life years, DALY is a common health metric that combine the different 
dimension of health outcomes to predict the burden of disease. To estimate the burden of disease 
of the cooking practices, we have applied the DALY model used in Hoekstra et al. (2012). The DALY 
is computed for each individual and summed up for each endpoint, in MS Excel 2010. A similar 
approach as Berjia, et al., (2012) was adopted to estimate all the input parameters.  
 
DALY(a,s)ep(cp) = Peff(a,s)ep(cp) * [(Prec*YLDrec*w + Pdie(YLDdie*w+LE(a,s) –CA -YLDdie) +  (1-Pdie -
Prec)*(LE(a,s) -CA)*w] * N(a,s)                                                                                                                                                               (10)  
                                                                                                                                                                                                                                                                                                                   
Where:  
DALY(a,s)ep(cp)  disability adjusted life years at age and sex for each endpoint per cooking  practice 
Peff(a,s)ep(cp)    probability of onset of the disease (ep) at age and gender, per cooking practice cp 
Prec                     probability of recovery from the disease 
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Pdie                            probability the disease causes death  
YLDrec                 mean duration of disease for those who recover  
YLDdie                 mean duration of disease for those who die  
CA                      current age of individual in year of disease onset  
LE(a,s)                   life expectancy for an individual of age at CA 
w     disability weight for disease.  
N(a,s)    number of people of age a and sex s in Denmark 
 
Peff(a,s)ep(i, cp) values are calculated for each endpoint as described in section 2.4. (Eqn 9). Pdie for 
colorectal, breast and prostate cancer is estimated from (Denmark Statistics, 2013) and for 
pancreatic cancer Pdie is obtained from (Sundhedsstyrelsen, 2010).  
 
If someone acquires a disease, either that person survives (Psur) with the disease until the normal 
life expectancy, recovers from the disease (Prec ) or dies due to the disease (Pdie) before normal life 
expectancy (Hoekstra et al., 2012). Then, these disease outcomes sum up to one. 
 
Prec + Psur + Pdie =1                                                                                                                (11)          
                                                                                                                   
Psur is obtained for colorectal cancer from (Iversen, 2011), prostate cancer (Borre et al., 2011), 
pancreatic cancer (MDACC, 2013) and for breast cancer (Lietzen et al., 2011). Then, Prec is estimate 
by 1 - (Pdie + Psur) for each endpoint. w is obtained from the WHO global burden of disease 
disability weight estimate (WHO, 2008).  
 
Table 5  
Summary of parameter values used for DALY calculation for each endpoint 
Endpoints Pdie Prec Psur YLDdie YLDrec w 
Colorectal cancer 0.016 0.24 0.74 0.08 5 0.2 
Prostate cancer 0.047 0.053 0.9 1 5 0.13 
Pancreatic cancer 0.043 0.32 0.64 1 5 0.2 
Breast cancer 0.03 0.03 0.94 1 5 0.09 
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YLDdie and YLDrec are assumed to be the minimum and maximum study period of Iversen et al., 
(2011), Borre et al. (2011), Lietzen et al. (2011) and Cronin-Fenton et al. (2011) for colorectal, 
prostate, breast and pancreatic cancer respectively.  The parameter values used are presented in 
table 5. 
 
The model is run for individuals that represent the Danish population. The total population sizes 
for the selected endpoints per sex and age (table 6) and life expectancy are obtained from 
Denmark Statistics (2013). 
 
Table 6 
The total number of population per sex and age ∑a Na,s for the selected endpoints in Denmark 
(2013) 
 Age (years) Men Women 
Colorectal cancer 50-71 694902 706881 
Prostate cancer  40-79 1187262  
Breast cancer  50-99  1000799 
Pancreatic cancer  50-71 694902 706881 
 
The total DALYtot per 100000 for each cooking practice and for each endpoint is calculated as 
 
DALYtot,ep(cp) = q(cp) * ∑a,s DALY(a,s) ep (cp) *100000 /∑a,s N(a,s)ep                                                                      (12)  
                                                                          
To estimate the total health loss per cooking practice, the DALY of all endpoints per cooking 
practice is summed up. 
 
3. Results 
 
Figure 1 illustrates the total burden of disease estimates of red meat consumption by cooking 
practice and for no intake of cooked red meat in DALY/100000 population. The population 
represents different individuals for the different endpoints (table 6) and the results can only be 
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interpreted for the population of age and sex per endpoints as indicated in table 1, but not for the 
general population.  
 
It appears that, the consumption of barbecued red meat is the leading cause of healthy life years 
loss, followed by fried red meat. Relatively, several healthy life years loss can be prevented by 
eating roasted instead of barbecued or fried red meat.  
 
The “no intake” scenario is calculated using the probability of illness Peff(a,s)ep(0) (eqn. 8) in the 
DALY calculations (eqns 10 and 12). The results show that the healthy life years lost for roasted red 
meat are lower than for the no intake scenario, whereas those for barbecued meat is higher and 
for fried meat slightly higher. This could suggests that consuming roasted red meat is healthier 
than no intake of red meat, and that barbecued meat and fried meat are less healthy. However, 
the “no intake” scenario is not directly comparable to the different cooking practices as additional 
health benefits and risks associated to red meat consumption are not included in the analysis. 
Furthermore, the impact of that part of the diet, which  substitutes the red meat is not included in 
the calculations. 
 
 
Figure 1. Estimated DALY/100000 population per cooking practice ∑ep DALYtot,ep(cp) 
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Figure 2 demonstrates the variation in DALYs for different sexes and endpoints after intake of red 
meat prepared by the different cooking practices. Note that, different populations are considered 
for different endpoints. It can be seen from the figure that colorectal cancer is a major cause of 
health loss in both men and women. The cooking practice that leads to the largest health loss due 
to colorectal cancer is barbecuing  followed by frying. The loss of DALYs seen for  breast cancer in 
women is primarily caused by barbecuing followed by frying.  
 
 
     BBQ;   Fried;         Roasted;                No intake 
Figure 2. DALYs per endpoint, sex and cooking practice, ∑a DALY(a,s)ep(cp) 
 
The healthy life years loss due to the increase risk of prostate cancer is nearly similar for all 
cooking practices. Concerning pancreatic cancer, the consumption of barbecued red meat 
increases the health loss  compared to the other cooking practices equally in both sexes. In 
general, with the exception of prostate cancer, roasting tends to provide a benefit by reducing the 
healthy life years loss compared to the other cooking practices and compared to no intake of 
meat.  
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Usually, individuals decide which cooking practice to apply when cooking meat, based on personal 
preference. It will be of interest for an individual consumer to know the assessed health burden 
associated to the choice of a cooking practice. This health burden can be assessed because 
individual healthy life days loss after a year long consumption of cooked red meat can be 
predicted with the available data and model for each specific cooking practice. We have 
performed an example for some selected ages (52, 60 and 67 years old) for both men and women 
(figure 3). First, the mean DALY is computed for selected age classes (50-54, 55-64 and 65-70 years 
old) for each endpoint, sex and cooking practice. Then, the mean DALY of all the endpoints per sex 
and age class are summed. Subsequently, the difference in DALY of the consumption of barbecued 
and fried is estimated in comparison with consumption of roasted red meat. To estimate the 
expected individual health loss in days, estimated DALY is divided by 100000 and multiplied with 
the number of days in a year.  
 
Figure 3 illustrates the predicted healthy life days loss for selected age and sexes for the 
consumption of barbecued and fried red meat compared to roasted red meat. In general, women 
have a higher loss of healthy life days due to barbequing than men. 
 
If a woman of age 52 years old consumes barbecued red meat during a year (given the distribution 
in table 2) instead of roasted red meat, the healthy life days loss can be close  to 4 days. Whereas, 
a man of the same age has a lower loss of healthy life days.  
 
If a man of age 67 years old prefers to consume roasted red meat in stead of barbecued red meat, 
he prevents the loss of approximately 3 healthy life days/year. Relatively, a women of age 67 years 
old can benefit more than men by preventing 4.5 healthy life days loss/year, if she consumes 
roasted red meat instead of barbecued red meat. In general, for the selected age class and sex, 
consumption of barbecued red meat seems to cause more healthy life days losses than 
consumption of fried red meat and all give a higher loss than roasted meat.    
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 BBQ;                Fried     
Figure 3. Individual healthy life loss (days/year) for the consumption of barbecued and fried red 
meat instead of roasted red meat. 
4. Discussion  
 
In this study, we have estimated and compared the burden of disease of red meat prepared by 
different cooking practices. Several studies suggest that barbecued meat is associated with higher 
concentrations of HCAs and PAHs, which increase the risk of cancers (Anderson et al., 2002; 
Knutsen et al., 2007; Badry, 2010; Aaslyng et al., 2013). The results obtained in this study support 
the notion that consumption of barbecued red meat is a major cause of healthy life year’s loss. 
According to the model prediction, the loss of 298 and 156 DALYs/100000 can be prevented in the 
selected populations, if roasted red meat is consumed instead barbecued and fried red meat, 
respectively.  
 
The results obtained in this study reveal that the choice of cooking practice has an impact on 
health outcome. Referring to Figure 3, regarding the individual healthy life day’s loss from all 
cancers, women seem to benefit more than men, if they consume roasted red meat instead of 
barbecued red meat. Therefore, attention should also be paid to the gender aspect in the choice 
of cooking method. 
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In contrast with the burden of disease studies looking at foodborne pathogens and nutritional 
deficiency diseases (Gkogka et al., 2011; Havelaar et al., 2012; Murray et al., 2013) and risk-benefit 
studies of food and food components (Berjia et al., 2012; Hoekstra et al., 2013), this study 
presents the burden of disease estimate of different cooking practices. In this study we have 
ignored the burden of disease linked to pathogens. Apparently, in meat products cooked at high 
temperature, the burden of disease linked to pathogens is likely to be trivial. In addition, the 
health benefits and risks associated with the nutrients in red meat were not included in this study 
because the current available data related to the effect of the different cooking practices on the 
concentration of the nutrients are insufficient to estimate their health outcomes. We assume that 
as the diet is basically unaltered, and that the nutritional benefits will be highly similar when 
different cooking practices are compared. 
 
The knowledge of the health loss and gain from different attributions gives an insight to prioritize 
the major causes of health loss in the population and support risk management decisions on 
control and prevention of foodborne disease. Usually, statistics on the public health impact of 
foodborne diseases focus on the burden of illness in a population (incidence), i.e. the incidence of 
non-fatal illness and of fatal cases (Adak et al., 2002; Scallan et al., 2011). The burden of disease 
metric DALY integrates incidence, severity, mortality, recovery and duration of a disease (Murray 
et al.,2002; Hoekstra et al., 2012). Hence, burden of disease estimate is a relatively powerful tool 
to report comprehensive public health statistics, which facilitates comparison between diseases in 
terms of healthy life year’s loss.  
 
This study compares the health burden related to the cooking practices of red meat, by combining 
epidemiological data of cancer risks associated with these cooking practices with the Danish red 
meat consumption data. Epidemiological data to model the dose-response relationship are scarce 
and not reported uniformly. Most of the dose-response data incorporated (see table 3) in this 
study are collected through interviews about cooking practices used by populations in different 
countries. Then, these data were combined with the consumption data to predict the odd 
ratio/relative risk of the different cancers. The red meat consumption data of these studies are 
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highly variable. When using the outcome of these studies to estimate burden of disease, several 
model assumptions had to be made to make the best use of the available data. For instance, the 
studies incorporated for the dose-response modeling describe the intake qualitatively or 
quantitatively (see section 2.4) and for some endpoints only a few data points (see table 3) were 
used to fit the equations for relative risks (Table 4). To make the best use of the available data, we 
have used different assumptions as a surrogate as described in section 2.4 and 2.5. One of these 
assumptions is the frequencies in which people in Denmark barbecue, fry and roast their red meat 
(q(cp)), for which we did not find any data. Hence, the results presented in this paper should be 
interpreted with care. 
 
Nevertheless, the results give an interesting impression of the impact of different  cooking practice 
on health. Moreover, this paper shows how the impact of cooking practices on burden of disease 
can be calculated, both at a population level and on an individual level. As shown in Figure 3, the 
method developed in this paper can offer a tool that estimates the health impact of a preferred 
cooking practice for an individual of a specific age and sex, compared to an alternative cooking 
practice. This may provide useful information to the l consumer that can decide whether for her or 
him personally the perceived benefit of a cooking practice (e.g. better flavor and food quality) 
outweighs the associated estimated risk of cancer in terms of healthy life days lost.  
 
5. Conclusion  
 
In this study, we estimated and compared in a quantitatively way the burden of disease for 
different cooking practices, using red meat as a case study. To our knowledge, this study is the first 
to estimate and compare the burden of disease for different food cooking practices. The result 
shows that the estimated burden of disease is largest for barbecued meat, followed by fried meat 
and roasted red meat.  
 
The methodology can provide a tool that can be a help to the consumer in deciding whether the 
health loss of preferred cooking practices weighs up against its perceived benefit. Even though the 
114 
 
method has been usefully applied in this paper to get quantitative data on the burden of disease, 
it can be even more improved by using more comprehensive data on the dose-response relations 
between red meat consumption after the application of a specific cooking practice and cancer 
risks, the frequency of current cooking practices (q(cp)) and the duration of the diseases. 
Therefore, the method applied in this assessment can be used as a basis for similar studies in the 
future.   
 
Future research may focus on the estimation of the burden of disease of the cooking practice of 
different food products to compare the burden with other foodborne chemical contaminants, 
pathogens and nutritional deficiency diseases in order to prioritize the major cause of health 
losses in the population and to take action to mitigate the health losses.   
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9. Discussion 
The main work performed in this PhD thesis includes: 1) a case study on risk-benefit assessment of 
cold-smoked salmon (Chapter 6 – Berjia et al., 2012); 2) method development for finding the 
optimum scenario in risk-benefit assessment: an example on vitamin D (Chapter 7 – MANUSCRIPT 
I); and 3) Burden of diseases estimates associated to different red meat cooking practices (Chapter 
8 – MANUSCRIPT II).  
This chapter is divided into four subsections which discuss the main findings of the different 
studies performed in this PhD-project. In addition, the challenges in performing comprehensive 
integrated quantitative risk-benefit assessment are discussed explicitly.  
9.1 Risk-benefit assessment of cold-smoked salmon: microbial risk versus nutritional benefit 
 
As indicated in chapter 4, several qualitative and quantitative risk-benefit assessment on fish have 
been conducted both at national and international level. Fish has been a target for several risk-
benefit assessment studies; this is because fish contains multiple beneficial and deleterious 
components that have considerable health effect. Most of these studies have been comparing the 
beneficial effect of fish as a source of omega-3 fatty acids, particularly EPA and DHA, and the risk 
of chemical contaminants. However, fish also contains vitamins (for example, A, B-complex, and D) 
and minerals (such as selenium, iodine, iron, and zinc) that are linked to various health benefits 
(Delange and Lecomte, 2000; Rayman, 2000; WHO, 2002). Besides the multiple beneficial 
components, there are several potential health hazards linked to fish consumption, including 
pathogens, marine toxins, environmental pollutants and heavy metals (Yasumoto and Murata, 
1993; Plessi et al., 2001; Storelli et al., 2003; Iwamoto et al., 2010). With regard to risk-benefit 
assessment of fish, the health benefit of fish intake lies in the reduction of CHD and stroke, as well 
as improved cognitive development; and the health risk primarily originates from contaminants 
like methyl mercury, but also dioxin and dioxin-like PCBs have been the focus area (Cohen et al., 
2005; Guevel et al., 2008; Hoekstra et al., 2013b).  
 
Even though pathogens may offer a serious risk to human health linked to fish consumption, this 
can usually be tackled by proper cooking, storage and handling. This is an important difference 
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compared with chemical contaminants. The adverse health effects of pathogens connected to fish 
consumption were not integrated in risk-benefit assessment of food so far. Nevertheless, the 
disease burden linked to pathogens may be considerable if the pathogens that may be present in 
fish are not overcome by proper cooking, storage and handling. This aspect has been taken into 
consideration through the study performed in the present thesis where the risk of Listeria 
monocytogenes and the benefit of fish consumption are compared quantitatively (Berjia et al., 
2012).  The aim of the study was to illustrate how a microbiological hazard can be included in risk-
benefit assessment of food and how this may add to the existing risk-benefit assessment tools and 
methodologies. Two consumption scenarios were considered: a reference scenario (current mean 
intake in Denmark, 23g/day and 20g/day for man and woman respectively) and an alternative 
scenario (40g/day for both sexes). 
 
The results of the study indicate that considerable health benefit is obtained through the 
reduction of CHD mortality and IQ improvement when changing from the reference to the 
alternative scenario. In Hoekstra et al. (2013b) fish risk-benefit assessment study, the health 
benefit was higher for stroke than IQ effect, whereas, in Berjia et al. (2012) study the health 
benefit is higher for IQ than stroke. This difference is related to the fact that salmon is an oily fish 
that have a more significant effect on IQ compared with other fish species. In addition, in this 
study the assessment focused on only the intake of cold-smoked salmon, whereas in Hoekstra et 
al. (2013b) a general fish intake is considered. Among the risk of L. monocytogenes, septicemia 
scores a higher DALY loss followed by abortion and meningitis. In addition to the quantitative 
result obtained, the study illustrates how microbial hazard can be included in risk-benefit 
assessment of food.  
 
The sensitivity analysis reveals that the shift of the net public health benefit to net public health 
risk is observed when cold-smoked salmon is consumed at five weeks of storage and more. This 
indicates that if food is not properly processed, handled and stored, the microbiological hazard 
could be a serious public health loss, which may leads to a shift from net health benefit to risk. 
Hence, integrating microbial hazards (when relevant) into risk-benefit assessment of food may be 
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important. In addition, the result of the sensitivity study suggests that the health effect of food 
consumption can be optimized by modulating the food processing, handling and storage.  
In this study only one hazardous (L. monocytogenes) and one beneficial component (omega-3 fatty 
acid) were considered. Since the main aim of the study was to show how microbial hazard can be 
included in risk-benefit assessment, other beneficial component such as vitamin D and hazardous 
component such as methylmercury were not included in the assessment. The pronounced 
negative health effect of methylmercury is on prenatal cognitive development. If methylmercury 
was included in the assessment, the quantitative result of the study may change (the net benefit 
may reduce slightly), but the balance of the health effect would likely remain the same. This is 
because the negative health effect of methylmercury is relatively minor compared to the positive 
health effect (CHD mortality, stroke and IQ) obtained from omega-3 fatty acids (Hoekstra et al., 
2013b).  
 
Moreover, other endpoints such as febrile gastroenteritis (due to exposure to L. Monocytogenes) 
that are related to the identified components are not considered in our assessment. We have only 
considered cold-smoked salmon components and respective endpoints that have a large public 
health impact, for which suitable quantitative data for the purpose of the study were reported. For 
instance, it is well known that infection by L. monocytogenes leads to febrile gastroenteritis 
(WHO/FAO, 2004; Allerberger and Wagner, 2010; Jensen et al., 2010) in addition to septicemia, 
abortion and meningitis. Nevertheless, the incidence and mortality for febrile gastroenteritis are 
relatively less reported or it is reported as a part of general listeriosis (Allerberger and Wagner, 
2010; Jensen et al., 2010).  
 
Compared to several classical QMRA studies, we have considered the specific clinical syndrome of 
L. monocytogenes. In classical QMRA, the assessment usually considers generic clinical syndrome 
of L. monocytogenes, which is listeriosis. But, in this study, we explicitly assessed the health impact 
of the specific clinical syndrome (septicemia, meningitis and abortion).  The advantage of 
considering the specific clinical syndromes of a disease is that it would take into account the 
health loss from all the specific clinical syndromes that contribute to the net health effect. In 
classical QMRA this is may not be important when the probability of the disease and number of 
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cases are of the greatest interest. For instance, in several QMRAs it is common to find cases of 
listeriosis, campylobacteriosis and salmonellosis instead of the specific clinical syndromes. If only 
the generic disease is included in integrated quantitative risk-benefit assessment, it means that 
the incidence, severity weight, mortality and duration of the specific disease are not included in 
the assessment. This will lead to miscalculation of the net health impact. Hence, it is crucial to 
consider the specific disease (when relevant) instead of the generic disease associated with the 
pathogens in integrate quantitative risk-benefit assessment.  
 
In addition to the specific clinical syndromes, some disease may have sequelae, recurrent effect 
and other complications; these were not considered in the present study.  The present DALY 
models do not allow the estimation of health effect for sequelae and recurrent disease, but 
seemingly the model can be extended to take into account these health effects in the future.   
 
In the study, several assumptions are used; many of the assumptions related to the dose-response 
modelling such as during the conversion of the relative risk to absolute risk for CHD mortality and 
stroke. Often, national data for the dose-response modeling are scarce. A surrogate from 
analogous countries or international data had to be used; for instance, the relative risk data for 
CHD and stroke. Then, to convert the relative risk to probability of onset of the diseases, it was 
assumed that the current incidences are associated with the current intake, which apparently also 
depends on other comorbidities.  In addition, a few aggregate data have been used to model the 
dose-response relationship of the hazardous endpoints. However, the results of the sensitivity 
analysis indicate that apart from the storage time, the analyzed parameters for sensitivity have 
trivial impact on the baseline result. Still, due to the several assumptions and simplifications 
considered for the purpose of the study, the quantitative results should be interpreted with care.  
 
The study is a comprehensive integrated risk-benefit assessment that quantified the health loss 
and gain of the selected hazardous and beneficial components linked to cold-smoked salmon 
consumption. As explained in chapter 3, there are few approaches on risk-benefit assessments of 
food (EFSA, 2010; Hoekstra et al., 2012; Fransen et al., 2010). These approaches suggest a 
stepwise risk-benefit assessment method, where one could stop the assessment at the early steps, 
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if it is clear that the benefit outweighs the risk or vice versa. This implies that the net health effects 
in DALY may not be estimated using a common health metric because a common health metric is 
not applied at the earlier steps in the existing risk-benefit assessment methodologies. The main 
advantage of performing comprehensive quantitative risk-benefit assessment of food is that, it 
helps to weigh the quantity of health loss and gain related to the hazardous and beneficial 
components of food, using a common scale. In addition, together with sensitivity analysis, a 
comprehensive assessment helps to identify the area where the potential risk can be reduced and 
the benefit can be maximized, so that it enables an optimization of the net health effect of food 
consumption, for example by changing the food processing and storage conditions.  
 
In summary, the cold-smoked salmon case study showed how the microbial hazard can be 
integrated in risk-benefit assessment of food. Besides this, it provides future implications for the 
improvement of the existing risk-benefit assessment of food method with regard to the 
importance of consideration of specific endpoints instead of generic endpoints linked to 
pathogens and extension of the current DALY model to consider recurrent health effects, sequelae 
and other complications of a disease. In addition, it indicates the importance considering 
pathogens in risk-benefit assessment of food (when relevant), as pathogens can be a serious 
health problem in case of improper processing and handling which give a substantial health loss. 
Moreover, it shows the importance of a thorough quantitative risk-benefit assessment of food, 
which enables to combine the health effects of the hazardous and beneficial components to 
determine the net health effect.  
 
9.2 Finding the optimum scenario in risk-benefit assessment: an example on vitamin D 
In chapter 7, a method for finding the optimum scenario that provides maximum net health gain in 
risk-benefit assessment of nutrient is developed, using vitamin D as an example (MANUSCRIPT I). 
This section discusses this method, its implication to general food risk-benefit assessment and 
what needs to be considered to find the optimum scenario in holistic risk-benefit assessment of 
food (nutrients, pathogens and chemical contaminants).  
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Several recent studies suggest determination of the optimum scenario as a future research issue in 
health risk-benefit assessment of food (Boobis et al., 2013; Hellberg et al., 2012). Specific to fish 
consumption, a risk-benefit analysis approach to determine optimal fish consumption that focus 
on nutrients and chemical contaminants has been proposed by Sirot et al. (2012). This approach 
optimizes the fish intake based on the condition to attain the recommended nutritional intake and 
limit the exposure to contaminants based on the condition that the level of contaminants does not 
exceed the tolerable upper intake level.  The approach takes into account the background intakes 
during optimization (Sirot et al., 2012).  
 
Several nutrients can have dual health effects; both beneficial and detrimental (see section 2.1.3 
and 2.3) effects are found at different intake levels.  For these types of nutrients it is imperative to 
determine the intake level where maximum health gain can be attained to improve public health 
linked to food consumption. Vitamin D is one of the essential nutrients that have dual health 
effects at high and low intake levels. Compared to the other essential nutrients, there are several 
convincing evidences that vitamin D prevents against osteoporosis disease in elderly population 
(IOM, 2010; Bischoff-Ferrari et al., 2009; Bischoff-Ferrari et al., 2005; Fødevareinstituttet, 2010). 
On the other hand there are emerging possible evidences that vitamin D could increase the risk of 
total mortality at both low and high intake, which is a very severe health effect that affects a large 
proportion of the population (Durup et al., 2012; Michaelsson et al., 2010). This implies that 
determining the optimal vitamin D intake or serum level, that provides maximum benefit and 
minimum potential risk, can help to prevent considerable public health losses and reduce the 
economic expenditure spent to prevent the health losses. To the author’s knowledge there is 
currently no internationally agreed method that enables to find the optimum intake or serum level 
that provides maximum health gain. With respect to vitamin D, there are limited studies that 
determine the optimal vitamin D intake or serum level needed to prevent some specific health 
effects (Dawson-Hughes et al., 2005; Bischoff-Ferrari et al., 2006; Durup et al., 2012). In these 
studies, the optimal vitamin D intake or serum level is determined semi-quantitatively by 
considering only either the beneficial health effects or detrimental health effects (but not 
combined), without integrating them in a common health scale like DALY. These aspects have 
been taken into account in the study performed on MANUSCRIPT I.  
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In MANUSCRIPT I, a method for finding an optimum scenario in risk-benefit assessment that 
provides maximum net health gain is developed, using vitamin D as an example. In the method an 
aggregate of health effects of vitamin D are considered, both beneficial and detrimental. The 
method is based on multiple scenario simulations. In addition to the reference scenario, several 
alternative scenarios are simulated to detect the scenario that provides maximum net health 
gains, using DALY as a health metric and implemented in the QALIBRA software. The study 
demonstrates how the optimum scenario that provides maximum net health can be determined 
for a nutrient.  
 
The health effects of vitamin D considered in the assessment encompass endpoints that have 
convincing evidences are fall, hip and nonvertebral fractures. In addition, an emerging severe 
health effect of vitamin D (total mortality) is considered. The result reveals that, among the 
simulated scenarios, the optimum vitamin D serum level that provides maximum net health gain is 
72 nmol/l. The healthy life year’s gain due to the prevention of total mortality is larger compared 
to the other endpoints, when the optimum vitamin D serum level is attained.  This is because total 
mortality has a severe health effect, with a severity weight of w = 1, and affects a large proportion 
of the population, which implies that the achievement of the optimum vitamin D serum level 
expectedly provides substantial healthy life years gain due to the prevention of total mortality.  
 
The optimum vitamin D serum level that provides maximum net health gain might be different for 
the different ages and sexes. However, in our assessment the optimum vitamin D serum level was 
determined for the general population. This is because the mean dietary vitamin D intake of the 
population was considered in the first place for all ages, separately for men and women. In 
addition, the mean dietary vitamin D intakes of men (3.8 μg/d) and women (3.1 μg/d) are not 
substantially different; especially when the intakes in μg/d is related to nmol/l, the differences are 
even more trivial (which varies between 41-43 depending on the data points used for conversion, 
see chapter 7. Furthermore, the dose-response relationship for men and women were similar for 
men and women; due to this the estimated relative risks were not substantially different for men 
and women for all the endpoints either (see table 4 in chapter 7). As a result, the probabilities of 
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onset of the diseases (especially for fall and fractures) as well as DALY were comparable for men 
and women (see figure 3 in chapter 7).  
 
In the study, several necessary assumptions and simplifications had to be made. First, not all the 
health effects associated to vitamin D are included in the study. There are several studies that 
suggest the association of vitamin D with different diseases (both beneficial and detrimental) 
(EFSA, 2010; IOM, 2010; Grant et al., 2009). However, in this study only health effects with 
convincing evidence, in addition we have included an endpoint where the evidence is relatively 
weak, but the reported quantitative data on the dose-response relationship are particularly 
suitable for the purpose of our study (total mortality). In addition, the optimum scenario is 
determined based on the vitamin D blood serum level in nmol/l. All the intakes given in μg/d and 
IU/d in the reference intake as well as in the dose-response studies incorporated in this study 
were related to serum level. By a lack of data, this relation was established based on a few data 
points only.  Moreover, to estimate the relative risk parameters for the dose-response relation, 
only few data points were available and extrapolation was needed, which is not common. 
Furthermore, the duration of the endpoints required for DALY estimation are based on a fixed 
value, which do however vary depending on ages and sexes of the population. Due to all these 
assumptions and simplifications, the quantitative result should be interpreted with care. 
Nevertheless, the result obtained in this study is in line with other studies (Dawson-Hughes et al., 
2005; Bischoff-Ferrari et al., 2006).  
 
In addition to the result obtained in this study, the assessment suggests what data and methods 
are required to find the optimum scenario that provides maximum health gain in particular to 
vitamin D and in general for nutrients that have both beneficial and hazardous health effects. For 
instance, the data needed to relate the nutrient intake to serum level are scarcely collected, 
implying that more data are needed. The importance of converting the intake to serum level 
(when needed) is that it reduces the uncertainty related to the nutrient after ingestion during 
intake-disease modeling, because etiologically the serum level is closer to the effect of vitamin D 
than the intake.    
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Despite the limitations mentioned above, the method seems to be applicable for the 
determination of an optimum serum or intake level that provides maximum net health gain in 
nutrient risk-benefit assessment. As a means of finding the optimum scenario in nutrients, only a 
multiple scenario simulation in comparison with reference level was applied, using a common 
health metric, DALY.  Because the mean vitamin D intake was considered from all dietary sources 
and converted to serum level, it was not necessary to include food processing parameter 
optimization to optimize the health effect of vitamin D. If the vitamin D intake from a specific food 
such as salmon was assessed, other factors that affect vitamin D concentration in salmon 
processing could be considered to achieve the optimum health effect. For instance, if vitamin D is 
sensitive to some of the salmon processing pathway, the parameters in the pathway could be 
identified and enhanced to maximize the net health gain of vitamin D. However, with regard to 
nutrients, experiences show that often there seem to be insufficient quantitative data to model 
the intake and health effect of nutrients following food processing pathway. Hence, multiple 
scenario simulation seems to be the most effective method to optimize the health effect of 
nutrients.  
 
9.2.1. Health impact optimization in holistic food risk-benefit assessment 
 
Section 9.2 discussed a method used to find an optimum scenario in risk-benefit assessment of a 
nutrient, with an example on vitamin D. Based on chapter 6, 7 and section 9.2, this section 
suggests some ideas that may help to optimize the health outcome of food consumption in holistic 
risk-benefit assessment of food (pathogens, chemical contaminants and nutrients). 
 
The concentration of nutrients, chemical contaminants and pathogens in foods could be affected 
by the processing pathway involved in the food chain.  Hence, it is may be important to identify 
the processing parameters that affect the concentration.  These parameters can then be included 
in a model that describes the effect of food processing on exposure, like in Berjia et al. (2012). 
Such a model can then be used to explore where maximum net health gain can be attained.  
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Depending on the characteristics of the hazardous and beneficial components being assessed, the 
parameters that affect the concentration of the components need to be identified. Usually, these 
parameters are associated with food processing pathway such as temperature-time of cooking. 
However, sometimes it may also be important to consider what happens after ingestion, 
depending on what is being assessed, the availability of quantitative data and the expected health 
impact of the component. For instance, some nutrients bioavailability could be improved by 
processing (Gibson et al., 2006); in this case it is useful to build a quantitative model including the 
processing, bioavailability and disease probability in order to describe the net health gain. The 
study by Gibson et al. (2006) shows how the nutrient bioavailability can be improved by different 
methods and its direct association with reduction of several diseases. For example, bioavailability 
can be improved by microbial fermentation or soaking that reduces the phytate and polyphenol 
content of cereals; addition of ascorbic acid-containing fruits to enhance non-haem-Fe absorption; 
heating to destroy heat-labile anti-nutritional factors such as goitrogens and thiaminases (Gibson 
et al., 2006). Diet-related issues in foods that affect bioavailability may comprise: the nature of the 
food matrix; interactions of nutrients and organic components (e.g. phytate, polyphenols, dietary 
fiber, oxalic acid, protein, fat, and ascorbic acid); pretreatment of food as a result of processing 
(Gibson et al., 2006). 
 
If a food contains beneficial nutritional components, pathogens and chemical contaminants, 
processing can affect them in different ways. Conditions like thermal processing and shortening 
the storage time of the food can limit the growth and survival of the pathogens. Similarly, the 
benefit of the nutrients could be increased by improving their bioavailability by processing and 
minimizing nutrient loss during processing.  The chemical contaminants that may be formed 
during processing (e.g. disinfection, fermentation or grilling) e.g. acrylamide and PAHs, can also be 
minimized by adjusting the processing.  Therefore, modulating of the food processing parameters 
associated to the components may be suitable to optimize the net health impact food 
consumption. Modulating the food processing parameters may not always necessarily result in the 
reduction of the health effect of hazardous component of a food; in certain cases it may also cause 
disease. For instance, when meat is cooked at high temperature, pathogens could be inactivated 
but at the same time carcinogenic chemical contaminants such as HCAs and PAHs may be formed. 
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In addition, heat sensitive beneficial nutrients can be destroyed when cooking at high 
temperature. Hence, modulating food processing parameters should be balanced from the 
perspective of harmonized health effects of nutrients, chemical contaminants and pathogens in 
holistic risk-benefit assessment of food. As a result, the net health impact would be optimized.  
In addition to food processing, various beneficial substances can be added to optimize the public 
health effect of food consumption. Enriching the food with a nutrient that has a beneficial impact 
on the identified endpoints, will increase the benefit; in this case, it is vital to take into 
consideration the background intake of the nutrient needed to be enriched as well as the potential 
negative health consequence due to the enrichment (Hoekstra et al., 2008).  Other substances 
may be added to reduce risks. For instance, if the assessment considers pathogens, then the use of 
organic acid to reduce the concentration of the pathogens can be considered. For example, the 
addition of antioxidant such as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), 
propyl paraben (PP) helps to control the growth of fungus and synthesis of aflatoxin, which is a 
potent carcinogen (Passone et al., 2009). Also, concerning chemical contaminants, the addition of 
calcium chloride, spices and certain food additives can significantly reduce the formation of 
acrylamide and PAHs during thermal processing of food (Gökmen and Şenyuva, 2009; Badry, 
2010). However, when maximizing the benefit through food enrichment and minimizing the risk by 
addition of antimicrobial or antioxidant or other means, there could be an associated risk that 
increases as a consequence of the assessment. When there is such an associated risk it should be 
considered as a part of the assessment.  
In broad context, one might consider applying hurdle technology and CCPs (Critical Control points) 
to minimize the risk of pathogens and chemical contaminants and to improve the quality of food. 
Hurdle technology is a technique of guaranteeing that pathogens in food products can be 
eliminated or controlled, so that the food product will be safe and will have extended shelf-life 
(Leistner and Gould, 2002). Examples of hurdles may include high temperature processing, low 
temperature during storage, increasing the acidity, lowering the water activity or the addition 
of preservatives (Leistner, 2000; Alasalvar, et al., 2010). Hurdle technology often focuses on 
pathogens and shelf-life extension of food. HACCP (Hazard analysis and critical control points), 
particularly critical control points (CCP), focuses on all hazards that may present in a food 
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(chemical, biological and physical hazards). CCP is a step in HACCP at which controls can be applied 
and a hazard can be eradicated or reduced to acceptable levels (Allie, 2004). The application of the 
combined effect of hurdle technology and CCP (when relevant) help to make food safe, but also 
improve the food quality, nutritional quality and economic viability of food products by using the 
synergistic effects of hurdles (Leistner, 1994; Leistner, 2000; Mayes, 1998; Leistner and Gould, 
2002; Giovannucci, et al., 2000; Alasalvar, et al., 2010).  
Once the health effect is optimized by different methods, alternative scenarios could be simulated 
in risk-benefit assessment models, in order to determine how much of that food or food 
component has to be consumed to achieve the optimal health effect.  
The practical application of the suggestions mentioned above for the optimization of the health 
effects of nutrients, chemical contaminants and pathogens in holistic comprehensive integrated 
quantitative health risk-benefit assessment of food may face certain limitation especially, with 
respect to the availability of data. The lack of several data for comprehensive health risk-benefit 
assessment of food has also been encountered in the main studies performed in this PhD thesis 
(chapter 6, 7 and 8). Nevertheless, it gives an interesting insight of the data needed and helps to 
guide future data collection.  
9.3 Burden of diseases estimates associated to different red meat cooking practices 
 
Compared to the disease attribute to foodborne pathogens and nutritional deficiency, the burden 
of disease related to chemical contaminants in food is not well investigated. As explained in 
section 2.1.2, some food processing practices can lead to the formation of chemical contaminants 
that are deleterious to human health; and to the author’s knowledge there is currently no 
information about the burden of disease connected to food processing practices. Chapter 8 
presents a burden of diseases estimates study associated to the different red meat cooking 
practices (MANUSCRIPT II). In this section, the major findings of MANUSCRIPT II are discussed.  
In MANUSCRIPT II, the burden of disease in Denmark due to the consumption of barbecued, fried 
and roasted red meat was compared. The result obtained in MANUSCRIPT II shows that the 
consumption of barbecued red meat leads to a larger health loss than the consumption of fried 
and roasted red meat.  Several healthy life years’ loss can be reduced in the population, if roasted 
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red meat is consumed instead of fried and barbecued red meat. The study indicates that the 
choice of cooking practice has an impact on the prevention of health loss.  
 
In contrast with the burden of disease studies of foodborne pathogens and nutritional deficiency 
diseases (Gkogka et al., 2011; Havelaar et al., 2012; Murray et al., 2013) and risk-benefit studies of 
food and food components (Berjia et al., 2012; Hoekstra et al., 2013b), this study presents the 
burden of disease estimates of different cooking practices. In this study we have ignored the 
burden of disease linked to pathogens. Apparently, in meat products cooked at high temperature, 
the burden of disease linked to pathogens is likely to be trivial. In addition, the health benefits and 
risks associated with the nutrients in red meat were not included in this study because the current 
available data related to the effect of the different cooking practices on the concentration of the 
nutrients are insufficient to estimate their health outcomes. As we assume the diets, except for 
the cooking practice, to be basically unaltered, the nutritional benefits will be highly similar when 
different cooking practices are compared. 
 
The knowledge of the health loss from different attributions give an insight to prioritize the major 
causes of health loss in the population and support risk management decisions on control and 
prevention of foodborne disease. Usually, statistics on the public health impact of foodborne 
diseases focus on the burden of illness in a population (incidence) (Adak et al., 2002; Scallan et al., 
2011). DALY integrates incidence, severity, mortality, recovery and duration of a disease (Murray 
et al., 2002; Hoekstra et al., 2012). Hence, the burden of disease estimate is a relatively powerful 
tool to report comprehensive public health statistics, which facilitates comparison between 
diseases in terms of healthy life year’s loss.  
 
A major problem in this study was that the epidemiological data to model the dose-response 
relationship are scarce and not reported uniformly. In MANUSCRIPT II, most of the dose-response 
data incorporated is collected through interviews about cooking practices applied and 
consumption of cooked red meat in different countries. Then, these data were combined with the 
consumption data to predict the odds ratio or relative risk of the different cancers. The red meat 
consumption data of these studies are reported differently and are highly variable (see section 2.4 
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of chapter 8). When using the outcome of these studies to estimate burden of disease based on 
the Danish red meat consumption data, several model assumptions had to be made to make the 
best use of the available data. For instance, the studies incorporated for the dose-response 
modeling describe the intake qualitatively or quantitatively and for some endpoints only a few 
data points were used to fit the equations to estimate the relative risks. One of the major 
assumptions was the frequencies in which people in Denmark barbecue, fry and roast red meat, 
for which we did not find any data. In addition, for the red meat intakes that are given 
qualitatively in the studies included for the dose-response relationship, we assume current Danish 
red meat intake as a surrogate. The assumptions considered in the study are more than the ones 
mentioned in this section (see chapter 8 for details).  
 
Despite the limitations, the results give an interesting impression of the impact of the different 
cooking practice on health. Moreover, the study shows how the burden of disease of the different 
cooking practices can be calculated, both at a population level and on an individual level. The 
method developed used can offer a tool that estimates the health impact of a preferred cooking 
practice for an individual of a specific age and sex, compared to an alternative cooking practice. 
The method applied in this study can be used as a basis for similar studies in the future. This may 
provide useful information to the consumer that can decide whether the perceived benefit of a 
cooking practice (e.g. better flavor and texture) outweighs the associated estimated risk of cancer 
in terms of healthy life days lost. In this study, the risk of cancers associated with red meat intake 
cooked in different ways are considered, the benefit can be seen as the associated perceived food 
quality (texture, color, flavor) of the different cooking practices. Future study may need to 
integrate and compare the health effect of the cooking practices with the associated perceived 
quality.  
 
9.4 Challenges in performing integrated quantitative health risk-benefit assessment of food 
With the increasing interest of knowing the net health impact of food consumption and burden of 
foodborne disease estimate attributed to food, integrating the health impact of nutrients, 
chemical contaminants and pathogens has become a core issue for public health improvement 
related to food consumption. Nevertheless, there are still challenges to be addressed when 
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integrating the different health impacts of food consumption. The main studies performed in this 
PhD thesis (chapter 6, 7 and 8) support the identification of these challenges, which could be 
addressed in future risk-benefit assessment studies. This section discusses the major challenges 
observed in present risk-benefit assessment of food studies.  
Concerning the differences in intake or exposure assessment of nutrients, chemical contaminants 
and pathogens, the exposure to pathogens is frequently modeled by describing a food pathway 
because pathogens can multiply, survive and be inactivated during food processing. On the other 
hand, in assessing the intake of nutrients and chemical contaminants the effect of food processing 
on the concentration of these components is often neglected.  
Most risk-benefit assessments of food and burden of foodborne studies, including the studies 
conducted in this PhD thesis, predict the health outcome only by comparing a limited number of 
hazardous and beneficial components of food. This is due to the demanding nature of all inclusive 
comprehensive quantitative risk-benefit assessment. 
When modeling the dose-response of nutrients, chemical contaminants and pathogens, different 
approaches are used. For instance, nutrients like vitamin D are usually modeled in terms of 
achieved serum concentration or intake and relative risks obtained from epidemiological studies. 
Using the serum concentration as a dose is expected to give a better prediction of probability of 
disease than the intake, because, clinically, the disease onset is more closely linked to the serum 
concentration than intake. Additionally, for nutrients or chemical contaminants that are modeled 
based on intake, the predicted probability of disease prevention or occurrence would be relatively 
uncertain due to, for example, not considering the bioavailability. Similarly, modeling of pathogens 
or their toxins by exposure would be uncertain due to not considering what happens after 
ingestion. Concerning chemical contaminants, from research ethics point of view, animal studies 
are often used to investigate the association of chemical contaminants with disease. To use the 
outcome of animal studies, further extrapolation is required to apply the results to human 
situation. At the other hand, dose-response models for microbial pathogens are usually based on 
human outbreak data or volunteer studies, because good animal models are lacking. These models 
describe the probability of infection or illness as a function of dose at intake.  Usually the health 
effects of pathogens due to food consumption are acute, whereas, the health effects of nutrients 
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and chemical contaminants are chronic. These differences make it difficult to compare the 
outcome of the assessment.  
The other challenge is integrating the risk and benefit using a common health metric to predict the 
net health impact of the positive and negative effects associated with consumption of food 
products or food components. Traditionally, the recommended and tolerable intake limits for 
nutritional and toxicological component of food have been used as a reference value. However, 
the application of these reference values results in a separate risk and benefit assessment and are 
not predictive of the health loss or health gain quantitatively. Currently, there is no internationally 
agreed robust model for integrating the health outcomes of beneficial and hazardous 
components; DALY or QALY is often considered a suitable common health metrics. However, there 
are still challenges when using common health metrics. For instance, it is under discussion 
whether or not DALY calculation should considers discounting, age weighting, social 
demographics, health economics, recurrent health effect and other disease complications 
(Robberstad, 2005; Sassi, 2006; Hart et al., 2013).  
One of the major challenges in performing integrated risk-benefit assessment of food and 
foodborne burden of disease studies is the unavailability of data, which leaves both the assessor 
and the recipient of the assessment uncertain about the interpretation of the final outcome. 
Experience shows that, when performing integrated health risk-benefit assessment of food, data 
scarcity can happen anywhere from exposure assessment to integrating the various health impacts 
of the different components of food. Usually, parameter values related to the use of common 
health metrics such as data on a disease linked to probability of recovery, survival, severity and 
duration are less commonly reported than incidence and mortality rate data.  
The genetic variation within the human population in relation to the impact of exposure to 
hazardous and beneficial components of food and prediction of the associated health effect is not 
considered in risk-benefit assessment of food.  Obtaining specific quantitative estimates of 
probability of disease occurrence and prevention for specific population groups in relation to 
genetic background and susceptibility is complex and challenging. There is currently no adequate 
quantitative data that support the quantification of health effect of hazardous and beneficial 
components of food linked to genetic variation of the population. However, the emerging “Omics” 
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research seem to be promising and may help to consider interspecies variability and susceptibility 
to disease in reaction to exposure to hazardous and intake of beneficial components of food.   
“Omics” is a suffix indicating “a totality of some sort”, which in biology is used for very large-scale 
data collection and analysis, i.e. measuring/profiling a large number of variables simultaneously” 
(Pielaat et al., 2013).  It allows to study the mode of action of compounds or to obtain more insight 
in processes involved in diseases (Dulin et al., 2013). The added value of “omics” studies to the 
current classical risk assessment of pathogens, chemical contaminants and some nutrients are 
suggested in Pielaat et al. (2013).  
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Chapter 10 
Conclusions and future perspectives 
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10. Conclusions and future perspectives 
 
This section presents the overall conclusions of the main studies conducted in this PhD thesis. In 
addition, providing the challenges in risk-benefit assessment of food methodologies (see section 
9.4), future perspectives that may improve the present risk-benefit assessment of foods are 
suggested.  
10.1 Conclusions  
This thesis aimed to further develop methods for health risk-benefit assessment of foods and food 
components. Three separate but related studies were conducted. The first study focuses on 
integrating microbial risk and nutritional benefits. The second study focuses on further 
development of methods for risk-benefit assessment of food, together with a study on vitamin D 
where a method for finding an optimum intake scenario is explored. The third study focuses on 
burden of disease study linked to red meat cooking practices. Based on these studies, it was 
concluded that:  
- In risk-benefit assessment of food, integrating microbial hazards may be important, 
because the healthy life years loss associated with pathogens could be substantial, 
especially when food is not properly processed, stored and handled.  
- When integrating microbial hazards into risk-benefit assessment of food, the specific major 
clinical syndromes that occur as sequelae of infection are more important than the generic 
endpoints, which are often used in QMRA. For instance, during infection by L. 
monocytogenes, cases of listeriosis are commonly used as an endpoint in QMRA. But, in an 
integrated risk-benefit assessment of food, the specific endpoints (in case of infection by 
listeria: septicemia, meningitis and abortion) should be considered as each specific 
endpoint has its own mortality, incidence, duration and severity.  
- Integrated risk-benefit assessment of food combines the health outcomes of nutrients, 
chemical contaminants and pathogens when relevant. By altering food processing 
parameters (to minimize hazards and maximize benefit) and scenario simulation, one can 
optimize the health outcome of consumption of food. Nevertheless, altering food 
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processing parameters should be balanced from the perceptive of harmonized health 
effects of nutrients, chemical contaminants and pathogens in holistic risk-benefit 
assessment of food. As a result, the net health impact would be optimized. 
- A comprehensive integrated quantitative risk-benefit assessment of food using common 
health metric helps to find the optimum scenario that provides maximum net health gains.    
- The burden of disease attributable to different aspects of food helps to rank and prioritize 
the major health loss in the population and supports to identify the potential mitigation 
strategy to prevent the health loss.   
- In the overall health impact evaluation of food, not only the reduction of health hazard and 
improvement of the health impact of beneficial components help to optimize the health 
effect, but also the choice of cooking practice substantially contributes for the 
achievement of maximum net health gain. 
- With regard to the choice of cooking practices, often it is the individual preferences to 
choose the cooking method by considering the associated risk and benefit. Nevertheless, 
food authorities consider priorities at population level. Thus, the individual and population 
level interpretation of the result of the assessment would help to make a better decision 
on the choice of cooking method 
The three studies performed in this thesis focus on three specific problems, combined they 
address the issue of health risk-benefit assessment of food or nutrients and burden of disease 
associated to cooking practices. To summarize, this PhD thesis 1) illustrates how a microbial 
hazard can be integrated into health risk-benefit assessment of food and indicates that improper 
storage of food could shift the balance of net health gain to net health loss. Thus, it suggests that 
optimizing food processing parameters (time, temperature, storage condition and other) together 
with several alternative scenario simulations may help to achieve best scenario that provides 
maximum health gain. 2) A method for finding the optimum scenario that provides maximum net 
health gain was developed, using vitamin D as an example. The method considers only several 
scenario simulations. The method seems the most effective approach to attain maximum net 
health gain with respect of nutrients risk-benefit assessment, especially for nutrients that are not 
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affected during food processing. For holistic risk-benefit assessment of food, food processing 
parameter optimization, addition of substances together with several scenario simulations can be 
considered to optimize the health effect of food consumption as discussed in section 9.2.1. 3) In 
order to show the health impact of food processing practices, burden of diseases estimates have 
been performed on a selected food item. The last study introduces new approach to estimate the 
burden of disease of food cooking practices, with an example on red meat. While we know that 
certain food processing practices induces the formation of hazardous compounds, their disease 
burden were not estimated. The last study estimates the burden of disease linked to red meat 
cooking practices and suggests that the choice of food cooking practice has a substantial impact in 
the prevention of health loss. The method applied in this study can be used as a basis for similar 
studies in the future.  
The three studies presented in this PhD thesis are performed on specific topics. Together, they 
indicate that risk-benefit assessment and burden of disease studies can make a substantial 
contribution to public health by considering food processing parameter optimization, several 
scenario simulations, the choice of cooking practice and comprehensive integrated quantitative 
health assessment of food. 
10.2 Future perspectives 
Despite the progressive improvements in method development in risk-benefit assessment of food 
during the last decade, there are still challenges that have to be addressed in the future. Section 
9.4 explicates the major challenges linked to the existing health risk-benefit assessment of food 
methods. This section remarks future perspectives that may help to further improve the existing 
health risk-benefit assessment of methods. To shift the theoretical study of health risk-benefit 
assessment of food to more tangible practical application, it is crucial to consider the following 
points: 
- Additional holistic risk-benefit assessment case studies that includes nutrients, chemical 
contaminants and pathogens (when relevant) need to be performed in the future. This 
would enable us to show the combined effect of food processing parameter optimization 
and multiple scenario simulations in maximizing the net health gain.  
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- As shown in PAPER 1, improper storage of CSS may lead to the shift of net health gain to 
net health loss due to the increased risk of the pathogen. This indicates that improper 
handling, processing and storage of food may have a major impact on the balance of the 
overall health outcome. Therefore, when relevant, future health risk-benefit assessment of 
food should consider integration of food processing into risk-benefit assessment of food.  
- In QMRA the effect of food processing on the concentration of pathogens is often taken 
into account during modeling the exposure assessment.  A similar approach may need to 
be considered to estimate the concentration of chemical contaminants and nutrients 
during intake assessment. This improves the accuracy of the estimate of the dose exposed.  
- It may be important to identify all the major associated hazardous and beneficial 
components in performing integrated risk-benefit assessment of food. In addition, it may 
be essential to identify all the associated specific health effects instead of generic health 
effects including recurrent disease, sequelae and any related complications during DALY 
calculation.  This enables to perform comprehensive integrated risk-benefit assessment of 
food and reduce the imprecision of net health impact estimation.  
- Although different approaches are used when modeling the dose-response relationship of 
pathogens, chemical contaminants and nutrients, it may be necessary to find a consistent 
modeling approach in the future.  For instance, when considering a fish product which 
possesses nutritional, chemical contaminants and microbial components; the health 
impact of vitamin D may be estimated as a function of the serum concentration, whereas 
the health impact of the chemical contaminants and pathogens are often estimated just 
from the intake and exposure. The negligence of factors that may affect the concentration 
after intake or exposure may lead to an error in the estimate of the probability of disease 
for the pathogens and chemical contaminants. Therefore, it may be relevant to take into 
account the factors that affect the concentration of the beneficial and hazardous 
components after intake or exposure.  
- Common health metric models to integrate the health risk and benefit of food 
consumption many need further development with regard to disease complication, 
recurrence and health economy integration.  
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- In order to perform more efficient health risk-benefit assessment of food, construction of a 
structured database that contains information about food, nutrient, chemical contaminant, 
pathogens and disease epidemiology is needed.  
- In order to consider individual genetic variations in response to exposure to nutrients, toxic 
chemicals and pathogens, the emerging nutrigenomics, toxicogenomics and 
pathogenomics data may need to be incorporated in future health risk-benefit assessment 
of food.  
- Moreover, consumer perceptions studies need to be performed with regard to the choice 
of food cooking practices and the associated perceived food quality benefits. This helps to 
weigh the health effect of the preferred cooking practices against the perceived food 
quality benefits (better texture, flavor, color, and aroma).   
- Furthermore, in the overall health impact evaluation of food, the presentation of the result 
of an assessment of health effects of the hazardous and beneficial components of food, as 
well as the health impact of choice of food cooking practice, may be insufficient for the 
recipients (food authorities and consumers). The associated food and nutritional quality 
aspects need to be included as well. This is because methods that can be applied to 
optimize the health effect of food or food components could have an important effect on 
the food and nutritional quality aspects, which eventually can have an effect on consumer 
perception. Therefore, future studies need to consider both food quality and food safety 
during the overall evaluation of food consumption.  
- The overall aim of evaluation of health impact of food is to improve public health, which 
requires extra costs to implement methods that make it possible to attain maximum net 
health gain. Contrary, if the methods implemented are able to attain maximum net health 
gain, the cost expenditure for the treatment of population health can reduce considerably. 
This implies that future study needs to consider economic cost-benefit analysis in health 
risk-benefit assessment of food.  
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